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Summary 
 
 
Imprinted genes show monoallelic parent-of-origin specific expression and have an 
important role in mediating adult behaviour. Previous research has indicated that 
maternally expressed Nesp and paternally expressed Grb10, which are expressed in 
overlapping brain regions, may have a role in mediating risk-taking and/or impulsive 
behaviours. 
 
Impulsivity and risk taking are natural parts of human behaviour; however pathological 
levels of impulsivity and risk-taking are recognised as clinical traits of many psychiatric 
disorders. The aim of the current research is to explicitly test whether these two oppositely 
imprinted genes influence impulsivity and/or risk-taking behaviour in mice by examining 
mouse models that lack functional copies of paternal Grb10 (Grb10+/p) and maternal Nesp 
(Nespm/+) in a number of tests of impulsivity and risk-taking. Unlike previous findings in 
Nespm/+ mice, Grb10+/p mice had the same propensity to explore a novel environment as 
wild type (WT) controls. However, in a measure of delay-discounting behaviour it was 
discovered that Grb10+/p mice were less likely to discount delayed rewards. This is in 
contrast to previous work with Nespm/+ mice, which discounted delayed rewards more 
steeply. This is the first demonstration that oppositely expressed imprinted genes 
antagonistically affect behaviour. 
 
To further explore these behaviours, a novel test of risk-taking was developed. Using 
predator odours a perceived ‘risky’ environment was created in order to measure the 
decision between fear and reward seeking. Using the Predator Odour Risk-Taking (PORT) 
task it was demonstrated that Nespm/+ and Grb10+/p mice showed comparable levels of risk-
taking behaviour to WT littermates. 
 
Finally, immunofluorescence was used to discover that Nesp55 and Grb10 are not only 
expressed in the same brain regions, but are co-expressed in some cells, particularly in 
serotonergic neurons. This suggests that these imprinted genes may be influencing delay 
discounting behaviour via the same integral neurotransmitter systems.  
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Chapter 1 – General Introduction 
 
 
1.1 Introduction 
 
 
Genomic imprinting is an interesting phenomenon in which epigenetic marking of a 
particular subset of genes results in monoallelic expression, in a parent-of-origin manner. 
These genes are not only interesting on a molecular level, but also on a systems level, 
whereby there is increasing evidence to suggest that they have an important role on not just 
development and growth, but adult behaviour too. This leads to intriguing possibilities 
about the neural mechanisms of imprinted genes and the behaviours that they regulate. 
Two examples of imprinted genes are Nesp and Grb10, which are of particular interest due 
to their striking over-lapping expression in discrete regions of the brain (Plagge et al., 2005, 
Garfield et al., 2011), which in turn may represent ‘hot-spots’ of imprinted gene expression 
(Gregg et al., 2010). Nesp and Grb10 are oppositely imprinted within the brain, whereby 
Nesp is expressed from the maternal allele (Plagge et al., 2005); and Grb10 from the 
paternal allele (Garfield et al., 2011). This expression pattern raises the question as to what 
role these two genes have in the adult brain, and also raises the hypothesis that these genes 
may be acting on the same behaviours, possibly antagonistically. This thesis will primarily 
focus on the functional studies examining whether these two imprinted genes have 
analogous or antagonistic roles in mediating adult behaviour, specifically in relation to 
impulsivity and risk-taking.  
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1.2 Imprinted genes 
 
 
1.2.1 Introduction to imprinted genes 
Imprinted genes represent a unique subset of mammalian genes which, despite 
having both maternal and paternal alleles present in the genome, are expressed from one 
parental allele only. Imprinting is a developmentally determined process, established during 
gametogenesis, whereby one parental allele is epigenetically marked, resulting in 
monoallelic expression (Wilkinson et al., 2007). Selection of which parental allele is 
expressed is also determined during development, and results in some imprinted genes 
being only maternally expressed (e.g. Nesp, Cdkn1c) whilst others are paternally expressed 
(e.g. Peg3, Igf2). This process occurs in a parent-of-origin manner, whereby the inherited 
gene maintains a molecular memory (or mark) of its parent-of-origin, resulting in differential 
transcription of that gene (Figure 1.1). These marks are created through epigenetic 
processes (commonly DNA-methylation) which regulate the expression of imprinted genes 
(Holmes and Soloway, 2006). This epigenetic mark is preserved throughout the somatic cells 
of the progeny; however these marks are erased in the germ cells of the developing embryo 
and subsequently re-set according to the sex of the developing individual (Delaval, 2004), 
therefore maintaining the imprint in a parent-of-origin fashion (Figure 1.1). Therefore 
parental genomes exhibit an epigenetic asymmetry at fertilization, which give rise to 
functional differences between parental genomes during development, differences which 
are maintained throughout life (Surani, 2001).  
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Figure 1.1 Simple schematic showing the process of genomic imprinting. Parent-of-origin monoallelic 
expression occurs through marking of either the male or female allele (represented by green lollipops), which 
occurs through epigenetic mechanisms such as DNA methylation and histone modification. The epigenetic 
mark established during embryogenesis results in differential transcription, resulting in predominant 
expression from one parental allele only. The epigenetic marks are then reset during egg and sperm formation. 
This inherited set of marks is maintained in the somatic cell lineages of the offspring, but in their germ cells the 
cycle of imprinting repeats, with erasure and re-initiation of the imprint. Therefore in the sperm, whether the 
gene is inherited maternally or paternally, all imprints are erased and re-written with the paternal pattern of 
imprinting; likewise in the egg, all imprints are erased and re-written with the maternal imprint. Consequently 
inheritance of imprinted traits is non-Mendelian, and is instead characterized by passage down one parental 
line. Image adapted from Wilkinson et al. 2007. 
 
 
1.2.2 Epigenetic regulation of imprinted genes 
 
Imprinted genes generally occur in clusters (Figure 1.2) within the genome, 
containing two or more imprinted genes (Bartolomei et al., 2011). Imprinting is an 
epigenetic process, such that regulation is achieved without altering the nucleotide 
sequence. The principle epigenetic mechanism for the establishment of imprinting and 
monoallelic expression at imprinted gene clusters is the parental specific DNA methylation 
of DMRs (differentially methylated regions) (Constancia et al., 1998). This occurs through 
the addition of methyl groups to the cytosine nucleotides of CpG islands. (Delaval and Feil, 
2004). CpG islands represent areas of the genome that have an elevated G+C base 
composition compared to the CpG poor landscape of the rest of the genome (Deaton and 
Bird, 2011). DMRs can be germline (methylation acquired during oogenesis or 
spermatogenesis) or somatic (methylation acquired after fertilisation) (John and Lefebvre, 
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2011). Somatic DMRs can also be tissue specific, in turn leading to tissue specific monoallelic 
expression, as occurs for some imprinted genes. Germline DMRs are essential for the 
establishment of somatic DMRs, and ultimately for all imprinted gene regulation (John and 
Lefebvre, 2011). Consequently some are known as ‘imprinting control regions’ (ICRs) or 
‘imprinting centres’ (ICs).  However, it is now known that the methylation of DMRs in the 
germline is more widespread and not specific to imprinted loci alone (Smallwood et al., 
2011). Germline DMRs are maintained by de novo methyl-transferases (DNMTs), which 
methylate the CpG sequence (Bartolomei and Ferguson-Smith, 2011). Specifically DNMT1 
targets newly synthesized complementary strands containing CpG regions for methylation, 
which enables germline DMRs to be maintained throughout embryogenesis. This is now 
thought to be the default marking process, with methylation at DMRs associated with 
imprinted genes is protected from the genome-wide wave of de-methylation that takes 
place early during embryogenesis (Kelsey and Feil, 2013). These initial DNA-methylation 
imprints are subsequently built upon with other modifications in order to preserve the 
imprinting status. This occurs through a combination of non-coding RNA, additional DNA 
methylation, changes in histone modifications and higher chromatin structure (Abramowitz 
and Bartolomei, 2012). This process allows the parental imprints to be relatively stable and 
robustly maintained.  
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Figure 1.2 Schematic showing the Gnas locus of the mouse and exon usage of cluster of imprinted genes. The 
maternal aspects of the locus are depicted by purple features, the paternal aspects by blue. Protein-coding 
exons are indicated by filled rectangles and non-protein-coding exons are indicated by open rectangles. 
Methylation regions are indicated by pink and blue zigzags above and below the locus. Gnas ex1 is maternally 
expressed in some tissues but shows biallelic expression in others. Gnasxl encodes an NH2-terminal variant of 
Gsα (XLαs) and a neural-specific, truncated protein (XLN1). A single upstream Nesp exon contains the Nesp55 
ORF. Image adapted from Dent and Isles 2013.  
 
 
1.2.3 Functional Importance of imprinted genes 
 
The functional importance of imprinted genes was first discovered during the 
seminal work of two laboratories, McGrath and Solter (1984) and Surani et al. (1984), who 
were the first to find evidence for the requirement of both the maternal and paternal 
genomes for normal development. During this research, Surani et al. (1984) used embryos 
created from oocytes to which the pronucleus of either another oocyte (therefore diploid 
for maternal genome only) or a sperm was added. They found that the oocytes which 
received a male pronucleus developed to term but those with two female pronuclei 
developed poorly after implantation (Surani et al., 1984); therefore demonstrating that 
maternal and paternal genomes were not functionally equivalent. It was concluded from 
this work that during gametogenesis some genes are imprinted with an indication (or mark) 
of the gamete in which the genes came from. Furthermore observations from work by 
Gsα 
Gsα 
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McGrath and Solter (1984), indicated that whilst neither gynogenetic nor parthenogenetic 
(diploid for maternal genome only) nor androgenic (diploid for paternal genome only) 
embryos were viable, prominent differences in the development of these embryos 
occurred. Notably that androgenetic embryos showed increased extra-embryonic tissue and 
foetal growth, whilst parthenogenetic embryos showed decreased extra-embryonic tissue 
and foetal growth (McGrath and Solter, 1984). This significant finding provided the first 
evidence that maternal and paternal genomes could differentially regulate gene expression, 
and subsequently influence cellular function in different ways.   
Following the early embryonic work, came the identification of the first paternally 
expressed (Igf2) and maternally expressed (Igf2r, H19) genes in the mouse (Barlow et al., 
1991, Bartolomei et al., 1991, DeChiara et al., 1991). To date there are approximately 150 
imprinted genes identified in the mouse 
(http://www.mousebook.org/catalog.php?catalog=imprinting) with a similar number in 
humans (Moore and Oakey, 2011). However a recent genome-wide analysis of the 
embryonic and adult mouse brain revealed more than 1300 potential loci for imprinting 
(Gregg et al., 2010). However the experimental validity of this study has been subject to 
criticism, suggesting that only a fraction (approximately 50) of these loci represent novel 
putative imprinted genes (DeVeale et al., 2012). 
Although only a handful of imprinted genes have been fully functionally 
characterised, with particular reference to their potential effect in the brain, it is clear that 
imprinted genes influence some key physiologies. The most well studied of these is the role 
of imprinted genes on in utero growth, placental function and nutrient transfer from mother 
to offspring (Charalambous et al., 2007, Gutierrez-Marcos et al., 2012). Furthermore it is 
becoming increasingly apparent that imprinted genes are also important for post-natal 
functions, such as suckling (Plagge et al., 2004), energy homeostasis (Smith et al., 2006) and, 
the focus of this thesis, adult behaviour. 
 
1.2.3.1 In utero growth 
The importance of imprinted genes on in utero development has been well 
established (Charalambous et al., 2007, Tunster et al., 2013). Based on the profound effects 
on extra-embryonic tissue found in the early embryonic work in mice, and the fact that the 
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majority of the imprinted genes are expressed in the placenta, highlights their importance 
for in utero growth. The two most prominent developmental functions imprinted genes 
have are nutrient transport and placental signalling (Tunster et al., 2013); both of which are 
key to the direct and indirect regulation of birth weight. The first imprinted genes to be 
identified (Igf2, Igf2r, H19) were all shown to play a critical role in embryonic development. 
Specifically Igf2, which has four main transcripts (P0, P1, P2, P3) expressed in the foetus and 
the placenta during development, has been shown to play a central role in the placental 
nutrient supply to the foetal nutrient demands for growth (Reik et al., 2003). Importantly 
mouse imprinting knock-out studies have shown that deletions of paternally expressed Igf2, 
Ins1/Ins2, Peg1, or Peg3 genes result in intrauterine growth restriction (DeChiara et al., 
1991, Duvillie et al., 1997, Lefebvre et al., 1998, Li et al., 1999). Conversely deletion of the 
maternally expressed Igf2r or H19 genes, or over-expression of the Igf2 gene, results in 
foetal overgrowth (DeChiara et al., 1991).  Similarly, a double dose (two copies) of the 
paternally expressed imprinted gene Dlk1 results in a growth enhanced foetus even when 
the placenta expressed normal levels of the gene (da Rocha et al., 2009). Furthermore mice 
deficient for the maternally expressed imprinted gene Cdkn1c, were found to have an initial 
20% increase in weight during early gestation but experienced a rapid reversal of this over-
growth phenotype in late gestation, resulting in newborn pups of normal weight (Tunster et 
al., 2011). This highlighted the role of imprinted genes in the allocation of the maternal 
resources via the placenta. 
The effect of in utero growth is not limited to the effects of paternally expressed 
genes; maternally expressed genes have also been shown to effect placental growth. It was 
shown that a single extra dose of the imprinted gene Phlda2 caused a dramatically altered 
placental structure leading to the restriction of embryonic growth (Tunster et al., 2010). 
Moreover mice that were null for Phlda2 and the maternally expressed imprinted gene 
p57Kip2 resulted in increased placental size (Takahashi et al., 2000, Frank et al., 2002). 
Taken together this is indicative that a significant role of imprinted genes is to control 
nutrient supply via the placenta (Isles and Holland, 2005). 
In recent research it has also been found that alterations in the normal expression 
pattern of the imprinted gene Igf2, known for its role in in utero development, can also 
influence anxiety in adulthood (Mikaelsson et al., 2013). Mutant mice null for the placenta 
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specific transcript (P0) of Igf2, which has been hypothesized to cause an imbalance between 
foetal demand and placental supply of nutrients, demonstrated increased anxiety in later 
life, suggesting a role for imprinted genes in the long term programming of emotional 
behaviour, via altered placental mechanisms (Mikaelsson et al., 2013).  
 
1.2.3.2 Energy homeostasis and adaption to post-natal life 
There is increasing evidence to show that imprinted genes do not just affect the 
nutritional resources of offspring in utero but also after birth via direct or indirect postnatal 
functions. Research has identified that imprinted genes demonstrate a role in prenatal 
growth, appetite, fat and lean mass deposition, metabolic function, energy homeostasis and 
insulin sensitivity/ production (Charalambous et al., 2007). For example the two reciprocally 
imprinted genes, Gnas (maternally expressed) and Gnasxl (paternally expressed) code for 
the proteins Gsα and XLαs, respectively, and have been found to have an antagonistic role 
upon glucose metabolism and energy expenditure (Charalambous et al., 2007). Gsα 
haploinsufficiency causes a reduced sensitivity to insulin which results in obesity and 
diabetes (Chen et al., 2005). In contrast, XLαs normally acts to reduce signalling to insulin-
responsive tissues, and mutant mice null for paternal Gnasxl showed impaired regulation of 
energy homeostasis, and were lean showing hypermetabolism and severely reduced 
suckling ability (Plagge et al., 2004, Xie et al., 2006).  
The imprinted gene Peg3 known for its role in mediating maternal behaviour, also 
has an effect on neonatal growth; mutant offspring null for paternally inherited Peg3 display 
reduced infant growth, delays in weaning and the onset of puberty (Curley et al., 2004). 
Furthermore recent research has highlighted the importance of imprinted gene dosage in 
regulating neonatal body temperature for survival. A mutation in the imprinted gene cluster 
on mouse chromosome 12, resulting in a triple dose of the imprinted gene Dlk1, caused 
postnatal lethality, highlighting that control of gene dosage at imprinted loci is essential for 
the successful transition into independent life (Charalambous et al., 2012). Taken together 
these findings demonstrate that imprinted genes have a crucial role in the postnatal control 
of nutritional resources through the central control of energy homeostasis (Bartolomei and 
Ferguson-Smith, 2011).  
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1.2.4 Evolution of imprinted genes 
 
Imprinted genes offer an interesting and unresolved evolutionary conundrum, 
whereby they negate the benefits of diploidy, yet appear to be necessary for normal 
development (Fowden et al., 2006). Therefore a number of theories have been proposed 
relating to how and why imprinting may have evolved (Haig, 2000, Wolf and Hager, 2006). 
Although most research on imprinting has focused on understanding the epigenetic 
mechanisms of imprinted genes (Ferguson-Smith, 2011), some researchers have attempted 
to address these ideas by focusing not on the epigenetic mechanisms, but the specific 
functions of imprinted genes. The effects that imprinted genes have on adult behaviour 
have prompted the idea that genomic imprinting may be evolutionarily adaptive, with one 
theory being that this class of genes has arisen in order to coordinate the co-adaptation of 
viviparity and maternal care in mammals (Keverne and Curley, 2008). One theory known as 
the ‘placenta hypothesis’ (Kaneko-Ishino et al., 2003) suggests that viviparity is the driving 
force for genomic imprinting in placental mammals, due to the fact that imprinted genes are 
found in eutherians (placental mammals) and in marsupials, which have a rudimentary 
placenta, but are absent in monotreme (egg-laying) mammals and birds (Kaneko-Ishino et 
al., 2003). The emergence of imprinted genes in placental animals has also been explained 
by the dynamics of retroviruses in the placenta (Haig, 2012). This highlights that genomic 
imprinting shares many of the same processes as the suppression of foreign DNA (e.g. 
retroviruses), such that DNA methylation both inactivates ‘foreign’ DNA and controls 
imprinted gene expression. It is therefore hypothesized that the ancestral function of DNA 
methylation is ‘host defence’ and that the reason imprinted genes contain sequences that 
are subject to methylation is because they look like foreign DNA (Barlow, 1993). This 
concept therefore argues that DNA methylation is a defence mechanism and therefore that 
genomic imprinting is an incidental side-effect for genes that happen to look ‘foreign’ (Haig, 
2012). 
A more widely accepted hypothesis comes from another theory of imprinted gene 
evolution, namely the intra-genomic conflict or kinship hypothesis (Haig, 2000). The basic 
concept here is that parental alleles act to promote their own interests and in some 
circumstances this leads to antagonistic action between maternal and paternal alleles. It is 
proposed that paternally expressed genes maximise the father’s reproductive success 
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through promoting embryonic and early post-natal growth by extracting nutritional 
resources from mother. Maternally expressed genes, in contrast, are thought to resist 
maternal resources being exhausted on a single pregnancy and ensure some reserves are 
withheld for subsequent pregnancies and future offspring (Keverne and Curley, 2008). 
Accordingly, paternally expressed imprinted genes tend to be growth promoting whereas 
maternally expressed imprinted genes tend to be growth limiting (Haig and Graham, 1991). 
One such circumstance where this intra-genomic conflict is illustrated at a physiological level 
is by the oppositely imprinted genes Igf2 and Igf2r. The insulin-like growth factor type 2 
gene (Igf2) is paternally expressed and is a critical foetal growth factor, whereas the 
maternally expressed Igf2 receptor gene (Igf2r) binds to Igf2 and targets it for degradation, 
therefore suppressing foetal growth (Haig and Graham, 1991). A similar asymmetry of 
relatedness arises within a social group when there is sex‑biased dispersal (Haig, 2000), and 
provides a route by which intragenomic conflict could influence behaviour, with a 
particularly impact upon social behaviour (Isles et al., 2006). 
The importance of many imprinted genes, such as Igf2, Peg1 and Peg3  in placental 
function and in utero growth, has also led to the suggestion that imprinted genes may have 
arisen as a mechanism to facilitate the co-adaptation of two important mammalian 
features, viviparity (Wolf and Hager, 2006) and maternal care (Curley et al., 2004). The co-
adaption theory postulates that instead of conflict, maternal–offspring interactions may 
reflect a co-adaptive integration of the maternal and offspring genomes; therefore 
developing traits that positively affect offspring development and fitness. Genomic 
imprinting with maternal expression is therefore most likely to evolve when selection favors 
co-adapted maternal and offspring traits, for example during mammalian development in 
utero (Wolf and Hager, 2006). This hypothesis therefore offers a rationale for the high 
expression of imprinted genes in the placenta. Furthermore the co-adaption theory offers a 
potential explanation for the preferential maternal contribution to gene expression as 
suggested by the recent genome-wide analysis of the murine brain (Gregg et al., 2010). 
Whilst the kinship and co-adaption hypotheses are appealing, both have their 
limitations and exceptions. For instance, the role of Peg1 and Peg3 in maternal care (Úbeda 
and Gardner, 2011) cannot be explained by the kinship hypothesis. Furthermore the 
maternal-offspring co-adaption theory does not easily explain the role of those imprinted 
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genes not expressed in the placenta and/or having a role in maternal provisioning and/or 
care, but which show strong expression and are imprinted in the brain. Of those well-
characterized imprinted genes (showing an epigenetic mechanism and parent-of-origin 
specific expression - http://www.mousebook.org/catalog.php?catalog=imprinting) approximately 40% 
are brain expressed in mice, with prominent examples including Ube3a (Rougeulle et al., 
1997), LRRMT1 (Francks et al., 2007) and Inpp5f_v2 & Inpp5f_v3 (Choi et al., 2005).  
 
 
1.2.5 Imprinted genes and the brain 
 
Imprinted genes play a role in a number of key functions and are expressed in 
various tissues throughout the body. Nevertheless, imprinted gene expression is particularly 
prominent in the placenta (Gutierrez-Marcos et al., 2012) and the central nervous system 
(Davies et al., 2005). Imprinted genes have an established role in the placenta in controlling 
in utero development in mammals (Tunster et al., 2013); however a number of imprinted 
genes are expressed in the brain into adulthood, pointing towards a role in the control of 
functions beyond early development.  
 
1.2.5.1 Early Chimera work 
Chimeras provide a useful laboratory method to study the differential effect of the 
paternal and maternal genome on development. Early work utilising mouse chimeras 
provided the first clue that imprinting plays a significant role in brain development (Barton 
et al., 1991, Keverne, 1997). Embryos constructed from a combination of normal cells with 
parthenogenetic (Pg)/gynogenetic (Gg) and androgenetic (Ag) cells were viable, but required 
less than 50% of the embryo to be chimeric to survive (Keverne et al., 1996). Using cells 
which expressed the marker LacZ, allowing the distribution of these cells to be followed, it 
was found that the contribution of Pg/Gg and Ag cells to brain development was dimorphic 
(Keverne et al., 1996). Whereby Ag and Gg contribution resulted in differences in brain size, 
specifically Ag chimaeras had smaller brains, whereas Pg/Gg chimeras had larger brains. As 
well as overall brain volume, the Pg/Gg and Ag cells were located reciprocally within the 
adult brain. Although initially distributed throughout the developing brain, Pg/Gg and Ag 
cells were selectively ‘lost’ from certain regions; leading to consistent populations in distinct 
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brain regions. Specifically, Ag cells contributed substantially to the hypothalamic structures 
and not the cortex (Keverne et al., 1996). Conversely, Pg/Gg cells contributed substantially 
to the cortex, striatum and hippocampus but not to the hypothalamic structures (Keverne et 
al., 1996). The strikingly contrasting contributions of maternal and paternal cells to 
telencephalic and diencephalic structures respectively, led the researchers to propose that 
cells may have functional differences in the brain according to their parent of origin 
(Keverne, 1997).  
 
1.2.5.2 ‘Maps’ of genomic imprinting 
The seminal findings of Keverne et al. (1996) were the first to uncover the patterns 
of imprinted gene expression in the brain. The discovery that maternal and paternal 
genomes have dissociable expression in distinct brain systems has been subsequently 
interpreted to explain the functional differences of the maternal and paternal genomes 
(Wilkinson et al., 2007). Specifically that the maternal interests are mediated by 'higher' 
cognitive systems, whereas the paternal interests are mediated by effects on brain systems 
that operate 'emotional' or 'autonomic' functions (Wilkinson et al., 2007). However without 
a full understanding of the developmental profiles of all brain-expressed imprinted genes, it 
is difficult to draw such conclusions and as a result no organisational ‘maps’ of imprinting 
have emerged. However, a recent genome-wide analysis of parent-of-origin allelic 
expression illustrated that there are many distinct regions of the brain in which putative 
imprinted genes are expressed (Gregg et al., 2010). Specifically, 26 out of 118 brain regions 
were identified as ‘hotspots’ for genes showing a parent-of-origin bias in expression (Gregg 
et al., 2010). These include the arcuate nucleus, dorsal raphe nucleus, substantia nigra pars 
compacta, ventral tegmental area, dorsal hypothalamic area, locus ceruleus, and nucleus 
accumbens. Whereas the expression hotspots of 20 randomly selected control genes with 
biallelic expression were located predominantly in cortical and olfactory regions and 
appeared entirely distinct from that of imprinted genes (Gregg et al., 2010). However, it is 
important to recognise that the genes identified in this study  were done so on the basis of a 
bias in parental allele expression, and do not have a robust associated imprinting mark (i.e. 
DMR) (Xie et al., 2012). Nevertheless this has made an important contribution to the 
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existing knowledge of areas of the brain that may be mediated by genomic imprinting. This 
may shed further light on the functions and behaviours that imprinted genes control. 
 
 
1.2.6 Imprinted genes and behaviour 
 
The use of mouse models has facilitated the understanding of the role that 
imprinted genes have on brain and behaviour. Early behavioural experiments using 
chimeras were the first to discover a role for imprinted genes on behaviour. Behavioural 
experiments revealed that mouse chimeras high in Pg cells were more aggressive (Allen et 
al., 1995). Given the importance of olfactory cues in animal aggression, the authors 
concluded this was as a result of the high levels of Pg cells found in the olfactory bulb. Since 
this finding there has been further evidence of imprinted genes in mediating olfaction (Isles 
et al., 2001, Swaney et al., 2007). Moreover, the discovery that Pg cells make a substantial 
contribution to the hypothalamus; a structure important for autonomic maintenance of 
homeostasis, means the paternal genome is likely to exert significant control over important 
behaviours such as feeding, sex, emotional and maternal behaviour (Goos and Silverman, 
2001). As well as chimeras, another way of investigating the role of genomic imprinting on 
behaviour is through targeted gene deletion. An increasing number of behavioural analyses 
have been performed on various imprinted gene knockout mice. As a result of this, there is 
evidence that a diverse array of behaviours appear to be influenced by imprinted genes, 
such as aspects of cognition, emotion and, most extensively, maternal care and mother-
infant interactions.  
 
1.2.6.1 Maternal behaviour 
The role of imprinted genes in maternal behaviour has been well documented in 
studies using laboratory animals. The first example of these is the role of the paternally 
expressed imprinted genes Peg1 and Peg3, which have been shown to have a role in 
nurturing (Keverne, 2001). Mice null for the paternal allele of Peg1 demonstrated impaired 
maternal behaviour including reduced pup-retrieval, nest-building and placentophagia 
(Lefebvre et al., 1998). This effect has also been observed in mice null for the paternal allele 
of Peg3, where reduced maternal behaviour often resulted in death of the offspring (Li et 
al., 1999). Similarly, it was found that mutant mothers null for the paternal allele of Peg3 
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have impaired maternal reproductive success through reduced maternal care, reduced 
maternal food intake during pregnancy, and reduced milk let-down (Curley et al., 2004). As 
well as impairments in maternal behaviours, imprinted genes are also critical for mediating 
maternal effects on offspring development, such as postpartum licking and grooming 
(Champagne et al., 2009). It is therefore increasingly evident that one area in which 
imprinted genes play an important role is the interaction between mother and offspring in 
early postnatal life. 
 
1.2.6.2 Cognition 
Exploration of the role of imprinted genes on cognition has been varied, due to the 
involvement of imprinted genes in syndromes with cognitive deficits. Clinical research 
carried out in the context of abnormal human conditions such as the X-linked imprinting 
disorder Turner’s Syndrome (TS) has demonstrated the involvement of imprinted genes in 
numerous cognitive functions (Isles and Wilkinson, 2000). These functions include 
behavioural inhibition (specifically the ability to withhold a prepotent response) and 
behavioural flexibility (Skuse et al., 1997), mental rotation and long-term memory (Bishop et 
al., 2000); as well as social cognition and visual-perceptual reasoning (Lepage et al., 2012). 
Strong evidence that imprinted genes affect cognition has also come from studies of Autism 
spectrum disorder (ASD). ASD, associated with impairments in social interactions and 
communication, and repetitive and stereotyped behaviour, is highly heritable (Badcock and 
Crespi, 2006). Genetic linkage studies have identified several genes associated with ASD, a 
proportion of which are imprinted. Which provides evidence for the notion that genomic 
imprinting causes a diversity in cognition and manifests as ASD (Badcock and Crespi, 2006).  
Preclinical research utilising mice with knock-outs of certain imprinted genes, 
particularly relating to Prader-Willi Syndrome (PWS), have led to the finding that a spectrum 
of cognitive functions are influenced by genomic imprinting. These include aspects of 
learning and memory, for example research using mice deficient for the imprinted gene 
Necdin showed improvement in particular cognitive functions associated with spatial 
learning and memory capability (Muscatelli et al., 2000). Furthermore, mice with a deletion 
of the PWS imprinting centre, showed impaired attentional function in the 5-choice serial 
reaction time task (5-CSRTT) (Relkovic et al., 2010). Therefore through the study of a 
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number of disorders, it is becoming increasingly clear that imprinted genes may also 
contribute to cognitive function.  
 
1.2.6.4 Neurobehavioral disorders 
There is a growing association of imprinted genes with neurological disorders and 
psychiatric illness. Such as the association of the imprinted region 15q11-q13 with the 
disorders PWS and Angelman Syndrome (AS) (Cassidy et al., 2000). PWS is a 
neurodevelopmental disorder characterized by an insatiable appetite, dysmorphic features, 
behavioural difficulties, and mild learning disabilities (Goldstone, 2004). AS is a neurogenetic 
disorder which results in severe intellectual and developmental disturbances, seizures and 
ataxia (Cassidy and Schwartz, 1998). Both PWS and AS are disorders of impaired imprinting, 
that result from the absence or lack of expression of one parental allele of the same region 
of chromosome 15q. This usually occurs through de novo microdeletion of the 15q11-q13 
region from either the paternal or maternal allele (Cassidy et al., 2000). Absence of 
expression from the paternal allele results in PWS, whilst absence of expression from the 
maternal allele results in AS; manifesting in two distinct forms of cognitive impairment.  
Furthermore altered dosage of imprinted genes is associated with abnormal brain 
function and neuropsychiatric illness (McNamara and Isles, 2013). Abnormalities in the 
regulation of the 15q11–q13 imprinting region have been shown to manifest in not just 
neurodevelopmental disorders such as PWS and AS, but increased incidences of psychosis 
(Ingason et al., 2011a) and autism (Hogart et al., 2009). Specifically an increased dosage of 
the maternally derived allele of 15q11–q13 results in increased susceptibility to autism. ASD 
has also been associated with the dysregulation of the imprinted gene Ube3a (Glessner et 
al.), as well as pre-clinical research demonstrating that mouse models carrying a ‘double 
dose’ (two copies) of Ube3Aa results in symptoms typical of psychosis and schizophrenia 
(Craddock and Owen, 2010). Although less well characterised, parent specific transmission 
and, by implication, genomic imprinting, has been shown to affect the inheritance of certain 
disorders such as epilepsy, Tourette’s syndrome and bipolar disorder (Goos and Silverman, 
2001). For example women with bipolar disorder are more likely to have children with the 
condition than are men with the disorder (Keverne, 1997). From the growing repertoire of 
evidence, it is becoming increasingly clear that imprinted genes are not just important for 
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the regulation of embryonic development and growth, but are also responsible for multiple 
human diseases and disorders.  
 
1.2.6.3 Emotional behaviour 
 The role of imprinted genes on emotional behaviour has been less well studied. 
However the high presence of paternal imprinted gene expressing cells in the hypothalamus 
has suggested an involvement of the paternal genome in emotional behavior (Goos and 
Silverman, 2001). Research into the role of genomic imprinting in emotional behavior has 
focused on maternal behavior and neurogenetic disorders where abnormal emotion is a 
symptom, for example AS and PWS (Cassidy and Schwartz 1998). In addition to being 
associated with neurological and motor impairments, AS is also associated with excessive 
laughter and smiling (Cassidy and Schwartz, 1998, Cassidy et al., 2000). Furthermore, as well 
as physical and cognitive symptoms, individuals with PWS also show increased negative 
affect signals such as stubbornness and temper tantrums (Goldstone, 2004). Although these 
disorders are distinct, they are both caused by genetic anomalies involving a cluster of 
imprinted genes on chromosome 15. Therefore through clinical data from 
neurodevelopmental disorders, it has been shown that imprinted genes have a role in the 
regulation of emotion. Moreover it has been found that imprinted genes influence 
emotional attachment between a mother and offspring, via the control of positive affect 
signaling (Isles and Holland, 2005). More specifically, maternally expressed genes such as 
UBE3A and ATP10C normally act to limit the amount of positive affect signals (Isles and 
Holland, 2005).  
 
 
1.2.7 Nesp 
  
The Nesp transcript is expressed exclusively from the maternal allele, and encodes 
Neuroendocrine secretory protein 55 (Nesp55), which consists of 244 amino acids 
(Bartolomucci et al., 2011). Nesp is part of the complex imprinted GNAS gene locus on 
human chromosome 20q13.2 and mouse chromosome 2 (Figure 1.2), which encodes the α-
subunit of the stimulatory G-protein Gsα (Bartolomucci et al., 2011). The biochemical 
function of Nesp55 is only partially understood but it appears to be related to fast 
anterograde axonal transport in the peripheral nervous system and represents a novel 
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peptidergic marker for a large constitutively secreting vesicle pool (Fischer‐Colbrie et al., 
2002). However, it is unknown whether Nesp55 influences the transport or release of 
neurotransmitter vesicles (Plagge et al. 2005). The protein can also undergo proteolytic 
processing resulting in the release of a carboxy-terminal octapeptide, although this process 
is limited in the brain (Lovisetti-Scamihorn et al., 1999). Previously generated mouse models 
have revealed an essential role of the Gnas imprinting cluster in postnatal viability, growth, 
and the regulation of energy homeostasis (Plagge et al., 2004), although Nesp55 itself does 
not appear to contribute to these functions (Plagge et al. 2005). 
The monoallelic expression of Nesp occurs as a result of complex imprinting at the 
Gnas locus. There is a somatic DMR spanning the promoter of Nesp55, this region is 
unmethylated in early embrogenesis but by embryonic (E) 10.5 it has acquired paternal 
promoter-specific differential methylation (John and Lefebvre, 2011). Therefore gametic 
methylation must occur to spare the Nesp-DMR of the maternal allele from somatic 
methylation. This suggests that either methylation occurs by default when Nesp55 is not 
expressed, or alternatively the Nesp antisense transcript may actively induce DNA 
methylation of the Nesp-DMR, therefore silencing the Nesp55 promoter (John and Lefebvre, 
2011).  
 
1.2.7.2 Expression of Nesp55 in the brain 
Nesp55 is expressed in endocrine and brain tissues, being neuronal specific 
(Fischer‐Colbrie et al., 2002). The expression of Nesp within the rodent brain is discrete, with 
a high-level of expression in the hypothalamus, pons and midbrain regions, specifically in 
the dorsal raphe nucleus (DRN), locus coeruleus (LC) and Edinger-Westphal nucleus (EWn) 
(Figure 1.3) (Bauer et al., 1999). The presence of Nesp expression in these brain structures, 
plus its potential role in vesicle formation and/or recycling, suggests a possible involvement 
in noradrenaline (NA) and serotonin (5-HT) release. No differences in total tissue levels of 5-
HT or NA has been detected in Nesp55 deficient mice (Bauer et al., 1999, Plagge et al., 
2005), but as yet no direct measurement of neurotransmitter release has been made. 
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Figure 1.3 Expression of Nesp55 in coronal sections of the adult mouse brain. Research utilising in situ 
hybridisation found high levels of expression in the locus coeruleus (LC) the dorsal raphe nucleus (DR), the 
periaqueductal gray (PAG) and the Edinger-Westphal nucleus (EW). Furthermore high expression levels were 
found in the hypothalamus, specifically: posterior hypothalamic area (PH); dorsal tuberomammillary nucleus 
(DTM); dorsomedial hypothalamic nucleus (DM); arcuate hypothalamic nucleus (Arc); lateral hypothalamic 
area (LH), zona incerta (ZI), suprachiasmatic nucleus (SCh), subparaventricular zone of the hypothalamus (SPa) 
Image taken from Plagge et al. 2005. 
 
1.2.7.3 Behavioural role of Nesp 
Although there were no gross alterations in general physiology, previous research 
utilising adult mice with a deletion of Nesp55 (Nespm/+) revealed an influence of this gene on 
exploratory behaviour (Plagge et al. 2005). This aspect of behaviour was assessed using two 
separate behavioural tasks of activity; locomotor activity (LMA) and the open field (Plagge et 
al. 2005). Nespm/+ mice were shown to have an increased reactivity to a novel environment 
relative to control mice. Specifically Nespm/+ showed heightened activity on the first day of 
LMA testing, and increased activity (quadrant crossings) over the duration of the 10-min 
open field test, which has been interpreted as altered reaction to novelty (Plagge et al. 
2005). In an additional explicit test of novelty investigation, the Novelty Place Preference 
task (NPP), results indicated that although Nespm/+ animals showed increased excitement 
toward the novel environment (making more entries), when given the choice between a 
familiar and a novel environment, Nespm/+ mice spent significantly more time in the familiar 
environment, demonstrating an un-willingness to explore a novel environment  (Plagge et 
al. 2005). This combination of behaviours indicates that Nesp55 has a role in mediating 
novelty exploration. 
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The role of Nesp on adult behaviour has been further investigated with the use of a 
delay discounting paradigm (Isles et al. unpublished data); which is the concept of 
measuring the choice between a small immediate reward and a large progressively delayed 
reward. This concept has been successfully translated into the ‘delayed-reinforcement task’, 
which has been utilized with rats (Winstanley et al., 2003) and mice (Isles et al., 2003). The 
delayed-reinforcement task is used as a measure of impulsivity, specifically ‘impulsive 
choice’, whereby selection of the small immediate reward is indicative of impulsive, and 
preference for the large reward is indicative of self-control (Winstanley et al., 2004). In 
previous research it was found that Nespm/+ mice exhibited significantly altered delay-
discounting behavior in the delayed reinforcement task (Isles et al., unpublished research), 
specifically showing an increased reluctance to wait for a larger reward, and instead 
preferring immediate gratification (Figure 1.4). The behaviour being measured in the delay-
discounting task is widely accepted as impulsivity (Winstanley et al., 2003), however some 
argue that delay-discounting behaviour can also be interpreted as risk-taking behaviour 
(Kalenscher, 2007). This interpretation is due to the theory that in the wild animals would 
perceive a delay in receiving food as a risk (due to risk of predation or loss of food) therefore 
the immediate reward is the ‘safer’ option (Kalenscher, 2007). Based on this interpretation, 
and taken together with behaviour in the LMA, NPP and open field tests, it has been 
suggested that Nesp55 normally acts to promote ‘risk-taking’ behaviour (Plagge et al., 2005, 
Isles et al., 2006). 
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Figure 1.4 Performance of Nespm-/p+ animals on a delay-discounting test of choice impulsivity. In previous 
research (Isles et al. unpublished data) Nespm-/p+ mice were tested in the delayed-reinforcement task; under 
increasing delay conditions (a) all subjects switched their responding to the smaller rewards associated with a 
fixed delay (1s). However, Nespm-/p+ animals were quicker to discount the large reward against the delay than 
controls. This demonstrates that Nespm-/p+ mice are significantly more impulsive (or less risk-taking) than WT 
animals, which suggests that the Nesp55 protein serves to moderate impulsive and/or risk-taking behaviour. 
Importantly when the large reward was associated with a fixed delay and remained at 1 second throughout 
the session, Nesp
m-/p+
 mice maintained a preference for the large reward (b). This demonstrates that the effect 
found was not a result of satiety or fatigue. Data shown are the mean ± SEM. Control N=7, Nespm/- N=9. 
 
 
1.2.8 Grb10 
  
Grb10 encodes growth factor receptor-bound protein 10, which is a cellular adapter 
protein lacking intrinsic enzymatic activity (Holt and Siddle, 2005). Grb10 is known to 
interact with numerous tyrosine kinases and signalling molecules, as well as several 
intracellular proteins (Blagitko et al., 2000), and has been suggested to function in diverse 
cellular processes; including the regulation of cellular growth and metabolism, apoptosis 
and cell migration (Holt and Siddle, 2005). Most notably Grb10 has been implicated in 
binding to, and regulating signals from, the IR (insulin receptor) and IGFR (type 1 insulin-like 
growth factor receptor) (Holt et al., 2009). Grb10 shares structural homology with Grb7 and 
Grb14 but is the only family member of the Grb genes subject to imprinted regulation (Holt 
and Siddle, 2005). Grb10 is also unique in its allele-specific expression in different tissues, 
whereby the maternal allele dominates expression but is confined to peripheral tissues 
outside of the CNS; whereas the paternal allele is exclusively expressed within the CNS, 
particularly within the brain (Garfield et al., 2011). As well as having allele-specific 
a b 
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expression, the two parental alleles of Grb10 seem to have distinct functions. Maternal 
Grb10 has a role in the regulation of fetal growth (Charalambous et al., 2010), and also 
influences insulin signalling and fat deposition during adulthood (Holt et al., 2009). Paternal 
Grb10 however, has no obvious effects on growth but has been shown to influence facets of 
behavior. 
The allele-specific expression of Grb10 is regulated by epigenetic mechanisms that 
occur during embryogenesis that differentially mark the parental alleles in order to make 
them active or repressed (Sanz et al., 2008). Epigenetic marking occurs at Imprinting Control 
Regions (ICRs), which regulate imprinted genes through DNA methylation and differential 
histone modifications (Sanz et al., 2008). During the onset of neurogenesis (between E11.5 
and E14.5) the ICRs are marked by differential histone modifications, resulting in a brain-
specific loss of a repressive histone modification (H3K27me3) from the paternal Grb10 allele 
(Sanz et al., 2008). This loss of H3K27me3 from the promoter region of the Grb10 paternal 
allele-specific transcripts leaves a permissive histone mark on the paternal allele 
(H3K4me2). In the maternal allele however, this region contains two repressive histone 
modifications (H3K9me3 and H4K20me3)(Sanz et al., 2008). This epigenetic regulation 
established early on in embryogenesis, results in the allele-specific expression of Grb10 in 
different tissues, and is maintained throughout development.  
 
1.2.8.2 Expression of paternal Grb10 in the brain 
Paternal Grb10 shows a discrete pattern of expression within the brain and, with a 
strikingly similar distribution to Nesp, is located in the hypothalamus, EWn, DRN and LC 
(Garfield et al., 2011). Additionally, paternal Grb10 expression is seen in the ventral 
tegmental area (VTA) and substantia nigra pars compacta (SNC) (Figure 1.5) (Garfield et al., 
2011). In the brain Grb10 also appears to be limited to neurons, as cellular expression of 
Grb10 is co-localised with serotonin (5-HT), the dopamine transporter (DAT) and choline 
acetyltransferase (ChAT)(Garfield et al., 2011). Like Nesp, this localisation suggests that 
Grb10 may exert an effect on behaviour via important neurotransmitter systems.  
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Figure 1.5 Expression of paternal Grb10 in coronal sections of the adult mouse brain. In situ hybridization of 
the LacZ reporter, shows expression of Grb10 within the substantia nigra pars compacta (SNC), supra-mam-
millary nucleus (SuM), ventral tegmental area (VTA), dorsal raphe nucleus (DRN), and locus coeruleus (LC). 
(4V indicates fourth ventricle). SNR, substantia nigra pars reticulata; Bar, Barrington’s nucleus; MnR, median 
raphe nucleus; VTg, ventral tegmental nucleus. Image taken from Garfield et al. 2011. 
 
1.2.8.3 Behavioural role of Grb10 
Behavioural studies of mice with a paternally inherited null Grb10 (Grb10+/p) 
demonstrated a role for this gene in social dominance (Garfield et al., 2011). The ‘tube test’, 
a measure of social dominance, forces an encounter between two unfamiliar animals. 
During the test animals are released simultaneously at opposite ends of a clear, narrow tube 
which allows one mouse to pass through, but is not big enough for two mice to pass. The 
more dominant mouse will exhibit signs of aggression which will force the ‘opponent’ out of 
the tube (Garfield et al., 2011). In this task Grb10+/p mutant mice were found to be 
significantly less likely to back down than their WT opponents. The same observation did 
not occur with Grb10m/+ mutant mice, suggesting that specific deletion of the paternal allele 
caused an increase in social dominance. Converging evidence for a role of Grb10 in social 
dominance was found from patterns of whisker barbering (Garfield et al., 2011). Cages 
containing at least one Grb10+/p mutant were significantly more likely to have cage mates 
whose faces showed evidence of barbering. Importantly when the Grb10+/p mouse was 
socially isolated, the remaining cage-mates re-grew their whiskers, suggesting that Grb10+/p 
mice were carrying out the barbering of their cage mates (Garfield et al., 2011). Social 
barbering is considered a robust correlate of social dominance (Long, 1972, Koh et al., 
2008), which is consistent with the results obtained from the tube test. Social dominance is 
a b c 
e f d 
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an important aspect of animal behaviour, whereby the establishment of dominance 
hierarchies is thought to confer major advantages for health, survival and reproductive 
success (Wang et al., 2011). Competing for social dominance to gain access to limited 
resources and mating opportunities, is not only an important part of animal behaviour, but 
may also be correlated with the propensity to take risks (Davis et al., 2009). 
 
 
1.2.9 Summary of Imprinted gene research 
 
The functional role of imprinted genes remains a fascinating phenomenon. Although 
understanding of genomic imprinting has developed considerably, the reason for the 
existence of imprinted genes remains conjecture until their function in the brain and body 
has been fully characterised. Recent advances have suggested that there may be 
significantly more imprinted genes in the genome than first thought; this coupled with their 
growing association with psychiatric illness and important role in development leave 
intriguing possibilities about what exactly imprinted genes do, and why they exist. The 
advances in targeted mutagenesis have provided an excellent opportunity to investigate 
these genes further, and specifically how they might control behaviour. Research employing 
Nespm/+ and Grb10+/p mice, have begun to uncover a fascinating role for these imprinted 
genes in mediating adult behaviour. Whereby Nespm/+ mice show altered behaviour in tests 
of novelty exploration (Plagge et al., 2005) and delay-discounting (Isles et al. unpublished 
data), and Grb10+/p mice show increased social dominance (Garfield et al., 2011). This 
existing research has alluded to both of these genes having an involvement in impulsivity 
and risk-taking based behaviour. Furthermore the kinship theory of imprinted genes, which 
proposes antagonistic roles of maternal and paternal alleles, would suggest that Nesp and 
Grb10 may be controlling this behaviour in opposing ways. The preliminary findings are 
consistent with this hypothesis, however further investigation is warranted, using more 
explicit tests of impulsivity and risk-taking.  
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1.3 Impulsivity and risk-taking behaviour 
 
 
The term ‘impulsivity’, defined as ‘action without adequate forethought’ (Winstanley 
et al., 2006), is a natural part of human behaviour. It is a multifaceted behavioural construct 
which encompasses a variety of underlying behaviours, such as ‘actions that are poorly 
conceived, prematurely expressed, unduly risky, or inappropriate to the situation and that 
often result in undesirable outcomes’ (Evenden, 1999). As a result of clinical and pre-clinical 
research it appears the heterogeneous underlying traits of ‘impulsivity’ are dissociable both 
behaviourally and neurologically; whereby separate aspects of impulsivity are underpinned 
by distinct biological mechanisms. These types of impulsive behavior can be broadly divided 
into two categories: ‘impulsive choice’ (impulsive decision-making) and ‘impulsive action’ 
(motor impulsivity) (Winstanley et al., 2004). Impulsive choice refers to actions that fail to 
take into account other possible options or outcomes, and hence may be sub-optimal; 
impulsive action refers to actions that are premature or difficult to suppress (Dalley and 
Roiser, 2012). 
 Another aspect of impulsive choice is risk-taking, which is a complex construct that 
often overlaps with impulsivity (Xu et al., 2013), as well as the broader subject of decision-
making (Rivalan et al., 2013). Although risk-taking refers to a slightly different aspect of 
behaviour to impulsivity, weighing up possible outcomes to make a choice is fundamental to 
both impulsive choice and risk-taking. Furthermore impulsive choice and risk-taking are 
both prevalent in certain psychiatric conditions and their pathology often go hand-in-hand. 
Risk-taking refers to the trade-off between a cost and a benefit, and the ability to assess risk 
appropriately is a requirement for survival in both humans and animals (Simon et al., 2009). 
This involves the assessment of the value of a potential gain, against the risk of a potential 
loss; such as the probability of death or harm. Risk-taking can occur in a variety of domains, 
including financial, health/safety, recreational and social, therefore ‘risky’ activities in 
humans could include such things as hazardous driving, parachuting, bungee jumping, and 
unprotected sex, as well as gambling and the use of psychoactive substances (Laviola et al., 
2003). Both humans and animals have individual differences in the degree to which they are 
willing to participate in sensation-seeking or risk-taking behaviours (Isgor et al., 2004). Risk-
taking therefore encompasses a spectrum of behaviour, whereby individuals can be 
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characterised from ‘risk-avoiding’ (avoiding behaviours due to the potential risk) to ‘risk-
seeking’ (taking part in behaviour due to the risk involved) (Schonberg et al., 2011). 
Impulsivity and risk-taking are normal aspects of life, and are therefore adaptive 
functions necessary for survival (Humphreys et al., 2013). However it seems that in certain 
individuals these behaviours can become pathological and result in negative consequences. 
Deficits in impulsivity and risk-taking have been recognised as a clinical trait of many 
psychiatric disorders, including schizophrenia, attention deficit/hyperactivity disorder 
(ADHD), obsessive compulsive disorder (OCD), mania and antisocial behaviour. As well as 
these disorders, the Diagnostic and Statistical Manual of Mental Disorders (DSM) IV also 
recognises a specific group of impulsive psychiatric illnesses known as ‘impulse control 
disorders’, which includes intermittent explosive disorder, pyromania, kleptomania and 
trichotillomania (American Psychiatric Association, 2013). Impulsivity and risk-taking 
behaviour also have important implications for drug-seeking behaviour and addiction 
whereby deficient ‘inhibitory control’, a feature of impulsivity, is recognised as an integral 
element of drug addiction in rodent models (Belin et al., 2008) and human studies (Mitchell, 
2004).  
The sub-categories of impulsivity are operational in that we have distinct tasks that 
measure impulsive choice and impulsive action, as well as tasks to measure risk-taking. 
Measuring impulsivity and risk-taking behaviour in humans has been successfully 
established using a number of tasks. With the increased recognition of impulsivity and risk-
taking as traits of psychiatric illness, these tasks have proved extremely useful in identifying 
and understanding disorders such as ADHD in children. The pursuit to identify the 
neurological basis and possible genetic predispositions of psychiatric illness has led to the 
increasing use of genetically modified animals in measuring behaviour. Therefore many 
neuropsychological tasks used to measure impulsivity and risk-taking in humans, have been 
successfully translated for use with laboratory animals.  
 
 
1.3.1 Choice impulsivity and risk-taking 
 
‘Choice impulsivity’ refers to the decisional aspect of impulsivity, as opposed to the 
motoric aspect described by impulsive action. Although all impulsivity involves an impulsive 
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action of some sort, the crucial difference conceptually is that, unlike for measurements of 
impulsive action, there is no “pre-potent” response that needs to be inhibited. Instead, 
impulsive choice reflects the decision-making processes rather than motoric inhibition 
(Winstanley et al., 2006). Choice impulsivity involves an abnormal level of delay aversion, as 
exemplified by increased preference for immediate reward over more beneficial but 
delayed reward (Brevers et al., 2012). This is operationalised by impulsive decisions resulting 
from a distorted evaluation of delayed or probabilistic consequences of behaviour and an 
increased preference for (smaller) immediate or frequent rewards over more beneficial 
(larger) delayed or infrequent rewards (Broos et al., 2012). Similarly, risk-taking, which also 
involves an action, refers to the weighing up of options and consequences in order to make 
a decision. The ability to appropriately assess cost vs. benefit analysis is essential in both 
impulsive choice and risk-taking. The inability to accurately assess cost vs. benefit results in 
maladaptive risk-taking behaviour, which can be dangerous and harmful (Steinberg, 2008). 
Much like impulsive action, impulsive choice and pathological risk-taking are significant 
symptoms in many psychiatric illnesses, it is therefore important to understand the 
neurological underpinnings of the dissociable aspects of impulsivity and risk-taking, and how 
alterations in the neurochemical systems involved can be treated. 
 
1.3.1.1 Assessing discounting behaviour 
One of the most prominent features of impulsive choice is an intolerance of the 
delay of a reward or gratification. The method used to target the measurement of this 
behaviour is the ‘delayed-reinforcement task’, part of the ‘delay-discounting’ paradigm used 
to measure impulsivity. This has been utilised extensively in humans (Crean et al., 2002), as 
well as successful translation of paradigms to laboratory animals such as rats (Evenden and 
Ryan, 1996), and mice (Isles et al., 2003). In animals, delay discounting tasks measure 
impulsivity using a system in which subjects have to choose between rewards that are 
relatively small but available immediately, and rewards that are larger but progressively 
delayed. In the context of delay discounting, impulsive choice is generally considered as an 
increased preference for immediate over delayed outcomes, even where the delayed 
outcomes are more advantageous (Mar and Robbins, 2001). Therefore the selection of 
smaller immediate reward in preference to larger delayed reward has been considered to 
Chapter 1 | General Introduction 
 
 
 
Page | 27  
 
reflect ‘impulsive’ choice, whereas the opposite bias toward delayed gratification has been 
taken to indicate increasing ‘self-control’. The delay-discounting task has been used 
extensively in behavioural research to measure impulsive choice, and has been useful in 
drug and lesion studies to further understand neurological underpinnings and therapeutic 
advances (Cardinal et al., 2000, Cardinal et al., 2001). For example the administration of 
amphetamine and atomoxetine (which upregulate dopamine and noradrenaline, 
respectively) have both been shown to increase the choice of the large reward in the delay 
discounting task (therefore decreasing impulsivity) (Winstanley et al., 2003, Robinson et al., 
2008). Furthermore recent research has shown that impulsive choice, as measured by delay-
discounting, and impulsive action, as measured by 5-CSRTT or the stop signal reaction time 
task (SSRTT), do not correlate in rodents or humans, strengthening the assertion that these 
are dissociable aspects of impulsivity (Broos et al., 2012).   
 
1.3.1.2 Assessing risk-taking 
Risk-taking or ‘risky decision-making’ can be defined and interpreted in numerous 
ways. For example neuroeconomists define risk in terms of the variability of possible 
outcomes, whereas clinicians and lay people tend to view risk as exposure to possible loss or 
harm (Schonberg et al., 2011). This spectrum of definition has led to a broad range of 
paradigms being developed to measure risk taking in humans. Furthermore many of the 
behavioural tasks used to measure risk-taking in humans have successfully been translated 
for use with laboratory animals, particularly rodents. As well as rodent analogues of human 
tasks, there is an increasingly recognised importance for the development of rodent-specific 
risk-taking tasks, in order to understand the neurological and genetic underpinnings of risk-
taking.   
The development of animal models of risk taking is critical for understanding the 
pharmacological and neurobiological substrates underlying the processing of risk and 
reward. Additionally, such models could be important for the development of treatment to 
combat the maladaptive risk-taking that frequently occurs in psychiatric conditions. The 
simplest ways of measuring risk-taking in animals are tasks which measure spontaneous 
activity and reaction to novel environments (Piazza et al., 1990, Palanza et al., 2001). For 
example tasks such as the locomotor activity task (LMA), or tests of anxiety such as open 
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field test (OF), elevated plus-maze (EPM) and novelty place preference (NPP) can measure 
the degree to which animals will seek novelty, through the way they explore an unfamiliar 
environment. Rodents have an innate fear of open spaces, due to their association with the 
risk of danger (Reul, 2014). Therefore, rodents stereotypically demonstrate two conflicting 
tendencies: desire to explore novel environments, and avoidance of open spaces (Dulawa et 
al., 1999). Deviation from this typical pattern of behaviour can be indicative of altered levels 
of anxiety, fear and risk-taking behaviour. For example, this has been demonstrated with 
mice lacking a functional copy of the imprinted gene Nesp, which demonstrated heightened 
locomotor activity in the LMA task, increased activity in the OF, and altered exploration of 
the novel environment in the NPP. Taken together these behavioural findings can be 
interpreted to suggest that Nesp normally acts to moderate ‘risk-taking’ behaviour (Plagge 
et al., 2005). 
As well as basic tasks that measure spontaneous risk-taking behaviour, many of the 
paradigms used to measure risk-based decision making in humans have been successfully 
translated into tasks for use with laboratory animals. Including rodent analogues of the 
balloon analogue risk task (BART) (Ashenhurst et al., 2012) and the Iowa gambling task 
(Zeeb et al., 2009). Probabilistic-discounting tasks, used to measure risk-taking behaviour in 
humans, refer to the observation that a probabilistic gain is considered to be worth less 
than the same amount of gain available for certain (e.g. £25 vs. 25% chance of £100) (Shead 
and Hodgins, 2009). This paradigm has also been translated for use with rodents in order to 
measure risk-taking behaviour (St Onge and Floresco, 2008).  Although delay-discounting 
tasks have been successfully and widely used to measure impulsivity, increasing research 
suggests that in animal behaviour temporal discounting is a facet of risk-taking (Hayden and 
Platt, 2007, Kalenscher, 2007). Therefore, when using this task with animals, choice of the 
temporally distal reward would be considered risky, and the temporally proximal reward is 
more favourable (Hayden and Platt, 2007, Kalenscher, 2007). This is explained by the 
postulation that animals associate the delay with collection as risky, this is because in the 
context of foraging behaviour, delaying the collection of a reward could result in loss of that 
reward (another animal taking it) or harm (predation) (Kalenscher, 2007). Therefore a 
temporally distal reward is perceived as being the same as an uncertain reward, which is 
less desirable to animals due to their risk-averse nature. Consequently in delay discounting 
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tasks, the preference for the small immediate reward which would be usually categorised as 
impulsive choice, is regarded as less risk-taking. Therefore impulsivity and risk-taking are 
opposite behaviours in this task, whereas in the investigation of novelty for instance, an 
animal that appears impulsive (going into the novel environment more) would also appear 
to take more risks. 
As well as animal analogues of human tasks, recent experimental paradigms have led 
to the development of novel techniques that allow the characterisation and measurement 
of risk-taking behaviour specifically in laboratory animals. For example rodent-specific tests, 
such as the risky-decision making task (Simon and Setlow, 2012) which presents rats with 
the choice between pressing a lever to obtain a small, “safe” food reward and a large food 
reward associated with risk of punishment (footshock). As well as tasks taxing regulatory 
focus (Franks et al., 2012) which evaluate risk-taking in rats by measuring how much they 
engage in promotion focus (pursuing gain) or prevention focus (pursuing safety). However 
whether or not these existing tasks truly model a ‘real-life’ risk-taking behaviour that is 
ethobiologically relevant to rodents is uncertain, and is discussed in this thesis. 
Nevertheless, development of animal models of risk-taking behaviour that are both reliable 
and possess face validity is critical for understanding the pharmacological and 
neurobiological substrates underlying the integration of risk and reward (Simon et al., 2011).  
 
1.3.1.3 Neurobiology of impulsive choice and risk-taking 
Due to the multi-faceted nature of impulsivity, deciphering the exact neurochemical 
processes that underpin the separate facets of impulsivity and risk-taking is a challenging 
process and therefore remains relatively unclear. Nonetheless it is thought that the 
dissociable aspects of impulsivity have independent but potentially overlapping 
neurobiological substrates (Evenden, 1999), and the role of the monoaminergic 
corticostriatal systems have been largely implicated (Jupp et al., 2013). Analysis of the 
neurochemical underpinnings of impulsive choice have revealed a role for the same 
neurotransmitter systems that are thought to mediate impulsive action, such as serotonin 
(5-HT), dopamine (DA) and noradrenaline (NA) (Winstanley et al., 2006). Investigation into 
the neurological pathways that control impulsive choice have principally used temporal or 
reward discounting paradigms. The roles of DA and 5-HT in controlling impulsive choice 
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have been demonstrated using pharmacological methods, in clinical and preclinical 
research. DA is heavily implicated in impulse control disorders, and the therapeutic effects 
of amphetamine in ADHD have been largely attributed to its ability to potentiate 
dopaminergic signalling (Zeeb et al., 2010). Both amphetamine and methylphenidate have 
previously been shown to decrease impulsive decision-making on delay-discounting tasks in 
rats (Winstanley et al., 2005, van Gaalen et al., 2006). Furthermore, the systematic 
administration of DA antagonists has been shown to increase delay discounting behaviour in 
rats (Zeeb et al., 2010). Lesions to the 5-HT system clearly effect impulsive action (Harrison 
et al., 1999, Winstanley et al., 2004), however the effect of global 5-HT depletion on 
impulsive choice is less clear (Winstanley et al., 2004). Although it has been shown that 
decreased 5-HT, via subcutaneous injections of SER-082 (5-HT2C,B antagonist) signiﬁcantly 
increased preference for the large reward in a delay-discounting task (Talpos et al., 2006). 
 Furthermore administration of a 5-HT1A receptor agonist has been found to increase 
impulsive choice on the delay-discounting task (Winstanley et al., 2005). Pharmacological 
evidence has therefore revealed a role for DA and 5-HT in mediating impulsive choice, and 
furthermore that these neurotransmitters have a receptor-specific effect. Therefore drugs 
which act as selective agonists or antagonists for particular receptor subtypes can therefore 
have very different effects on impulsivity (Winstanley, 2011). 
The exact neuroanatomical structures of the brain that control impulsive choice 
remain uncertain. However, the nucleus accumbens (NAcb) along with its cortical afferents, 
such as the medial prefrontal cortex (mPFC) and anterior cingulate cortex (ACC), are known 
to play an important part in the motivational aspect of impulsivity and decision-making 
(Cardinal et al., 2001). Experiments in animals have implicated a network of limbic-striatal 
brain structures in the regulation of decision making and impulsive choice. Evidence is 
perhaps strongest for the mPFC, as well as the ventral striatum (VS) and dopaminergic 
innervation from the ventral tegmental area (VTA) (Setlow et al., 2009). Lesions within both 
of these systems produce profound alterations (either increases or decreases) in impulsive 
choice (Mobini et al., 2002, Winstanley et al., 2004b). Fronto-striatal systems have been 
heavily implicated in the control of numerous aspects of impulsivity (Dalley et al., 2008). 
Specifically it has been suggested that projections to the Locus Coeruleus (LC) via the NA 
system from the ACC and orbifrontal cortex (OFC), has control in the ‘effortful processing’ 
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involved in decision-making processes (Dalley et al., 2008). Research assessing the effect of 
lesions to specific brain regions has revealed that impulsive choice, like other aspects of 
impulsivity/decision making, is regionally dependant (Jupp et al., 2013). For example the 
role of the NAcb in mediating impulsive choice, whereby excitotoxic lesions of the NAcb 
core sub-region results in a significantly increased desire for the small immediate reward 
(Cardinal et al., 2001a), whilst conversely, lesioning the NAcb shell does not have an effect 
on this behaviour (Pothuizen et al., 2005). However, this is unsurprising given that the NAcb 
core is part of a larger neuronal network including the amygdala and PFC, which have an 
established role in the control of impulsive behaviour (Winstanley et al., 2004b). Lesion 
studies have also provided evidence for the role of the OFC and basolateral nucleus of the 
amygdala (BLA) in mediating impulsive choice (Winstanley et al., 2004b). Rats with BLA 
lesions showed increased choice of the small immediate reward (increased impulsivity) in a 
delay discounting task, whilst, OFC lesions increased preference for the large delayed 
reward (decreased impulsivity) (Winstanley et al., 2004b). More specifically, studies using 
lesions to sub-regions of the OFC have revealed that medial OFC-lesioned rats showed 
increased preference for the large reward in a delay-discounting task, conversely lateral 
OFC-lesioned rats showed decreased, preference for the larger-delayed reward (Mar et al., 
2011). Furthermore the DRN has also been implicated in the regulation of impulsive choice 
behaviour and specifically in waiting for rewards (Miyazaki et al., 2012).  Specifically 
suppression of 5-HT neural activity in the DRN impaired patience for delayed rewards in a 
delay discounting task (Miyazaki et al., 2012). Therefore, despite gross similarities in the 
regions which regulate decision-making behaviour, research suggests there are specific sub-
regions that control impulsive choice behaviour, most notably the DRN, OFC, BLA and NAcb 
core (Winstanley et al., 2004b).  
The underlying neurobiology of risk-taking and how dysfunction may arise is not 
completely understood (Llewellyn, 2008), however the systems involved are analogous with 
those that control impulsive choice. Neuroimaging studies have proven extremely useful in 
highlighting areas key to modulating risk-taking behaviour in humans. Generally, studies 
have demonstrated frontostriatal activation during risky decision-making and that 
subcortical-cortical networks including multiple prefrontal, parietal, and other limbic regions 
are involved. The processing of risk based decision making can be divided into gains 
Chapter 1 | General Introduction 
 
 
 
Page | 32  
 
(reward) and losses (cost), with suggestions that perhaps different neurological regions 
govern these two separate constructs (Floresco et al., 2008) . Reward is a particularly salient 
feature of any decision-making process, and has been the focus of a lot of research 
investigating the neural substrates of risk-taking. Whereby the PFC has been heavily 
implicated in regulating reward-seeking behaviour; lesions to the PFC in rodents has been 
shown to induce increased risk-taking behaviour (Floresco et al., 2008). For example the 
striatum, the input structure of the basal ganglia, is thought to be the circuit responsible for 
mediating goal-directed behaviour, and therefore the ‘reward’ aspect (Delgado, 2007). 
Specifically it is thought that DA rich mesolimbic regions including the midbrain, striatum, 
and frontal cortex, have been suggested to play a particular role in processing the reward 
aspect during decision-making under risk (Rao et al., 2008). However other studies using 
fMRI have not found separate brain systems for governing gains and losses, but found areas 
in the brain, including the ventral striatum (VS), ventromedial prefrontal cortex (VMPFC), 
ventral anterior cingulate cortex (ACC), and medial orbifrontal cortex (OFC), that were 
sensitive to the both gains and losses (Rao et al., 2008). Activation in these areas increased 
with increasing potential gains and decreased with increasing potential losses (Rao et al., 
2008).  
Neurochemically, the importance of the DA system in the modulation of risk-taking 
has been widely acknowledged, and has been the subject of a great deal of research into the 
neurobiology of risk-taking behaviour. These studies suggest that increased DA activity may 
impair risk-based decision making (St Onge and Floresco, 2008). Animal studies making use 
of lesioning, and pharmacological exploration have made significant advances in our 
understanding of how DA modulates risk and reward. Specifically, research has evidenced 
that neural activity is adaptive, and therefore activity in dopaminergic neurons increases 
with the magnitude of anticipated rewards (Tobler et al., 2005), and that reward induces 
dopamine release and activation in the NAcb. Furthermore, blockade of DA receptors 
reduces the preference for rodents to either wait longer or work harder to obtain a larger 
reward (Cardinal et al., 2000, Salamone et al., 2001). However which specific DA receptors 
are responsible for risk-taking behaviour remains unclear. Some have argued that agonists 
more selective for D3 receptors, are more likely to induce gambling behaviour (Szarfman et 
al., 2006), whereas others have reported that D1/D2 receptor agonists can also stimulate 
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these effects (Lu et al., 2006); whilst a recent study using PET scans in humans reports that 
striatal D2/D3 receptors are the most important in the modulation of risk-taking behaviour 
(Kohno et al., 2013). This is also supported by a study of risk-taking in rats, using 
pharmacologically induced dopamine receptor activation, it was shown that risky decision-
making was attenuated by D2, but not D1 receptor activation (Simon et al., 2011b). Existing 
research therefore suggests that dopamine signalling in prefrontal cortical-striatal circuitry 
is key to the integration of reward information with risk information; but moreover that the 
exact neural substrates of decision-making may vary in the striatal dopamine system as a 
function of individual differences, and also as a function of the type of risk-taking being 
measured (Kohno et al., 2013). 
 
 
1.3.2 Impulsive action 
 
Impulsive action is the motoric (as opposed to decisional) aspect of impulsivity, and 
refers to action without adequate forethought (Winstanley et al., 2004a). Impulsive action is 
thought to be underpinned by poor ‘impulse control’, which is described as “an active 
inhibitory mechanism which modulates the internally or externally driven pre-potent desire 
for primary reinforcers such as food, sex or other highly desirable rewards” (Winstanley et 
al., 2006). Behaviourally this is operationalised as the inability to withhold a pre-potent 
response, thereby reflecting poor response inhibition.  Impulsive action is both 
behaviourally and neurobiologically distinct from impulsive choice, where dysregulation 
of impulsive action results in clinical disorders where diminished inhibitory control is a 
feature (Brevers et al., 2012).   
 
1.3.2.1 Measuring impulsive action in rodents 
Although no tests of impulsive action are used in this thesis, it is important that a 
brief overview is provided to demonstrate the contrast with tasks of impulsive choice, 
below. Numerous tasks have been developed to measure impulsive action. The majority of 
these tasks take advantage of the enhanced stimulus-control of operant methods, but some 
maze-based approaches have also been deployed successfully to examine this dissociable 
aspect of impulsive behaviour. ‘Response inhibition’ is the main feature of impulsive action, 
and refers to the ability to exert executive control over automatic response systems during 
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the decision-making process. ‘Go/No go’ tasks specifically target the measurement of this 
aspect of motor impulsivity (Eagle et al., 2008). This is achieved by measuring the ability to 
inhibit a pre-learnt response, for example making a motor-response to a certain stimuli (‘go’ 
trial) and refraining from making the motor response to a stimulus during a ‘no-go’ trial 
(Eagle et al., 2008). This basic concept has been further developed through the ‘Stop signal 
reaction time task’ (SSRTT), which measure the ability to stop or cancel a motor action once 
started in response to a ‘stop-signal’ (Humby et al., 2013). This has been used widely in the 
clinical setting to measure impulsivity, for example, children with ADHD are slower to inhibit 
their responses than normal children, as indicated by increases in their stop signal reaction 
time e.g. Purvis and Tannock (2000) and similarly fail to inhibit their “go” response on the 
“no-go” trials in go/no-go tasks. The SSRTT has been successfully translated for use with rat 
models (Eagle and Robbins, 2003) and more recently mouse models (Humby et al., 2013).  
The 5-Choice Serial Reaction Time Task (5-CSRTT), originally developed to assess 
attentional and executive functions, can also be used to measure motor impulsivity. This 
paradigm requires subjects to detect and respond to brief flashes of light presented in a 
pseudorandom order in one of five spatial locations, in order to receive a reward (Robbins, 
2002). Increased instances of premature responding in this task are indicative of impulsive 
action.  
 
1.3.2.2 Neurobiology of impulsive action 
 Many of the same systems that control impulsive choice have been implicated in 
controlling impulsive action, although there are some dissociable aspects (Evenden, 1999). 
Research has identified the importance of the monoamine neurotransmitters 5-HT and DA 
in regulating impulsivity (Dalley and Roiser, 2012). Dysregulation of these monoamines are 
associated with various psychiatric disorders, and are known to manifest in impulsive 
behaviours, such as aggression, suicide and gambling (Dalley and Roiser, 2012). Specifically, 
DA is thought to regulate the cognitive aspects of impulsive action, such as attention and 
reward processing (Bevilacqua and Goldman, 2013). Pharmacological studies, have also 
found that enhancing DA signalling increases impulsive responding, whilst administration of 
D2-like receptor agonists reduces impulsivity in rats exhibiting impulsive behaviour on the 5-
CSRTT (Fernando et al., 2012).  
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The importance of 5-HT was first identified through psychopharmacological 
manipulation of rats in assays of anxiety (Soubrie, 1986). This demonstrated that 
administration of drugs which decreased 5-HT transmission resulted in decreased 
behavioural inhibition. Since this discovery extensive research has been conducted in an 
attempt to understand this process, and it has been found that the neurological regions 
known to regulate impulsivity are dense in 5-HT and DA releasing neurons (Harrison et al., 
1997). Animal studies have provided support for the role of 5-HT and DA in modulating 
impulsive action. Depletion of DA in the ventral striatum of rats, including the NAcb, 
reduced impulsivity on a 5-CSRTT (Cole and Robbins, 1989). Furthermore drugs that increase 
brain DA neurotransmission (eg, methylphenidate or amphetamine) produce profound 
effects on impulsive behavior, whereby they act to improve stopping performance on the 
SSRTT and reducing delay-discounting impulsivity, whereas they increase impulsivity in the 
5-CSRTT (van Gaalen et al., 2006, Eagle et al., 2008, Navarra et al., 2008). Globally reducing 
forebrain 5-HT, increased premature responding on the 5-CSRTT (Harrison et al., 1997) and 
disrupted acquisition and performance of a go/no-go task (Harrison et al., 1999). However 
increased 5-HT levels in the PFC were associated with elevated premature responding in the 
“one choice” task (a simplified version of the 5-CSRTT) (Dalley et al., 2002). Therefore, it has 
been suggested that global reduction in 5-HT increases impulsive action, whereas reduction 
in 5-HT in specific receptors or brain regions decreases impulsive action (Talpos et al., 2006).  
As well as the known interplay between DA and 5-HT, NA has also been implicated in 
the modulation of impulsivity (Economidou et al., 2012). Dysregulation of NA 
neurotransmission has been widely linked with the manifestation of maladaptive impulsive 
behaviour, such as ADHD (Arnsten and Pliszka, 2011). The role of NA in impulsivity has been 
principally focused on motor impulsivity, with widespread findings from pharmacology 
studies showing that increased NA release, via injections of the NA re-uptake inhibitor, 
atomoxetine, reduced impulsive behaviour (Robinson et al., 2008, Winstanley, 2011). 
Moreover the clinical efficacy of atomoxetine as a treatment for ADHD strongly implicates 
NA as a modulator of impulsivity (Del Campo et al., 2013). Noradrenergic transmission has 
also been found to be deficient in patients with impulse control disorders (Faraone et al., 
2005).  
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The neuroanatomical correlates of impulsive action are still not completely 
determined, but research has principally focused on response inhibition. Growing research 
has led to an increased understanding of this circuitry in humans (Kim and Lee, 2010) and 
pre-clinical research has assisted the identification of this circuitry in rodents (Dalley et al., 
2011). Primarily the prefrontal cortical, striatal and limbic brain regions have been found to 
play an important role in impulsivity, with research implicating that the NAcb plays a 
significant role in impulsive behaviour (Dalley et al., 2011). Specifically, the PFC in 
conjunction with the NAcb, assists in the structuring of impulsive behaviour (Cardinal et al., 
2001b, Mobini et al., 2002, Winstanley et al., 2004b). As is the case with impulsive choice, 
the LC has also been implicated in the modulation of impulsive action, whereby deficits in 
Cingulate Cotex (Cgl)-LC interactions may contribute to impaired impulse control measured 
by the 5-CSRTT (Dalley et al., 2008). It is suggested that glutamatergic inputs from the 
amygdala, hippocampus, midline thalamus and PFC, along with dopaminergic inputs from 
the mesolimbic dopaminergic system act together to exert an influence on the NAcb core 
and shell sub-regions (Caprioli et al., 2014). Recent research utilising the SSRTT in rats has 
shown that different facets of impulsive behaviour are governed by dissociable neural 
circuitry, namely that ‘waiting impulsivity’ and ‘stopping impulsivity’ depend upon entirely 
separate neurological systems governed by different regions of the brain (Dalley et al., 
2011). It is therefore becoming increasingly clear that even within the sub-category of 
impulsive action, separate elements of impulsive behaviour may be neurally dissociable. 
 
 
1.3.3 Summary 
Impulsivity and risk-taking represent behaviours that are clinical components of a 
multitude of psychiatric illnesses, and are especially important in addictive disorders. Both 
clinical and preclinical research surrounding the neurobiology of impulsivity and risk-taking 
has established a role for 5-HT, DA and NA in mediating these behaviours. This has been 
demonstrated through a number of human and animal studies, which have utilised lesioning 
and drug studies to discover the specific processes involved in impulsive action, impulsive 
choice and risk-taking behaviour. The ways in which these neurotransmitters exert influence 
on certain brain regions, as well as the way they interact with other monoamine 
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neurotransmitters is still not conclusive. What is clear however, is that impulsivity is made 
up of several different dimensions, most broadly ‘impulsive choice’ and ‘impulsive action’, 
which are dissociable behaviourally. Although the regions of the brain controlling these 
behaviours are overlapping, impulsive choice and impulsive action are also dissociable 
neurologically. Furthermore risk-taking is an over-lapping construct with impulsive choice, 
where the analysis of options to make a decision is central to both of these behaviours. 
However, in certain circumstance (e.g. discounting paradigms) one would expect risk-taking 
and impulsive choice to dissociate; whereby preference of the small reward could be 
interpreted as both increased impulsivity and decreased risk-taking (Winstanley et al., 2004, 
Kalenscher, 2007).  
In relation to the central aims of this thesis, mice lacking functional copies of the 
imprinted genes Nesp and Grb10 show behavioural phenotypes that are indicative of, and 
have been interpreted as altered risk-taking behaviour (Plagge et al., 2005, Garfield et al., 
2011). Specifically this has been demonstrated in tasks that measure reaction to novel 
environments and social dominance, in Nespm/+ and Grb10+/p mice respectively. 
Furthermore, the initial findings in Nespm/+ mice have been followed up with a study of 
delay discounting, with the mutant animals having a reduced tolerance of delay (Isles et al., 
unpublished data). Finally, many of the regions in which Nesp and Grb10 are co-expressed 
such as the VTA, LC and DRN, together with their forebrain projections, are central to the 
control of impulsivity and risk-taking. Taken together, there is a strong hypothesis for a role 
for these two imprinted genes in meditating impulsive/risk-taking behaviour; based on the 
regional distribution and expression patterns of these genes in these particular brain 
regions. This suggests that testing mice null for Nesp and Grb10 in behavioural tasks of 
impulsivity might determine if these imprinted genes influence impulsivity and risk-taking. 
This tentative finding highlights the need for further investigation into the role of Nesp and 
Grb10 in risk-taking behaviour, and therefore the need to measure risk-taking using more 
sophisticated behavioural paradigms than previous studies. As well as existing paradigms of 
risk-taking behaviour, it is also clear there is a need for the development of risk-taking tasks 
which have increased face validity and are more ethobiologically relevant to rodents.   
By assessing, in these tasks, mice carrying specific gene deletions or transgenes, 
there is the possibility of further delineating the genetic contribution underlying the 
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neurobiology of impulsivity and risk-taking behaviours. Importantly, in combination with 
previous studies investigating specific brain lesioning and psychopharmacological 
manipulations, further insight into the neurological underpinnings of this behaviour will be 
reached; which in turn could lead to innovation and development of novel drug therapies 
for the psychiatric disorders in which abnormal impulsivity is a feature. 
 
 
1.4 Aims of thesis 
 
 
The genes Nesp and Grb10 represent brain expressed imprinted genes that have 
been partially characterised behaviourally. This includes evidence for the role of Nesp in 
reactivity to novel environments and in delay-discounting behaviour; and the role of Grb10 
in social dominance. These earlier findings suggest that Nesp is involved in impulsive and/or 
risk-taking behaviours and that Grb10, although less well-characterised, may be involved in 
these behaviours also. The strikingly similar expression of Nesp and Grb10 in the brain has 
lead to the exciting possibility that these two genes may be acting upon the same 
neurological and behavioural systems (Dent and Isles, 2013). Furthermore the fact that 
these genes are oppositely imprinted in the brain (Nesp – maternal expression, Grb10 – 
paternal expression) has led to the hypothesis that these genes may have antagonistic roles 
in mediating behaviour (Plagge et al., 2005). The distinct brain regions where Nesp and 
Grb10 are co-expressed represent areas key to the mediation of impulsivity and risk-taking. 
The aim of this thesis is, therefore, to functionally examine the roles of Nesp and Grb10 in a 
variety of tests that are indicative of risk-taking and/or impulsive behaviour, and to carryout 
experiments to better understand the expression of these two imprinted genes. The main 
hypothesis of this research is that Nesp and Grb10 both influence risk-taking and/or 
impulsive behaviour. The initial chapters are concerned with examining the behaviour of 
Grb10+/p mice in those tests on which Nespm/+ mice have previously been assessed. This is 
followed by a number of experiments examining behaviour of both mouse lines in a novel 
risk-taking task. 
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Specific experimental aims of the thesis are to: 
 Assess Grb10+/p in the tests of novelty exploration and locomotor activity previously 
carried out with Nespm/+ mice (Chapter 3). 
 Assess Grb10+/p mice on the delayed reinforcement task, to examine if Grb10 affects 
delay-discounting behaviour (Chapter 4). 
 Develop a novel test of risk-taking behaviour (Predator Odour Risk Taking - PORT) 
(Chapter 5).   
 Assess risk-taking behaviour in Nespm/+ and Grb10+/p mice using the PORT task 
(Chapter 6).  
 Determine if Nesp55 and Grb10 are co-localised within the same cells; and examine 
if like Grb10, Nesp55 is co-localised with key neurotransmitters (Chapter 7).  
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Chapter 2 – General methods and materials 
2.1 Introduction 
 
The purpose of this chapter is to describe the general procedures that were 
performed throughout the course of this thesis, and illustrations of the behavioural 
apparatus that were employed. All procedures that involved the usage of live animal 
subjects were carried out in accordance with the requirements of the U.K. Animals 
(Scientific Procedures) Act (1986) and in line with the Home Office Project Licence granted 
to Dr Anthony Isles (PPL: 30/2673). Work was carried out under the Home Office Personal 
Licence granted to Claire Dent (PIL: 30/9361). 
  
2.2 Subjects and animal husbandry 
 
2.2.1 Subjects 
2.2.1.1 Nespm/+ 
 Nesp55 deficient mice were created as described previously in Plagge et al. (2005) 
using a mutation which targets the Nesp coding exon, this mutation stops protein 
translation but has no effect on transcription.  This was achieved through a lox-P flanked 
targeting cassette which was excised through germ-line specific expression of Cre 
recombinase in male chimeras, resulting in offspring carrying a mutant allele in which one 
lox-P site replaced the Nesp translation initiation sequence. Nesp is preferentially expressed 
from the maternal allele, therefore maternal transmission of the mutation results in 
Nesp55-deficient progeny, which will be referred to throughout this thesis as Nespm/+. These 
subjects were compared to wild-type (WT) littermate controls. Paternal transmission of the 
mutation results in deletion of the paternal allele (Nesp+/p), which means the normally 
expressed maternal Nesp is still intact, and is therefore functionally the same as a WT. 
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2.2.1.2 Grb10+/p  
Grb10 deficient mice were created using a LacZ:neomycin gene-trap cassette within 
Grb10 exon 8, as described previously in Garfield et al. (2011). Grb10 shows a complex 
pattern of monoallelic expression. Paternal Grb10 is transcriptionally silent and only the 
maternal allele is expressed in peripheral tissues; in contrast, paternal Grb10 is expressed in 
the CNS, where the maternal allele is silenced. Therefore, paternal transmission of the 
targeted mutation, referred to as Grb10+/p, results in loss of Grb10 expression in the CNS 
only.  Grb10 KO animals used in this research were paternal KO of Grb10 (Grb10+/p) and 
were compared to WT littermate controls. 
Breeding stock of both lines were maintained in-house on a mixed “F1” (CBA/Ca x 
C57Bl/6) background. Experimental cohorts of Nespm/+ plus WT littermates, and Grb10+/p 
plus WT littermates were generated from these breeding stocks by crossing F1(CBA/Ca x 
C57Bl/6) with either F1 Nespm/+ or F1 Grb10+/p respectively to create experimental cohorts 
of F2 animals.   
 
2.2.2 Animal husbandry 
Mice were single-sex group housed (2-5 mice per cage) in environmentally enriched 
cages (i.e. with cardboard tubes, shred-mats, tissue paper) in a temperature and humidity 
controlled animal holding room (21 ± 2°C and 50 ± 10%, respectively) with a 12-hour light-
dark cycle (lights on at 07:00 hours/lights off at 19:00 hours). Only subjects of the same line 
were housed together, and the majority of the home cages included at least one animal of 
each genotype; birth litters were kept together whenever possible. Standard rodent 
laboratory chow and water were available ad libitum, unless otherwise stated. Home cages 
were cleaned and changed once a week, at approximately the same time of the day and on 
the same day of the week, in order to cause minimal disruption to the behavioural testing. 
Only male subjects were used in all experiments in this thesis, in order to avoid the potential 
confound of hormonal changes in female mice. Experimental animals were regularly 
monitored and weighed from approximately 8-10 weeks of age for signs of ill health. Any 
mice showing signs of illness were immediately assessed by a Veterinarian and, if necessary, 
withdrawn from the experiment.  
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2.3 Behavioural methods 
 
2.3.1 Handling  
All behavioural cohorts were handled regularly from approximately 8-10 weeks of 
age, for approximately 1 minute per mouse, twice a week. Prior to behavioural testing, 
animals were handled every day for a period of two weeks. 
 
2.3.2 Measurement of body weight 
Body weights of all mice were recorded on a regular basis as an index of growth and 
development and a measure of general health. Weights were registered daily for the period 
of two weeks prior to and during the administration of the water restriction protocol (see 
section 2.3.4). This was carried out at the same time of day (at approximately 10:00). 
Subjects were also weighed before any behavioural experiments began. 
 
2.3.3 Behavioural testing environment 
Behavioural testing was carried out in sealed and air-conditioned testing rooms 
during the light period. Testing rooms were lit by fluorescent lights, except where stated. 
Temperature and humidity levels were not strictly controlled, but were generally 
maintained at around 21 ± 2°C and 50 ± 10% respectively. Rooms were thoroughly cleaned 
once a week. 
 
2.3.4 Protocol for the water restriction schedule 
Prior to testing in behavioural paradigms where condensed milk was used as a 
reinforcer, subjects were placed on a schedule of reduced home cage water access (in order 
to enhance motivation for the reinforcer). This schedule lasted 6 days, encompassing 4 days 
of 4hr access/day and 2 days of 2 hr access/day. Mice were weighed daily during this time, 
as were their drinking bottles to ensure they were drinking during the period of water 
access. In the event of an animal losing >20% of its ad libitum body weight or showing 
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clinical symptoms of dehydration or ill-health animals would immediately be given ad 
libitum water access until normal ad libitum body weight was re-established. However this 
was never observed. Subjects were allowed ad libitum access to standard laboratory chow, 
throughout the duration of the water restriction schedule. After these 6 days, mice were 
maintained on a 2 hr access/day schedule for the duration of the experiments that required 
water restriction. During periods of water restriction, subjects were given ab libitum access 
to water at weekends. 
 
2.3.5 Reinforcer preference test/reactivity to a novel food substance 
Prior to experimental testing, all subjects were habituated to the liquid reinforcer 
(10% condensed milk solution, Nestle Ltd, U.K.) used in behavioural tasks such as the 
delayed discounting task, progressive ratio task and the predator odour risk-taking (PORT) 
task. Briefly, the reinforcer preference test (see Plagge et al., 2005) was carried out in a 
number of holding cages (285 x 130 x 120 mm) with a single subject per cage, during a single 
10 minute session per day, across a six-day period. During the first session, subjects were 
allowed to habituate to the test apparatus, while general water consumption was measured 
by placing two containers (max vol. 3 ml each)  containing an excess of tap water of 
registered weight, to the rear of each cage. Following each test session, the containers were 
re-weighed in order to determine the total water consumption. Over the next four sessions, 
one of the containers was filled with the condensed milk reinforcer, and the second 
container was filled with tap water. The locations of the two containers within the cage 
were pseudo-randomly switched between days. As before, the containers were weighed 
prior to, and immediately after testing, in order to determine the consumption of each 
liquid as well as the daily preference for the condensed milk. Reinforcer preference was 
defined as the amount of reinforcer consumed in the final session of reinforcer preference 
testing, as a percentage of the total amount of liquid (i.e. the reinforcer and water 
collectively) consumed during that session. The final day of testing involved filling both 
containers with condensed milk, for the ‘milk vs. milk’ condition. This was to ensure that all 
of the subjects had sampled the condensed milk reinforcer before testing in the behavioural 
paradigms. Any subjects failing to reach 70% preference for the condensed milk on the final 
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day of preference, and failing to consume condensed milk on the milk vs. milk day, were 
excluded from any experiments using condensed milk as a reinforcer. 
 
2.3.6 Behavioural phenotyping: general experimental control measures 
 Behavioural testing always coincided with the light phase of the light-dark cycle of 
the animal holding room (i.e. between 07:00 hours and 19:00 hours), and water access was 
provided immediately subsequent to any behavioural assessment. Moreover, in order to 
maintain a constant time period between the time of testing and water access (which might 
affect motivation for the liquid reinforcer), and also to minimise any behavioural variation 
due to when the subjects were tested, individual subjects were tested at the same time 
each day.  In addition, possible ‘order of experimental run’ effects were negated by running 
the experimental and control subjects in a pseudo-random order. To minimise possible 
confounds related to cage/litters, the experimental subjects were drawn from as large a 
number of cages/litters as available.  
 
2.3.7 Culling protocol 
At the end of the experiment, or in case of illness/injury, subjects were generally 
culled through cervical dislocation in accordance with Schedule 1 of Animals (Scientific 
Procedures) Act (1986). However, for collection of brain tissue samples, a number of 
animals were subjected to terminal anaesthesia and perfusion with 10% formalin (outlined 
in Section 2.5.3.1). 
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2.4 Behavioural apparatus 
 
The current section describes the apparatus used for behavioural experiments 
employed in this thesis. The exact procedures used are described in detail in the subsequent 
experimental chapters.  
 
2.4.1 Locomotor activity 
 
 
Figure 2.1 Locomotor activity apparatus. Testing of 
locomotor activity (LMA) was carried out in an 
apparatus consisting of twelve clear Perspex chambers 
(each 21 x 36 x 20 cm, width x length x height), with 
two embedded infra-red beams crossing each cage 30 
mm from each end and 1 cm from the floor. Beam 
breaks were recorded as an index of activity, using a 
computer running custom written BBC Basic V6 
programmes (Dr Trevor Humby) with additional 
interfacing by ARACHNID (Cambridge Cognition Ltd, 
Cambridge, U.K.). Data stored were the total number 
of beam-breaks from each 2 hour session, as well as 
the number of beam-breaks made over each 30 
minute quartile.  
See Chapter 3 for experimental details. 
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2.4.2 Novelty Place preference 
 
 
Figure 2.2 Novelty place preference apparatus. Testing of 
novelty place preference (NPP) was carried out in an 
apparatus consisting of two adjacent chambers (each 30 x 
30 x 20 cm, width x length x height) with an opening in the 
middle, which could be occluded by a door (attached with 
Velcro). The 2 arenas were made distinct by the colour 
(black or white) and the texture of the floor (plastic or 
sandpaper). The time spent and the number of entries 
into the novel compartment was measured automatically 
by a video tracking system, using Noldus software.  
See Chapter 3 for experimental details. 
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2.4.3 Delayed reinforcement and progressive ratio 
 
 
Figure 2.3 Delayed reinforcement and progressive ratio apparatus. Testing was carried out in “9-
hole” operant chambers (Cambridge Cognition Ltd, U.K.) based on a design first used in rats (Carli 
et al., 1983) and tailored for use in mice (Humby et al., 1999). The chambers were made of 
aluminium, with a clear Perspex roof, and a curved rear wall (at a distance of 130 mm) into which 
nine 10 mm diameter holes were set. Set into each aperture was a 2.5 W bulb and for the 
progressive ratio task, aperture 5 (from the left side) was used, and for the delayed reinforcement 
apertures 3 and 5 were used. Responses made by subjects into each aperture were measured by a 
vertically orientated infra-red beam. Opposite the aperture array was a food magazine (accessed 
through a clear Perspex door), into which condensed milk reward was delivered to a small food well 
in the floor via 0.8 mm silicone tubing (Watson & Marlowe, U.K). This food delivery process was 
controlled by a peristaltic pump, with standard food delivery of 22 l (equivalent to driving the 
pump for 1 second). A micro-switch recorded when the door to the food magazine was opened, 
and two infra-red beams (located 5 mm off the floor, emanating from the side wall) detected 
general movement in the chambers. A loudspeaker was also located in the side wall, as well as two 
infra-red LEDS (providing background illumination for the CCTV systems) and two 2.5 W house 
lights. The chamber was located in a sound attenuating outer box complete with a fan to keep a 
constant low background noise and provide ventilation. Infra-red sensitive cameras mounted in the 
roof of the outer boxes meant that CCTV could be used to observe the mice (Watac WM6, Tracksys 
1. Response array (9 apertures,  10 
mm diameter, spanned by 
vertical infra-red beams and 
each containing a small light) 
 
2. Food magazine (containing tray 
light  and food well) accessed via 
a hinged panel  
 
3.  Silicone tubing 
4.  Peristaltic pump 
5.  Reinforcer bottle (10%   
 condensed milk solution)  
6.  House light  
7.  Loudspeakers 
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Ltd, U.K.), located 100 mm above the chambers. Control of the chambers was managed by an Acorn 
RISC-PC computer running custom-written BBC BASIC V6 programmes with further interfacing by 
ARACHNID (CeNeS Ltd, U.K.). 
See Chapter 4 (delayed reinforcement and progressive ratio tasks) for experimental details. 
 
2.4.4 Elevated plus maze 
 
Figure 2.4 Elevated plus-maze apparatus.  The 
elevated plus-maze (EPM) was constructed of 
dulled black Perspex covered in white tape (to 
enable tracking of dark coated mice) and 
consisted of two exposed open arms (17.5 x 
7.8 mm, length x width) and two enclosed 
arms (19 x 8 x 15 cm, length x width x height) 
with an open roof. The maze was positioned 
94 cm above the floor and illuminated evenly 
with a 60 W bulb.  
See Chapter 5 for experimental details. 
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2.4.5 Startle chamber 
   
 
Figure 2.5 Startle/Prepulse inhibition apparatus. 
The startle chamber apparatus consisted of 
ventilated and sound attenuating SR-LAB startle 
chambers (San Diego Instruments, CA, USA) 
containing a non-restrictive Plexiglas cylinder (3.5 
cm in diameter) mounted on a Perspex plinth. 
Directly beneath the centre of the tube was a 
Piezoelectric sensor that detected flexion in the 
plinth: the measure of startle reactivity.  Above the 
animal enclosure (12 cm) a loud speaker was 
mounted, via which all white-noise stimuli were 
presented. The motor responses of the subject 
were recorded via the piezoelectric accelerometer 
and values were transduced and digitised by a 
transducer linked to the computer. For each day of 
testing, the test chambers were calibrated, using 
mice of equivalent bodyweight to the test subject 
to equalise the measure of startle response from 
each chamber.  Similarly, the peak amplitude of the 
stimuli presented in each chamber was made 
equivalent. 
See Chapter 5 for experimental details. 
 
 
 
 
 
 
 
 
 
Chapter 2 | General methods and materials 
 
 
 
Page | 50  
 
2.4.6 Predator odour risk-taking task 
 
Figure 2.6 Predator odour risk-taking task (PORT) testing apparatus. Apparatus consisted of three 
adjacent chambers of equal size (30 x 30 x 40 cm), separated by walls containing guillotine doors 
operated by a pulley system. A video camera, connected to a video recorder, was mounted above 
the apparatus to allow video tracking (by EthoVision, Noldus Information Technology, The 
Netherlands) of the animals behaviour and video recording of the experiments. Mice would start in 
one of the outer chambers (shown here as the left chamber, but counterbalanced across subjects) 
and would be required to cross the middle chamber (containing an odour) in order to collect a food 
reward in the opposite chamber (shown here as the right chamber). 
See Chapters 5 and 6 for experimental details. 
 
2.4.7 Ethovision tracking 
Assays using the EthoVision Observer video tracking software (version 3.0.15, Noldus 
Information Technology, Netherlands) included the NPP task, EPM and the PORT task. Video 
tracking was used to track and analyse the behaviour, movement and activity of the mice. 
EthoVision tracks a subject’s movement within previously defined zones within the total 
arena, which are designed specifically for each task. The EthoVision tracking system 
performed calculations over a series of frames (12 frames/sec) to derive a set of 
quantitative descriptors about the movement and location of subjects, and variables such as 
duration, movement, entries and latency to enter each the chamber were determined by 
the EthoVison programme in terms of location of the greater body-proportion of subjects. 
Tracking of the subject was calibrated for the test apparatus prior to testing using non-
experimental mice of the same body size and coat colour as the experimental subjects. 
doors 
30cm 
30cm 
reward 
Start chamber Odour chamber Reward chamber 
40cm 
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Specific zone designs as well as specific parameters measured are outlined in each 
experimental chapter. 
 
2.5 Molecular methods 
 
2.5.1 Standard genotyping protocol 
To identify the different genotypes of mice, DNA was extracted from hair samples 
and/or tail biopsies (~4 mm) collected when the mice were 5 weeks old. All genotypes were 
re-confirmed from tail biopsy samples following culling at the end of an experiment. DNA 
was amplified by Polymerase chain reaction (PCR) and imaged using gel electrophoresis. 
 
2.5.1.1 DNA extraction from hair samples 
 Tufts of hair were obtained by plucking with tweezers, and placed in 1.5 ml micro-
centrifuge tubes. 100 μl of 50 mM NaOH (sodium hydroxide) was added to samples and 
centrifuged for 60 seconds at 13,000 rpm. Samples were then put on a heating block and 
left to heat at 100˚C for 10 minutes. Following this, samples were put on ice and allowed to 
cool for 5 minutes, and then centrifuged for 1 minute at 13,000 rpm. 2 µl of sample was 
used per PCR reaction. 
 
2.5.1.2 DNA extraction from tail samples 
Tail biopsy samples were placed in 1.5 ml micro-centrifuge tubes and digested in 400 
μl of lysis buffer (0.2% SDS, 50 mM Tris (tris(hydroxymethyl)aminomethane); pH=8.0, 10 
mM EDTA (ethylene-diaminetetra-acetic acid), 100 mM NaCl (sodium chloride) with 2 μl of 
Proteinase K (Qiagen, Crawley, U.K.) with a final concentration of 0.2 mg/ml, at 55-60°C 
overnight. The following day, digested tissue samples were vortexed briefly and spun in a 
centrifuge for 10 minutes (13,000 rpm) to sediment debris, the supernatant subsequently 
transferred into new micro-centrifuge tubes. Next, an equal volume of cold isopropanol 
(400 μl) was added to the obtained supernatant and the samples refrigerated for 20 
minutes to facilitate DNA precipitation. Samples were then re-centrifuged for 10 minutes 
(13,000 rpm), following which the supernatant was discarded and the tubes left on a 
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heating block for 10 minutes in order to allow the isopropanol to evaporate. A volume of 
100 l of TE buffer, (10 mM of Tris and 1 mM of EDTA, bought to pH=8 with hydrogen 
chloride to down-regulate the activity of nucleases), was added to stabilize and protect the 
dissolving DNA from degradation.  
 
2.5.1.4 Genotyping primers 
PCR genotyping was carried out using primers designed specific to Nesp, as shown in 
Table 2.1. Primers for Grb10 were designed to the β-galactosidase/neomyicin (β-geo) 
cassette integrated into the Grb10 locus, the details of which can be found in Table 2.1.  
 
Gene         Primer                             Primer sequence                          
Nesp Forward (NL3)  AGTGGAGGCACCTCTCGGA 
 Reverse (Ne-R7)  TCGTGATCAGACTCAGATTCA 
Grb10 Forward (β-geo F2)  CCGACGAAAACGGTCTGCG 
 Reverse (β-geo R2)  CTTCCCGCTTCAGTGACAACG 
Table 2.1: List of primer sets used for genotyping. 
 
2.5.1.5 Polymerase chain reaction (PCR) protocol 
Reaction mixtures and the programme used for Nesp and Grb10 genotyping PCR are 
described in Table 2.2, using the respective primer sets detailed in Table 2.1. The reactions 
were run in a Peltier Thermal Cycler (MJ Research, U.K.). 
 
 Programme 
Reaction               Nesp Grb10 
2.5 µl of 10x buffer 1. 95oC for 10 minutes 1. 96˚C for 10 minutes 
2.5 µl dNTPs 2. 95oC for 30 seconds 2. 96˚C for 30 seconds 
1 μl Forward primer 3. 58oC for 30 seconds 3. 60˚C for 30 seconds 
1 μl Reverse primer 4. 72oC for 45 seconds 4. 68˚C for 30 seconds 
0.4 μl Taq 5. Stages 2-4, 30 cycles 5. Stages 2-4, 36 cycles 
1 μl sample 6. 72oC for 10 minutes 6. 72˚C for 300 seconds 
16.6 μl H2O 7. 10
oC forever 7. 10˚C forever 
Total: 25 µl   
Table 2.2: List of reaction conditions and programme used for PCR 
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2.5.1.6 Gel electrophoresis 
Amplicons were run on an electrophoresis gel to separate out fragment sized DNA, 
where 5 μl of 6x DNA loading buffer was added to each reaction product and a total of 30 μl 
of the reaction/loading buffer mixture was loaded on to a 1.2 % agarose gel. Finally, 5 μl of 
DNA ladder (Hyperladder IV, Bioline, U.K.) was loaded in the first well, and the gel 
subsequently run at 110 V for 30-40 minutes. After electrophoresis, the agarose gel was 
placed under UV light and the amplicons examined for bands. In genotyping the Nesp cohort 
an upper band (700 bp) corresponded to the mutant allele, a lower band (600 bp) to the 
WT. Therefore, the presence of 2 bands was indicative of a Nespm/+ genotype, and the 
presence of 1 band was indicative of a WT animal (Figure 2.6a). In the Grb10 cohort the 
presence of a mutant allele was identified by a single ~600 bp product, WT mice had no 
product present (Figure 2.6b). 
 
 
    
 
 
       
Figure 2.6 Example images of DNA bands used to identify genotypes of individual animals. (a) 
Shows image of genotyping for mice in the Nesp cohort, where a double band (at 600 and 700 bp) 
is indicative of a Nespm/+ subject, and a single band (at 600 bp) is indicative of a WT subject. (b) 
Shows image of genotyping for mice in the Grb10 cohort, where a single band (at ~600 bp) is 
indicative of a Grb10+/p subject and no band is indicative of a WT subject. 
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2.5.2 Real time qPCR 
 
2.5.2.1 Preparation of brain homogenates for real- time qPCR analysis 
 The isolation of good quality total RNA is of paramount importance in order to 
produce high quality gene expression data. All usual precautionary measures were taken to 
prevent degradation and/or contamination of the RNA samples, i.e. tissue samples kept at -
80°C immediately following dissection, and using RNA-free working surfaces and 
consumables.  
 
2.5.2.2 Isolation of total RNA: Trizol method 
 Cerebral tissue (only hypothalamus and midbrain were processed for the current 
research, see Chapter 7) extracted from whole brains was transferred to lysing matrix tubes 
(FastPrep-24, MB Biomedicals, U.S.). 400 μl of Trizol (Tri Reagent from Sigma-Aldrich, U.K.) 
was added to each tube and the tubes then homogenised at 4°C in a FastPrep FP120 micro- 
homogenizer (MB Biomedicals, U.S.) for 2 x 10 seconds, at 5 m/s. Tubes were then spun in a 
centrifuge at 12,000 rpm at 4°C for 10 minutes, the supernatant removed from the matrix 
tubes and discarded, and 200 μl of chloroform added to each tube. The tubes were vortexed 
for 15 seconds and then incubated at room temperature for 10-15 minutes. The mixture 
was then spun in a centrifuge at 12,000 rpm at 4°C for 10 minutes, and supernatant 
(containing the RNA) transferred to a fresh polypropylene centrifuge tube. A volume of 300 
μl of isopropanol was then added to each sample; they were then briefly vortexed (10 
seconds) and then incubated at room temperature for 10 minutes. The mixture was then 
spun in a centrifuge at 12,000 rpm at 4°C for 10 minutes, forming a pellet; after which the 
supernatant was removed and discarded. Subsequently, the RNA pellet was washed in 500 
μl of 75% ethanol, vortexed briefly and spun in a centrifuge at 12,000 rpm at 4°C for 5 
minutes. The RNA pellet was next allowed to dry for approximately 45 minutes and then 
resuspended in an appropriate volume of DEPC-treated MilliQ water. Finally, the samples 
were incubated at 55˚c for approximately 20 minutes to ensure total re-suspension. 
 
 
Chapter 2 | General methods and materials 
 
 
 
Page | 55  
 
2.5.2.3 Quantification of the RNA sample 
 A spectrophotometer (NanoDrop® ND-1000 UV-Vis, Wilmington, DE) was used to 
quantify the amount of RNA in each sample, by measurements of UV absorption. Since RNA 
absorbs maximally at 260 nm, the ratio of absorbance at 260 nm and 280 nm (protein) was 
used to assay the RNA purity of a given RNA preparation.  Pure RNA has an A260/A280 ratio 
of 2.1. For nucleic acid quantification, the Beer-Lambert equation is manipulated to give: 
 
Where c is the nucleic acid concentration in ng/µl, A is the absorbance in AU (for the 
arbitrary absorbance units), e is the wavelength-dependent extinction coefficient in ng-
cm/microliter and b is the path length in cm. For the nucleic acid, data are normalised to a 1 
cm path.  The generally accepted extinction coefficient for RNA is 40. The 
spectrophotometer enabled highly accurate analysis of particularly small sample volumes. 
Surface tension was used to hold a column of liquid sample in place while a measurement 
was made. A small quantity of the sample (1 μl) was pipetted directly onto a measurement 
pedestal, and a measurement column was then drawn between the ends of two optical 
fibres in order to establish a measurement path. The measurement was carried out and 
displayed on the screen of an attached computer.  
 
2.5.2.4 Removal of DNA from the RNA sample 
 To create high quality cDNA from the RNA sample, all traces of DNA were removed 
from the sample using Turbo DNA-free protocol (Ambion, UK). The typical reaction was a 50 
μl volume, containing nuclease free water, 1x TURBO DNase buffer, 1 μl of TURBO DNase for 
up to 10 μg of RNA. The reaction mixture was incubated at 37°C for 30 minutes. 1x DNase 
Inactivation reagent was then added to the reaction and thoroughly mixed. After a 2 minute 
incubation period at room temperature the sample was centrifuged at 10,000 rpm for 1.5 
minutes. The RNA was then transferred into a fresh tube.  
 
 
b
eA
c


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2.5.2.5 RNeasy purification of extracted total RNA 
 The RNeasy Mini Kit for RNA clean-up (Qiagen, UK) was used to purify the extracted 
RNA (binding capacity 100 μg) according to the manufacturer’s instructions. The total RNA 
sample was adjusted to 100 μl with RNase free water, and 300 μl of RLT buffer was added to 
the sample and mixed well. Subsequently, 250 μl of absolute ethanol was added to the 
RNA/RLT solution and mixed thoroughly, and then 700 μl of the sample was applied to an 
RNeasy mini-spin column membrane sitting in a collection tube. The sample was then spun 
in a centrifuge for 15 seconds at 10,000 rpm, transferred to a mini-spin column membrane 
of a collection tube, and spun again for 15 seconds at 10,000 rpm. Once, the RNA had been 
transferred into a new collection tube, 500 μl of buffer RPE was added and the solution then 
spun in a centrifuge for 15 seconds at 10,000 rpm to wash. The same volume of buffer RPE 
was added onto the column membrane again (once the remaining buffer RPE had been 
discarded), and then spun in a centrifuge for 2 minutes at 13,000 rpm to dry the RNeasy 
membrane. Next, the RNA spin column was placed in a new 2 ml collection tube and spun in 
a centrifuge for 1 minute. The column was then transferred into a new 1.5 ml collection 
tube and 20 μl of RNase-free water was pipetted directly onto the membrane and allowed 
to stand for 1 minute, after which it was spun in a centrifuge for 1 minute at 10,000 rpm. 
This step was repeated but with only 10 μl of RNase-free water this time.  RNA was eluted in 
a total volume of 30 μl nuclease-free water and again was quantified by absorbance using 
the NanoDrop® ND-1000 UV-Vis Spectrophotometer machine (see Section 2.5.2.3). 
 
2.5.2.6 cDNA synthesis  
 The synthesis of first-strand cDNA from the total extracted RNA was carried out 
using Clontech® RNA to cDNA kit for PCR (Clontech, Mountain View, U.S) in accordance with 
the accompanying Poly-dT protocol, based on the methods of Ausulbel et al. (1995). The 
extracted (and purified) total RNA in RNase-free water, was adjusted to obtain 2.5 μg of 
total RNA in a final volume of 20 μl, based upon the previous determination of total RNA 
concentration. Next, the total RNA samples were pipetted into individual wells of the Sprint 
RT complete product and mixed thoroughly with the lyophilised reagents by pipetting up 
and down. The wells containing the reaction mixtures were then incubated at 42˚C for 60 
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minutes. Finally, the reactions were terminated by heating at 70˚C for 10 minutes, thus 
ending the synthesis of cDNA from the RNA reactions.  
 
2.5.2.7 Quantitative PCR (qPCR) primer sets 
 The primer sets used for the real-time quantitative PCR analysis, were designed 
using Primer3 (http://primer3plus.com/web_3.0.0/primer3web_input.htm). Each of the 
primer sets (Table 2.3) was designed across intron-exon boundaries, thus eliminating signals 
from contaminating genomic DNA.  Working concentrations of primer pairs were optimised 
to provide the best signal-to-noise ratio. Optimisation of the primer sets was performed by 
combining different dilutions of the forward primer with varying dilutions of the appropriate 
reverse partner. Furthermore, every combination was assessed in two kinds of reactions; 
the real-time PCR reaction using a test DNA sample and the non-template control reactions 
(NTC). Since the NTC reactions did not contain any DNA sample, any false amplification 
signal could only originate from primer dimers. The obtained Ct values (see Section 2.5.2.9) 
of the NTC reactions were compared to the Ct values obtained in the DNA-containing PCR 
reactions. Details of the primers and the working concentrations used can be found in Table 
2.3. 
Gene             Primer           Primer sequence                                                          Concentration 
Nesp Forward 5’-GACGGTCAAGAAGGTGGAAA-3’ 700 nM 
 Reverse 5’-CACTGCGCCTGCAGTCCC-3’ 700 nM 
Grb10 Forward 5’-TGCACCACTTCTTGAGGATG-3’ 700 nM 
 Reverse 5’-ACCAGTGAGCTCCGGAAATG-3’ 700 nM 
18S Forward 5’-GTAACCCGTTGAACCCCATT-3’ 300 nM 
 Reverse 5’-CCATCCAATCGGTAGTAGCG-3’ 300 nM 
Table 2.3: List of qPCR primer sets used for the qPCR gene expression analysis. 
 
2.5.2.8 qPCR  
Gene expression analysis was performed using a Rotorgene 6000 RT-PCR machine 
(Corbett Research, UK), while the consumables used in the experiments were provided by 
Corbett Research and Bioline, UK. The reactions and programme used were set up in 
accordance with the protocol listed in Table 2.4, where the purpose of stage six and seven in 
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the programme was to obtain ‘melting curve’ data, which enabled confirmation that only a 
single amplicon was produced, and that minimal primer dimerisation had occurred. 
Reaction Programme 
1.4 µl of H2O 1. 95°C for 10s 
7.5 SensiMix 2X 2. 57°C for 15s 
0.3 Syber (50X) 3. 72 °C for 20s 
Forward primer 4. Go to Step 1; 40 times 
Reverse primer 
10 µl of cDNA (1/10) 
5. Ramp from 72°C to 95°C rising 1°C each  step 
(melting curve analysis) 
 6. Wait for 90’’ of pre-melt conditioning on first 
step and for 5’’ for each step afterwards. 
 7. End 
21 µl  
Table 2.4: Protocol of reactions and programme used for qPCR analysis. 
 
2.5.2.9 Data analysis using the 2- ΔΔCt method 
 Since gene expression was compared between mutant mice and their WT-littermate 
controls, a relative quantification method was selected as the appropriate method of 
analysing the data. Therefore, the 2-ΔΔCt method was used to calculate relative changes in 
gene expression determined from each real-time quantitative PCR experiment. Derivation of 
the 2-ΔΔCt equation, including assumptions, experimental design and validation tests have 
been previously described by Livak and Schmittgen (2001). Housekeeping genes are 
commonly used as an internal control in order to normalise the qPCR data for the amount of 
RNA that is added to a reaction. In this thesis, 18S was selected as the reference gene due to 
its widespread uniform and high levels of expression (Doe et al., 2009). The change in 
expression of the target gene was normalized to the Ct values of 18S rRNA for each 
individual sample.  Each sample was run in triplicates in order to minimise sampling errors. 
The Ct values (defined by the number of cycles required for the fluorescence to cross the 
threshold, i.e. exceeding the background level) obtained from the Rotorgene 6000 RT-PCR 
software were imported into Microsoft Excel, which enabled descriptive analysis of the 
data, and conversion to 2-ΔΔCt for subsequent analysis (see VanGuilder et al., 2008). The Ct 
values for the 18S and the target gene mRNAs were averaged across the triplicates for each 
sample, prior to performance of the ΔCt calculation. The ΔCt value was calculated by 
subtracting average Ct values of the target genes from the average Ct values of the 18S (i.e. 
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the control sample). Next, the subtraction of the ΔCt values of the control samples from the 
ΔCt values of the target gene samples yielded the ΔΔCt values. The negative values of this 
subtractions, the - ΔΔCt values, were then used as the exponent of 2, and represent in 
“corrected” number of cycles to threshold (Livak and Schmittgen, 2001), but the exponent 
conversion is based on the fact that the reaction doubles the amount of product per cycle. 
These values were then combined with the values of relative change in the expression of the 
target gene between the comparison groups and presented as a graph. 
 
2.5.2.10 Statistical analysis of the real-time qPCR data 
 The final stage of the real-time qPCR analysis was to determine the threshold cycle 
or the Ct value. The Ct value was derived from a log-linear plot of the PCR signal against the 
cycle number, which depicts the Ct value as an exponential instead of a linear term. Hence, 
the data were converted to a linear form using 2-ΔCt (transformed data). In order to examine 
the statistical significance of the relative change, independent two tailed T-tests were 
performed on the transformed data.  
 
2.5.3 Histology 
2.5.3.1 Adult mouse perfusion 
 Grb10+/p mutant mice, plus their WT littermates, and Nespm/+ mutant mice and their 
respective WT littermates were anaesthetised using an intraperitoneal (IP) injection of 
pentobarbitone. Once the mouse was fully anaesthetised (as determined by toe-pinch), the 
chest was cut open and the right atrium of the heart was punctured to allow blood to drain 
from the circulatory system. Mice were then fixed via perfusion using PBS followed by 4% 
PFA in PBS, through an injection into the left ventricle of the heart. Brains were dissected 
whole and placed in 4% PFA overnight, the following day tissues were then transferred to a 
30% sucrose solution (in PBS) at 4˚C for 24 hours, in order to dehydrate and cryoprotect 
them.  
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2.5.3.2 Mictrotome sectioning of tissues 
 In order to complete immunohistochemistry and immunofluorescence analysis, 
whole brain samples were sectioned using a freezing microtome. Before sectioning, the 
cerebellum and olfactory bulb were removed from whole brains. Brains were then mounted 
on to the microtome platform using an embedding matrix and allowed to freeze fully. Serial 
coronal sections of 40 µm were sliced and put into 25-well containers containing 
cryoprotectant (6 sections per well). The free-floating sections in cryoprotectant were 
stored at -20°C until required. 
 
2.5.3.3 Antibodies 
The Grb10+/p mutant mouse strain is derived by insertion of a LacZ:neomycinr gene-
trap cassette within Grb10 exon 8, therefore transmission of the Grb10KO allele separately 
through the paternal line generates heterozygous progeny in which the paternal 
Grb10 allele is disrupted by the β-geo cassette (Grb10+/p) . Therefore, the LacZ reporter gene 
is expressed in place of paternal Grb10. As a proxy for Grb10 visualisation, a β-galactosidase 
(β-gal) specific antibody was used as previously (Garfield et al., 2011). The Nesp55 primary 
antibody (generated and obtained from Reiner Fischer-Colbrie Lab) has been well 
characterised previously. Specifically it is a rabbit anti-Nesp55 polycolonal antibody, 
recognizing the free terminal end (GAIPIRRH) of Nesp55 (Ischia et al., 1997) used at a 1:1000 
dilution (as used previously). All antibodies were optimised (with the exception of anti-
Nesp55), using 3 relevant dilutions of the antibodies (based on recommended dilution), in 
order to determine the optimal dilution. For immunohistochemistry, a biotinylated 
secondary antibody was used as part of the VECTASTAIN® Elite ABC System (Vector 
Laboratories, Canada). The antibodies used for immunofluorescence are detailed in Table 
7.1.  
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Primary antibodies Secondary antibodies 
Antibody Dilution Antibody Dilution 
Rabbit polycolonal anti-Nesp55 
(R. Fisher-Colbrie) 
1:1000 Donkey anti-rabbit ALEXA FLUOR 
568 (Life Technologies) 
1:1000 
Goat polycolonal anti-β-gal 
(Abcam) 
1:1000 Donkey anti-goat ALEXA FLUOR  
488 (Life Technologies) 
1:1000 
Goat polycolonal anti-Tyrosine 
Hydroxylase (Abcam) 
1:500 Donkey anti-goat ALEXA FLUOR 
488 (Life Technologies) 
1:1000 
Rat polycolonal anti-Serotonin 
(Abcam) 
1:500 Chicken anti-rat ALEXA FLUOR 488 
(Life Technologies) 
1:1000 
Table 7.1 Details and optimized dilutions of primary and secondary antibodies used for 
immunofluorescence analysis. 
 
2.6 General data presentation and statistical methods 
 
The data in this thesis is presented as mean values ± standard error of the mean 
(SEM), calculated from the following formula;  
 
Standard error of the mean = standard deviation of values 
                                                   number of values 
 
All statistical analyses were carried out using SPSS (version 18.0 for windows). The data 
were analysed by either, 2-tailed, paired T-test, independent-samples T-test, one-way 
analysis of variance (ANOVA) or repeated measures analysis of variance (ANOVA), where 
appropriate. All significance tests were performed with an alpha value of <0.05 regarded as 
significant. Interaction statistics are only reported if they reach significance, unless 
otherwise stated in experimental chapters. Post hoc pairwise comparisons were performed 
using Tukey’s HSD test. Repeated measures data were assessed for equality of variance 
using Mauchley’s test of sphericity, where if this was significant Greenhouse-Geisser 
corrections were applied. Wilcoxen Signed Rank test or Kruskal-Wallis H tests were applied 
as a nonparametric substitute for t-test or repeated measures analysis where required.  
Specific details of statistical analyses are described in the relevant experimental chapter. 
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Chapter 3 – Investigating novelty exploration in Grb10+/p mice 
 
 
3.1 Introduction 
 
 
Previous research has found that maternally expressed Nesp55, encoded by the 
gene Nesp, has a role in mediating adult behaviour (Plagge et al., 2005). Research exploring 
the role of Nesp55 has employed the use of various behavioural tests in order to 
characterise the specific nature of the effect that Nesp55 has on behaviour. Behavioural 
testing utilising genetically modified animals, null for the maternally expressed protein, have 
indicated that Nespm/+ mice have specific changes in their reactivity to novel environments 
(Plagge et al., 2005) suggesting that Nesp55 itself may be associated with the promotion of 
risk-taking behaviour. Impulsivity and risk-taking are fundamental components of numerous 
psychiatric illnesses, such as schizophrenia, and attention deficit hyperactivity disorder 
(ADHD). Nesp55 is also expressed in regions that represent key areas within the monoamine 
neurotransmitter system which are associated with modulating risk-taking and impulsive 
behaviour, further strengthening the link between these behaviours and this transcript 
(Plagge et al., 2005).  
 The Locomotor activity (LMA) test provides an automatic measure of general motor 
activity. Assessing locomotor activity has been widely used as a behavioural assay, as 
unconditioned motor activity in rodents probes a variety of behaviours (Paulus et al., 1999). 
Although it is a relatively simple task, the constructs it measures are multifaceted. The 
interpretation of spontaneous locomotor activity in rodents has been varied; including 
arousal, novelty seeking, exploration, anxiety and stereotypy (Geyer, 1990). In the LMA task 
animals were placed in a novel cage and their movement was measured by infra-red beams 
for 2-hour sessions on three successive days. As well as using this task to quantify the 
spontaneous activity of an animal, we used this test as a measure of reactivity to a novel 
environment; and examined the way in which subjects reacted, and became habituated to a 
novel surrounding. Using this test, it has been previously demonstrated that Nespm/+ mice 
were more active than their wild-type (WT) counterparts, but only during the first day of the 
3-day test (Plagge et al., 2005). This finding was supported by data from the open field (OF) 
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test, where Nespm/+ were also more active, specifically performing more quadrant crossings 
than controls. Importantly however, the movement in the open field was not indicative of 
anxiety-related behaviour, as although the Nespm/+ animals were more active, they spent no 
extra time in the centre of the open field arena, which is generally regarded as the primary 
measure of anxiogenic behaviour. Furthermore, behaviour in the elevated plus-maze, 
another test of anxiety which specifically assesses the conflict between approach and 
avoidance, confirmed unaltered anxiety in Nespm/+ mice. Therefore, these data gave rise to 
the conclusion that Nespm/+ mice show increased reactivity to novel environments, but 
independent of differences in anxiety (Plagge et al., 2005).  
In addition to the measurement of reactivity to novelty in the LMA and open field 
tasks, the novelty place preference (NPP) test was also used, as it provides a specific test of 
novelty seeking behaviour (Mikaelsson et al., 2013) . This paradigm assesses the conflict 
between the propensity to explore a novel environment and the fear provoked by the 
uncertainty of entry to a novel environment. During the NPP task animals were given a 
period of time to habituate to an environment, followed by the opportunity to explore a 
novel environment or remain in the familiar habituated environment. The degree to which 
the animal explored the novel environment can be indicative of novelty seeking behaviour 
(Redolat et al., 2009). An increased locomotor response to a novel environment is thought 
to be a marker of novelty seeking, an aspect of impulsivity/risk-taking behaviour (Beckmann 
et al., 2011). Previous research has demonstrated that preference for novelty, in a NPP task, 
predicts risk-taking behaviours, such as addiction and drug self-administration in rodents 
(Belin et al., 2010). It has been shown that rats with heightened locomotor response to a 
novel environment in a NPP task also show enhanced self-administration of amphetamine 
(Cain et al., 2005). In a previous study using the NPP task, it was shown that whilst Nespm/+ 
mice made significantly more entries into the novel environment, they spent significantly 
less time in the novel environment than WT mice (Plagge et al., 2005).  Researchers have 
interpreted these findings as being indicative of risk-averse behaviour (Plagge et al., 2005, 
Isles et al., 2006).  
The altered reactivity to novel environments in addition to the attenuated 
exploration behaviour that was exhibited by Nespm/+ mice led to the suggestion that Nesp55 
normally acts to promote ‘risk-taking’ behaviour (Isles et al., 2006). However the 
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explanations for the underlying neural mechanisms that are driving this behaviour remain 
unresolved. Previous experiments analysing the expression pattern of Nesp55 have 
identified expression in discrete, but key, areas of the serotonergic and noradrenergic 
systems, for example in the dorsal raphe nucleus and locus coeruleus (Plagge et al., 2005). 
Lesions to these areas, as well as pharmacological manipulation of these areas have shown 
an impact on novelty exploration, impulsivity and risk-taking behaviours (Dalley and Roiser, 
2012, Macoveanu et al., 2013). This suggests that Nesp55 may be exerting its influence on 
risk-taking and impulsivity via the serotonergic system. Recently it has also been shown that 
the paternally expressed imprinted gene Grb10  which is  oppositely imprinted to Nesp 
gene, is expressed in very similar areas to that of Nesp (Garfield et al., 2011), suggesting that 
this overlapping expression may give rise to the possibility that Grb10 may be exerting an 
influence on similar adult behaviours as Nesp. Therefore, this Chapter outlines experimental 
work that addresses this hypothesis, focusing on examining reactivity to novel environments 
in Grb10+/p mice and their WT littermates using the LMA and NPP, under the same 
conditions as the previous study investigating Nespm/+ mice (Plagge et al., 2005). 
 
3.2 Methods 
 
 
3.2.1 Subjects, handling and genotyping 
The subjects used in the experiments outlined in this chapter consisted of a cohort of 
13 Grb10+/p mice and their 11 WT littermates. All animals were male, aged 16-20 weeks at 
the beginning of testing, Grb10+/p mice weighed an average of 32g (±2g) and WT mice 
weighed an average of 35g (±2g). Animals had ad libitum access to standard lab chow and 
water for the duration of the experiments, (except when they were in the experimental 
apparatus). Details of general housing, husbandry and handling leading up to the 
experimental period were as described in Chapter 2, Section 2.3.   
 
3.2.2 Locomotor Activity  
 LMA was measured using specific test apparatus outlined in Chapter 2, Section 2.4.1. 
This consisted of a battery of 12 activity cages, each measuring 21 x 21 x 36 cm. The activity 
cages were clear Perspex boxes containing two transverse infrared beams 10 mm from the 
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floor, spaced equally along the length of the box, linked to Acorn computer using ARACHNID 
software (Cambridge Cognition Ltd., Cambridge, UK). The number of times an animal 
crossed the infrared beams was measured automatically, and the behavioural measure was 
obtained in terms of ‘breaks’ and ‘runs’. A ‘break’ was defined as a crossing one of either of 
the infrared beams, and a ‘run’ was defined as crossing both the infra-red beams 
consecutively. Animals were placed individually into the boxes, and were examined in the 
LMA test for 2 hour sessions in the dark, across 3 consecutive days. The experiment was 
carried out at the same time of day, and the animals were placed in the same box, for each 
of the 3 days. The cages were thoroughly cleaned after each animal, using 1% acetic acid 
solution. 
 
3.2.3 Novelty Place Preference 
 NPP was assessed using the apparatus described in Chapter 2, Section 2.4.2. This 
consisted of two adjacent boxes that have an opening in the middle which could be 
occluded by a door. Each box measured 29 x 29 x 32 cm. The 2 boxes were made distinct by 
the colour (black or white) and the texture of the floor (smooth plastic or sandpaper). In the 
first stage of the test the door is closed and the animal is placed in one of either of the two 
boxes for 1 hour and allowed to habituate. The mouse was then removed, the door opened 
and the mouse put back in the habituated side. Subjects were then free to explore both the 
habituated side and the novel side for 30 minutes. The side in which the animal was 
habituated, and in which the sand-paper was placed, was pseudo-randomly allocated to 
avoid confounding the results.  
The movement of each subject was tracked using a camera mounted approximately 
2 metres above the test area, which was connected to EthoVision Observer software 
(Noldus Information Technology, The Netherlands). The test area was divided into 2 virtual 
‘zones’, which were defined as ‘habituated’ and ‘novel’. EthoVision video tracking software 
was used to obtain behavioural data, as detailed in Chapter 2, Section 2.4.7. Behavioural 
measures, obtained automatically in 5 minute bins, included the duration of time spent in 
each zone, frequency of entries into the each zone, latency of first entrance into the novel 
zone and amount of rearing. The testing apparatus were cleaned after each animal using 1% 
acetic acid solution. 
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3.2.4 Statistics 
 LMA data (number of breaks and runs) were analysed using a 3-level repeated 
measures ANOVA, whereby the within-subjects factors were DAY (test days 1-3) or BIN (24 x 
5 minute bins within a session) and the between-subjects factor was GENOTYPE (control, 
Grb10+/p). The primary measure of NPP was the total duration, the number of entries made 
into the novel arena, and the latency to the first entrance into the novel arena; a student’s 
t-test was employed to analyse the difference in total time spent and number of entries 
made, and latency into the novel arena between the Grb10+/p and WT mice. Where the data 
do not meet the assumptions of independence for parametric testing, non-parametric tests 
were used; a Kruskal-Wallis H test was employed to analyse the genotype difference in time 
spent in the habituated and novel environments. Data was also analysed by BIN for both the 
1 hour ‘habituation’ stage, and 30 minute ‘test’ stage. Whereby a repeated measures 
ANOVA was used for habituation data, whereby within-subjects factors were BIN (6x 5 
minute bins within a session) and the between-subjects factor was GENOTYPE (control, 
Grb10+/p); where the data did not meet assumption of independence for parametric testing 
(during the choice stage) a Kruskal Wallis test was used to analyse data. All significance tests 
were performed at an alpha level of 0.05. Greenhouse-Geisser degrees of freedom (df) 
corrections were applied as appropriate to repeated-measures factors. Behavioural data are 
presented as mean values ± the standard error of the mean (SEM). All statistical analysis 
was carried out using SPSS (Version 18.0). 
 
 
3.3 Results 
 
 
3.3.1 Locomotor Activity 
 Results of the LMA task revealed that all subjects exhibited the expected habituation 
to the test boxes over the three days of testing. This was evidenced by a significant decline 
in activity across time, both in terms of the number of breaks (Figure 3.1a; main effect of 
DAY: F2,42=8.37,p<0.001) and the number of runs (Figure 3.1b; main effect of DAY: 
F2,42=7.70,p<0.005). Data from 1 Grb10
+/p subject was removed from all analysis due to 
increased variance (defined as 2 standard deviations away from the mean). There were no 
significant differences in locomotor activity between Grb10+/p and WT mice, as measured by 
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the number of breaks (Figure 3.1a; main effect of GENOTYPE: F1,21=0.47,p=0.50) or the 
number of runs (Figure 3.1b; main effect of GENOTYPE: F1,21=0.01,p=0.95), across 3 days.  
   
 WT N=11 
 Grb10+/p N=12 
Figure 3.1 Performance of Grb10+/p and WT mice in the LMA task. Graphs show the mean number of total 
‘breaks’ (a) and ‘runs’ (b) performed during the 120 minute session, across the 3 consecutive days of testing. 
The data presented are mean values ± SEM. 
***P<0.005. 
 
 
A more detailed analysis of the activity during each of the 120 minute LMA sessions 
was carried out in order to determine if Grb10+/p and WT mice exhibited parallel behaviour 
throughout the task. A repeated measures ANOVA was used to analyse the activity in 5-
minute time bins, in terms of the number of breaks (Figure 3.2) and the number of runs 
(Figure 3.3). The analysis of the number of breaks confirmed a significant decline in activity 
across time bin for day 1 (Figure 3.2a; main effect of BIN: F23,483=13.98,p<0.001), day 2 
(Figure 3.2b; main effect of BIN: F23,483=8.94,p<0.001) and day 3 (Figure 3.2c; main effect of 
BIN: F23,483=10.02, p<0.001). This effect was mirrored in the number of runs, which showed a 
decline on day 1 (Figure 3.3a; main effect of BIN: F23,483=15.78,p<0.001), day 2 (Figure 3.3b; 
main effect of BIN: F23,483=10.45,p<0.001) and day 3 (Figure 3.3c; main effect of BIN: 
F23,483=12.45, p<0.001). There was no difference between Grb10
+/p and WT mice in the 
number of breaks for day 1 (Figure 3.2a; main effect of GENOTYPE: F1,21=0.03,p=0.86), day 2 
(Figure 3.2b; main effect of GENOTYPE: F1,21=1.32,p=0.27) or for day 3 (Figure 3.2c; main 
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effect of GENOTYPE: F1,21=0.37,p=0.55). Furthermore there was no difference between 
Grb10+/p and WT mice in the number of runs for day 1 (Figure 3.3a; main effect of 
GENOTYPE: F1,21=0.20,p=0.66), day 2 (Figure 3.3b; main effect of GENOTYPE: 
F1,21=0.10,p=0.76) and for day 3 (Figure 3.3c; main effect of GENOTYPE: F1,21=0.01,p=0.92). 
These data show that Grb10+/p mice showed an unaltered reactivity to the novel 
environment, showing analogous behaviour to the WT mice throughout the LMA task. 
 
 
  
 
        
     
 
 
     WT N=11 
   Grb10
+/p
 N=12 
Figure 3.2 The number of breaks performed by  Grb10
+/p
 and WT mice across 3 days of the LMA.   Graphs 
depict number of ‘breaks’, broken down in  to 5 minute bins for Day 1 (a) Day 2 (b) and Day 3 (c). The data 
presented are mean values ± SEM. 
   ***P<0.005. 
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 WT N=11 
 Grb10+/p N=12 
Figure 3.3 The number of runs performed by Grb10+/p and WT mice across 3 days of the LMA. Graphs depict 
number of ‘runs’, broken down into 5 minute bins for Day 1 (a) Day 2 (b) and Day 3 (c). The data presented 
are mean values ± SEM.     
***P<0.005. 
 
3.3.2 Novelty Place Preference 
 
3.3.2.1 Habituation stage 
 During the 1 hour habituation stage of the NPP Grb10+/p and WT mice showed similar 
behaviour, specifically there was no difference in the amount of distance travelled (Figure 
3.4a; t=0.18 (df=21), p=0.86). Furthermore, subjects showed similar amounts of rearing, a 
behavioural index of novelty exploration, (Figure 3.4b; t=-0.01 (df=21), p=0.99). When the 
data were broken down into 5 minute bins across the 1 hour session (12 bins in total), the 
amount of exploratory behaviour, as measured by distance moved, significantly declined 
throughout the 1 hour habituation period (Figure 3.4c; main effect of BIN: F11,231=14.62, 
p<.0001). There were no genotype differences in the distance travelled across bins (Figure 
3.4c; main effect of GENOTYPE: F1,21=0.03, p=0.86). The decline in exploratory behaviour 
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was also evidenced by a significant decline in rearing across the habituation session (Figure 
3.4d; main effect of BIN: F11,231=5.17, p<.0001), with no genotype difference (main effect of 
GENOTYPE: F1,21=0.00, p=0.99). These data therefore show that Grb10
+/p and WT had similar 
behaviour during this stage of the NPP, and demonstrated the expected habituation to the 
novel environment; evidenced by a significant decline in exploratory behaviour throughout 
the habituation session. 
 
  
  
 WT N=11 
 Grb10
+/p
 N=12 
Figure 3.4 Behaviour of Grb10
+/p
 and WT mice during the habituation stage of the NPP. The Grb10
+/p
 mice 
showed analogous behaviour to the WT mice during the 1 hour habituation stage of the NPP. Specifically they 
showed no difference in the distance travelled (a), or in the amount of rearing (b), during the habituation 
period. When the data were broken down into 5 minute bins, there was a significant decline in exploratory 
behaviour, as evidenced by reduced movement (c) and rearing (d).***P<0.005. 
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3.3.2.2 Test stage 
 Results from the test stage of the NPP task showed that, in general, all mice had a 
propensity to explore the novel arena, shown by the overall distribution of behaviour for 
each subject (Figure 3.5). Data from one WT subject was removed from all stages of the NPP 
due to escaping from the apparatus during the habituation stage. A Kruskal-Wallis H test 
revealed all subjects spent significantly more time in the novel arena compared to the 
habituated arena (Figure 3.6a; χ2(1)=16.08, p<0.001 ). There was no difference between 
Grb10+/p and WT mice in the amount of time spent in the habituated (Figure 3.6a; 
χ2(1)=0.55, p=0.46) or novel arena (Figure 3.6a; χ2(1)=0.47, p=0.50), furthermore there was 
no difference in the latency of the first entrance into the novel arena (Figure 3.6b; t=-0.32 
(df=21),p=0.75). Subjects from each group also showed similarities in the number of entries 
made into the novel arena (Figure 3.6c; t=-0.549, (df=21), p=0.59). These data were further 
analysed in 5 minute bins across the 30 minute session, a Kruskal-Wallis H test showed no 
significant differences between Grb10+/p and WT mice in the duration of time spent in the 
novel arena across all time bins (Figure 3.6d; , χ2(1)=2.241, p=0.13). 
 
 
  
 
Figure 3.5 Example traces of Grb10+/p and WT behaviour in the test stage of the NPP, taken by a video 
tracking system. During the test stage of the NPP, subjects were free to explore both chambers, counter-
a 
Habituated 
Novel 
Grb10 +/p WT 
b 
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balanced between mice of each genotype.  In the example traces shown above, the novel chamber is white 
and the habituated chamber black for both mice. The traces show that both Grb10+/p (left) and WT (right) mice 
showed a propensity to explore the novel environment, as expected. 
 
 
 
 
  
 
 WT N=10 
 Grb10
+/p
 N=13 
 
Figure 3.6 Behaviour of Grb10+/p and WT mice in the NPP. Both Grb10+/p and WT mice spent significantly more 
time exploring the novel arena compared to the habituated arena (a). There was no difference between 
Grb10
+/p
 and WT mice in the latency to make the first entrance into the novel arena (b), or the total number of 
entrances made. The data presented are mean values ± SEM.   ***P<0.005. 
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3.4 Discussion 
 
 
The principal aim of this chapter was to assess the behavioural response of Grb10+/p 
mice to novel environments, to gauge their performance in relation to a previous study with 
Nespm/+ mice (Plagge et al., 2006). Behaviour was assessed using the tests of novelty 
reactivity and exploration, identical to that used previously (Plagge et al., 2006). These tests, 
the LMA and NPP, provided a basic characterisation of the activity of mice in novel 
environments; which taken together, can be used as an indicator of risk-taking and 
impulsive behaviour.  
The LMA and the NPP tasks successfully targeted a measure of spontaneous 
exploratory behaviour. For the LMA, this was demonstrated by the fact that exploratory 
behaviour significantly reduced both across the three days of testing (Figure 3.1) and within 
each of the 2 hour sessions, both in terms of breaks and runs (Figure 3.2 and Figure 3.3, 
respectively). This behaviour is indicative of habituation to the novel environment, with the 
mice exploring the apparatus less over time. Furthermore, mice of both genotypes showed 
typical exploratory behaviour in the habituation phase of the NPP task. All of the subjects 
were initially inquisitive about the novel chamber and displayed high levels of movement 
and rearing in this environment, and by the end of the session, the mice displayed a 
significant decline in their explorative activity as they became habituated to the 
environment and it became familiar  (Figure 3.4c and 3.4d).  
 The results of the LMA demonstrated that Grb10+/p mice have analogous behaviour 
to that of their WT littermate mice. Grb10+/p mice carried out an equivalent amount of 
‘breaks’ and ‘runs’ on all three days of testing in the LMA task. The results found here are 
consistent with previous results (Garfield et al., 2011) that have measured locomotor 
activity using slightly different behavioural assays, which found no dissociation between 
Grb10+/p and WT animals. This suggests that Grb10 does not influence levels of motor 
activity or novelty reactivity in this task.    
 The NPP task provided a more specific test of novelty exploration, as it explicitly 
measured novelty- investigation/seeking behaviour, by measuring the preference for a 
novel environment compared to a familiar environment. The results showed that all 
subjects spent significantly more time in the novel environment compared to the habituated 
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environment, as expected (Figure 3.6a); thus confirming that mice have a natural propensity 
to explore a novel environment (Figure 3.5). This is consistent with previous research 
employing the use of NPP, and is considered normal reactivity to a novel environment 
(Plagge et al., 2005, Milkaelsson et al., 2013). There was no significant difference between 
Grb10+/p and WT littermate animals in terms of the number of entries into the novel arena 
or time spent in the novel arena, which suggests that Grb10+/p mice do not have altered 
reactivity to novel environments and therefore that the Grb10 gene itself is not associated 
with the aversion or promotion of novelty-seeking behaviour in this task. Based on the fact 
that Grb10 and Nesp show overlapping expression in the brain, and their opposing patterns 
of imprinting, it was predicted that Grb10 may have had the opposite effect to Nespm/+ mice 
on behavioural responses to novel environments, whereby Grb10+/p animals might spend 
significantly more time in the novel arena than WT. However the results found here are not 
consistent with this hypothesis.  
 As well as the LMA and NPP tasks, previous research assessing Nesp, utilised the OF 
test to show that Nespm/+ mice demonstrated increased excitement towards a novel 
environment; specifically performing more quadrant crossings than WT mice (Plagge et al., 
2005). The OF test has also been previously carried out in Grb10+/p animals, the results of 
which indicated that Grb10+/p mice do not have altered behaviour in this task in comparison 
to WT mice (Garfield et al., 2011). The results of the previously carried out OF test, coupled 
with the results of the two tasks carried out in the present chapter (LMA and NPP), illustrate 
that Grb10+/p mice do not show altered novelty-seeking behaviour. This suggests that Grb10 
may exert its influence on adult behaviour in a different way to Nesp55 and, if it is involved 
in impulsive or risk-taking behaviour, in a different facet of this cognitive function. 
Research exploring the role of Nesp has employed the use of various behavioural 
tests in order to characterise the specific nature of the effect that Nesp55 has on behaviour. 
This has included tests of LMA, novelty reactivity, as well as tests of fear and anxiety. It is 
using this spectrum of tests that has allowed the observation that disruption of normal Nesp 
expression specifically affects novelty reactivity independently of general activity, and 
furthermore that the effects were independent of differences in fear or anxiety-related 
behaviour. The dissociable nature of impulsive and risk-taking behaviour means that 
different behavioural tasks can be used to target and measure distinct elements of 
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impulsivity (Dent and Isles, 2011). These can be broadly divided into two categories: tasks 
measuring impulsive choice or impulsive decision-making, and those that measure impulsive 
action or motoric impulsivity (Winstanley et al., 2004). The paradigms employed in this 
chapter were used to measure spontaneous novelty-seeking behaviour, an aspect of risk-
taking and impulsive action; they therefore do not assess more complex types of impulsivity 
such a cognitive or decision-making impulsivity. Therefore, to elucidate the potential effects 
Grb10 may have on impulsive or risk-taking behaviour, Grb10+/p mice need to be assessed 
on a wider range of tasks within the umbrella of ‘impulsivity’. 
 
3.4.1 Summary of key results from Chapter 3 
 Grb10+/p and WT littermate controls demonstrated the expected pattern of 
habituation behaviour in the LMA task. 
 Grb10+/p and WT littermate controls demonstrated the expected pattern of 
behaviour in response to a novel environment in the NPP task, showing a preference 
for the novel arena. 
 Grb10+/p and WT mice showed equivalent behaviour in the two assays of 
spontaneous novelty exploration; suggesting Grb10+/p mice have normal levels of 
novelty reactivity/ exploration. 
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Chapter 4 – Assessment of delay discounting behaviour in Grb10+/p 
mice 
 
4.1 Introduction 
 
 
Previous research has demonstrated increased reactivity in Nespm/+ mice when 
placed in a novel environment, with corroboratory evidence derived from three separate 
tasks: locomotor activity (LMA), novelty place preference (NPP) and open-field (OF) (Plagge 
et al., 2005). Additionally, as yet unpublished work has shown, maternal Nesp affects 
behaviour measured in the delayed reinforcement task, a ‘delay-discounting’ paradigm 
(Isles et al., unpublished research). These results have been interpreted in the context that 
the maternally expressed imprinted gene Nesp is associated with the promotion of risk-
taking behaviour.  Chapter 3 described the results of testing of Grb10+/p mice on the LMA 
and NPP tests, which found that Grb10+/p mice did not exhibit altered behaviour in these 
tests, in contrast to the pattern of behaviour shown by Nespm/+ mice.  
The ‘delay-discounting’ paradigm used in this thesis to assess behaviour in mice is 
based on the principle of selecting between either small immediate gratification or larger 
but delayed gratification. This concept was developed from the ‘Stanford Marshmallow 
Experiment’ (Mischel et al. 1972), which sought to investigate the age at which delayed 
gratification, the ability to wait for something desired, developed. In this experiment, 
children were presented with the choice between a single marshmallow immediately and 
two marshmallows at a later time. The majority of children preferred to wait for the larger 
reward, and the ability to tolerate longer delays increased with age.  In the delay 
discounting task selection of the small immediate reward is considered to be indicative of 
impulsive choice, whilst selection of large delayed reward is considered to be indicative of 
increased ‘self control’ (Evenden and Ryan, 1996, Winstanley et al., 2004). Delay-discounting 
tasks have since been developed to measure this decision making behaviour in adults and 
are usually based on hypothetical or actual monetary reward (Madden et al., 2003, Demurie 
et al., 2012). A bias towards impulsive choice, measured in this type of task, has been 
observed as a symptom in several psychiatric conditions, including attention deficit 
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hyperactivity disorder (ADHD) (Demurie et al., 2012), pathological gambling (Albein-Urios et 
al., 2012)  and drug addiction (Kirby et al., 1999, Amlung et al., 2012, Kobiella et al., 2013). 
The delayed-reinforcement task has also been adapted for use with animals, 
including pigeons (Rodriguez and Logue, 1988), macaques (Hayden and Platt, 2007), and 
rodent analogues for rats (Evenden and Ryan, 1996) and mice (Isles et al., 2003). Decision 
making behaviour measured in delay-discounting tasks has been shown to be sensitive to 
experimental manipulation in animals (Evenden and Ryan, 1996, Mobini et al., 2002, 
Cardinal, 2006). For example administration of d-amphetamine induces preference for the 
smaller, immediate reinforcer, thus increasing impulsive choice in both rats (Evenden and 
Ryan, 1996) and mice (Isles et al., 2003), conversely administration of diazepam, 
metergoline and atomoxetine have all been shown to significantly decrease impulsivity by 
increasing preference for the large-value reward across increasing delay (Evenden and Ryan, 
1996, Robinson et al., 2008). Furthermore lesions to the orbital prefrontal cortex, the medial 
prefrontal cortex and basolateral amygdala in rats have all induced an increase in impulsive 
choice in tests of delay-discounting (Mobini et al., 2002, Churchwell et al., 2009). As well as 
animal studies, delay discounting has also been observed in a clinical population; where a 
bias towards impulsive choice has been observed as a symptom in several psychiatric 
conditions, including Attention deficit hyperactivity disorder (ADHD) (Demurie et al., 2012), 
pathological gambling (Albein-Urios et al., 2012) and drug addiction (Kirby et al., 1999, 
Amlung et al., 2012, Kobiella et al., 2013).  
As mentioned previously Nespm/+ mice showed increased impulsive responding when 
tested in a delayed-reinforcement task (DRT) (Isles et al., unpublished research). During this 
task the delay associated with the larger reward was progressively delayed within each test 
session (consecutive blocks of trials with delays of 1s, 8s, 16s), whilst the small reward was 
consistently associated with a short (1s) delay. It was found that under increasing delay 
conditions both types of mice switched responding to the smaller reward associated with a 
fixed short delay (Figure 4.1), however as the delay increased, Nespm/+ mice became 
increasingly reluctant to wait for a reward, and instead opted for immediate gratification; 
thus exhibiting significantly altered delay-discounting behaviour, indicative of increased 
impulsive ‘choice’ behaviour. 
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Figure 4.1 Performance of Nesp
m/+
 and WT control mice in the DRT. Nesp
m/+
 mice, lacking functional Nesp55, 
and their WT littermates were tested in the DRT under increasing delay conditions (a) (Isles et al, unpublished 
results).  All subjects switched their responding to the smaller rewards associated with a fixed delay (1s) as the 
delay to the large reward increased. However, Nespm/+ animals were quicker than WT to discount the large 
reward against the delay, demonstrating that these Nespm/+ mice are significantly less risk-taking than their 
littermates.  Therefore this suggests that the Nesp55 protein serves to promote risk-taking behaviour. As a 
control, when the large reward was associated with a fixed delay and remained at 1s in all trials, both Nespm/+ 
and WT mice maintained a preference for the large reward throughout the session (b). This demonstrates that 
the effect found was not as a result of satiety or fatigue affecting responding in the task. Data shown are the 
mean ± SEM. Control N=7, Nespm/- N=9. 
 
The previous finding that Nesp influences delay-discounting behaviour (Isles et al., 
unpublished results), taken together with the reciprocal pattern of imprinting between Nesp 
and Grb10 (Plagge et al., 2005, Garfield et al., 2011), and the overlapping expression of Nesp 
and Grb10 in areas of the brain that are involved in impulsivity/decision-based behaviour, 
suggests that Grb10 may also influence delay-discounting behaviour, and perhaps in an 
opposing direction to Nesp. Therefore the experiments in this chapter address this 
hypothesis by assessing if behaviour in the DRT is altered in Grb10+/p mice compared to their 
WT littermates. Furthermore, as an additional control measure to dissociate DRT 
performance from effects on motivation, Grb10+/p mice were also assessed in a progressive 
ratio task (PRT). 
 
 
a b 
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4.2 Methods 
 
 
4.2.1 Subjects 
13 male Grb10+/p mice and 11 WT littermates were used. Mice were 6 months old at 
the start of testing (mean weight: 30.38 ± 0.49 g). All subjects were group housed (2 to 4 
mice/cage) in environmentally enriched cages (i.e. with cardboard tubes, shred-mats and 
tissue paper) in a temperature and humidity controlled vivarium (21 ± 2°C and 50 ± 10%, 
respectively) with a 12-hour light-dark cycle (lights on at 07:00 hours/lights off at 19:00 
hours).  Animals had ad libitum access to standard lab chow, but home cage water was 
restricted to 2 hours access per day during the period of testing (access occurred after 
testing). This regime maintained the subjects at ~90% of free-feeding body weight.  Prior to 
experimental testing animals were handled daily for 2 weeks (Hurst and West, 2010), and 
then the water restriction schedule was gradually introduced over a further 2 weeks. 
 
4.2.2 Water restriction and Condensed milk preference test 
In order to increase motivation and performance in the DRT and PRT, subjects were 
placed on a schedule of water restriction. Water access was reduced gradually, in 
accordance with the protocol outlined in Chapter 2, Section 2.3.4. After this procedure mice 
were maintained on a 22 hour water restriction schedule. Prior to testing a condensed milk 
test (CMT) was carried out in order to ensure all subjects had a ≥70% preference for the 
condensed milk reinforcer. Details of how the CMT was performed are outlined in Chapter 
2, Section 2.3.5. 
 
4.2.3 Apparatus 
The DRT and PRT were performed in eight ‘9-hole’ operant chambers, as described in 
Chapter 2, Section 2.4.3. The control of stimuli and recording of responses were managed by 
an Acorn RISC-PC computer running custom-written BBC BASIC V6 software (programmed 
by Dr Trevor Humby) with additional interfacing by ARACHNID (CeNes Ltd., U.K.).  
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4.2.4 Delayed-reinforcement task 
4.2.4.1 Panel Push Training 
Panel push training was carried out over 6 sessions (one session per day). Each 
mouse was put into a chamber for a period of 20 minutes and was presented with 22 μl of 
reward (equating to 1s delivery time) every 30 seconds. For the initial 3 sessions the panels 
to the food magazines were wedged open, in order to allow a period of familiarisation, and 
to allow the mice to learn that the condensed milk was available in the chamber. For the 
remaining sessions panels were free, and subjects were therefore required to push the 
panels in order to gain access to the condensed milk reward. Once subjects were able to 
panel push successfully, they continued to the next stage of training. 
 
4.2.4.2 Single Nose Poke Training 
The initial stage of the DRT was to teach subjects to nose poke in response to a 
stimulus in order to receive a reward (initiate a trial). During this stage a light in the central 
aperture came on, nose-poking in this aperture resulted in delivery of the reward. Subjects 
had a limited period of time (limited hold) that the light was on for, signaling the period of 
time that the mouse can make the ‘nose poke’. This limited hold (LH) value was set 10 
seconds for each trial. Once each mouse was successful completing a minimum of 60% of 
trials, they were able to progress to the next stage of training. The principle parameter 
measured at this stage was the number of trials initiated (out of a maximum 100 trials).  
 
4.2.4.3 Double Nose Poke Training 
The double nose poke phase involved teaching subjects to make a central nose poke, 
followed by a second nose poke, in response to a stimulus presented (pseudo-randomly) 
either left or right, in order to receive the condensed milk reward. The initial stimulus 
(centre light) was set to a 10 second duration, and when a mouse made a central ‘initiation’ 
nose poke, the second stimulus was triggered (pseudo-randomly presented either left or 
right) for 10 seconds. Therefore the central nose poke acted as a cue to start the trial; and 
to focus attention on the subsequent presentation of stimuli in lateral locations. At this 
stage each subject was given 40 trials per session.  Once each mouse could successfully 
double nose poke to receive a reward, at a level of at least 70% correct, they were able to 
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move on to the DRT proper. The principle parameter measured at this stage was the 
percentage of correct responses to the second stimulus.  
 
4.2.4.4 Delayed reinforcement testing 
The DRT required the subject to first make a central nose poke to initiate a trial; then 
make a nose poke response, either left or right, to indicate their choice between the 
delivery of 50 μl reward (3s of reward delivery), or a response in the other direction 
resulting in the delivery of 22 μl reward (1s of reward delivery) (Figure 4.2).  The large and 
small response directions were kept constant for each mouse but were counterbalanced 
between subjects and across genotypes. The task comprised of three sequential blocks of 12 
trials, in block 1 either response led to the delivery of reinforcer after a 1 s delay.  In blocks 2 
and 3 increasing delays were introduced between the response and the delivery of the 
larger reinforcer, whereas the delay between response and delivery of the small reinforcer 
was fixed at 1 s.  The length of the delay introduced in blocks 2 and 3 was increased through 
a series of stages (A, B, and C) until baseline stage D (Table 4.1). Trials 1 - 4 in any block were 
‘forced’ information trials, whereby after the central nose poke only one of the two 
response options was available. The order of presentation during the forced trials was 
counter-balanced pseudo-randomly across subjects.  This was designed to provide the 
subjects with prior notice of the extent of any delay associated with the larger reward 
response.  In the next 8 trials, the animals had a choice of responding to either the right or 
left stimulus after the central nose poke. 
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Delay associated with large reward 
Stage Block 1 Block 2 Block 3 
A 1s 1s 1s 
B 1s 2s 4s 
C 1s 4s 8s 
D 1s 8s 16s 
 
Table 4.1 The delay associated with the large reward during the training stages of the DRT. The task 
comprised of three sequential blocks of twelve trials. During the DRT the small immediate reward was always 
delivered after 1s throughout the duration of the task. However the large reward was delivered after an 
increasing delay. In block 1 of any given session the delay associated with the large reward was always 1s. 
Subjects started at stage A, where the delay stayed at 1s throughout. Subjects then completed stages B-D 
during which the delay increased incrementally during block 2 and 3. The first four trials of any block, were 
‘information trials’ which, after the central nose poke, forced a choice either left or right, to allow the subject 
to learn the size of the delay associated with the large reward.   The final eight trials were ‘choice’ trials where 
the subject could select between the small immediate (1s delay) reward or the larger delayed reward. 
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Figure 4.2 Schematic showing the sequence of events in the DRT. Illumination of the initiation stimulus in the 
central aperture of the 9 hole array, signalled the start of a trial. The subject was required to initiate a trial by 
making a nose poke in this location. In a choice trial, stimuli were simultaneously illuminated in the apertures  
to the left and right; in forced trials only a single stimulus was illuminated. Through training, the animal had 
learnt that one side was associated with the large reward and the other with the small reward (kept consistent 
for each mouse, but counterbalanced across subjects); thus presenting the animal with a choice between the 
stimulus associated with a small immediate reward, or a large increasingly delayed reward. The subject made a 
choice by nose poking at one of stimuli locations and the appropriate reward delivered. The subject is then 
required to make a panel push to collect the reward, located on the opposite side of the chamber. Image taken 
from Isles et al. 2003. 
 
Subjects completed 5 sessions at each of the four training stages (A, B, C, D) in order 
to allow the opportunity to learn the task and progress through the stages gradually. 
Subjects were required to complete >70% of trials in order to continue to the next stage. 
During the task, both initial (central) and choice (left or right) stimuli were presented for 
10s, and were extinguished once an animal made a nose poke. If the subject made no 
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central nose poke when the initial stimulus was presented, it was recorded as a ‘non-started 
trial’; performing an initiation central nose poke and subsequently failing to make a choice 
nose poke was recorded as an ‘omission’. Regardless of the outcome of the trial, a new trial 
was started 45 s after the presentation of the previous central stimulus. The food hopper 
light was illuminated when the reward was delivered, and subjects were required to panel 
push in order to collect the food reward from the hopper. Final baseline performance was 
calculated as an accumulation of their last 3 sessions at stage D. The principal measure of 
the DRT was the bias to choose the large reward, recorded by the number of correct 
responses made for the large choice as a percentage of all choice trials. In addition to this 
measure, other parameters included number of non-started trials, number of omitted trials, 
the latency to initiate a trial (start latency), the latency to make a choice (choice latency), 
the total number of nose pokes in a session and the total number of panel pushes in a 
session. 
 
4.2.5 Progressive ratio task 
4.2.5.1 Subjects 
The same subjects used in the DRT were used to carry out the PRT; two subjects (1 
WT and 1 Grb10+/p) were removed from the study due to illness/death. This left a cohort of 
12 male Grb10+/p mice and 10 WT littermates. As before, the animals had ad libitum access 
to standard lab chow, and were maintained on a 22 hour water restriction schedule during 
the period of testing (2 hour access occurred after testing). 
 
4.2.5.2 Transfer from DRT to PRT 
In order to transfer subjects from the DRT to the PRT, mice were initially trained over 
5 sessions on a continuous reinforcement (CRF) schedule. During this stage subjects were 
required to make a single nose poke in response to the central stimulus, in order to initiate 
delivery of the condensed milk reward (22 μl, 10% concentration). These CRF sessions 
terminated after collection of 100 rewards or if 30 minutes had elapsed.  
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4.2.5.3 Progressive ratio schedule  
After the 5 sessions at CRF, subjects were moved to a progressive ratio (PR) schedule 
of reinforcement. Under this schedule, the nose poke requirement for food delivery was 
increased with the following progression: 1, 2, 4, 6, 8 (then further incrementing by 2 nose 
pokes/ratio), with two trials at each ratio. The progression continued until the subject failed 
to complete the ratio requirements, determined by the failure to make a further nose poke 
within 4 minutes of the previous response (timed out). Sessions could also be terminated if 
100 rewards had been delivered or if 30 minutes had elapsed, as per the CRF sessions. 
Subjects carried out three sessions of the PR schedule, across three consecutive days, with 
performance averaged across the 3 sessions. After the PR schedule subjects were returned 
to the CRF schedule for 3 days; performance here was averaged over the 3 days. The 
principal measure of the PRT was the amount of rewards earnt, and the ‘break point’ (the 
maximum ratio a subject reaches during the PRT). Additional measures also included the 
session duration, the latency to nose poke, and the intra-trial trial NP latency. 
 
4.2.6 Data analysis and statistics 
All statistical analyses were carried out using SPSS (version 18.0 for windows). The 
preference for the condensed milk reinforcer was calculated, based on the volume of 
condensed milk consumed as a percentage of total liquid consumed, for each of the 5 days 
of the CMT. During the single nose poke training stage, the principle measure was the 
number of trials initiated (successfully making a central nose poke when central stimulus is 
presented). During the double nose poke training stage, the principle measure was the 
percentage of correct responses (correctly nose-poking the lit stimulus – left or right, after 
making the initial central nose poke).  The principle measure of the delay discounting task 
proper was the bias to the large reward, defined as the number of times the large reward 
was chosen as a percentage of the total number of choices within a given delay block. This 
was taken as a sum of three stable sessions at the stage ‘D’ (the last 3 sessions).  Additional 
measures included; non-started trials (no centre nose poke, so a trial was not started), 
omissions (centre nose poke, but no choice made), initiation latency (time taken to centre 
nose poke once the centre light was illuminated), and choice latency (time taken to make a 
choice nose poke after the centre nose poke), as well as the total number of nose pokes and 
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panel pushes made throughout the duration of a session. For the progressive ratio task the 
main measures of interest were the number of rewards collected, the breakpoint of nose 
poking (the maximum number of nose pokes a mouse would perform for a single food 
delivery), the overall session duration, the average latency to make the first nose poke for 
each reward, the latency to collect a reward and the intra-nose poke duration. Behavioural 
data are presented as mean values (M) along with the standard error of the mean (SEM), 
unless stated otherwise. All data were analysed by either ANOVA or t tests. All significance 
tests were performed at alpha level of 0.05 and where significant interactions were 
identified in the main ANOVA, post-hoc tests using appropriate pair-wise comparisons were 
performed. For repeated-measures analyses, Mauchly’s test of sphericity of the covariance 
matrix was applied. Huynh-Feldt corrections were applied as necessary, and adjusted 
degrees of freedom are provided.  
 
 
4.3 Results 
 
 
4.3.1 Milk preference testing 
All animals showed an initial aversion to the novel foodstuff (preference of less than 
50%), but with subsequent exposures acquired a preference for the milk reinforcer over 
water (preference of approximately 75%) (Figure 4.3a; main effect of DAY, F4,88=34.91, 
p<0.001). However, there was no difference between Grb10+/p and WT mice in either their 
overall preference (Figure 4.3a; main effect of GENOTYPE, F4,88=1.69, p=0.21) nor in the rate 
at which their preference was acquired (interaction between GENOTYPE and DAY, 
F4,88=0.69, p=0.42). This was also reflected in the total volume of milk consumed, which 
increased during the testing procedure (Figure 4.3b; main effect of DAY, F4,88=33.28, 
p<0.001), but again did not differ between Grb10+/p and WT mice (main effect of GENOTYPE,  
F1,22=0.34, p=0.57). 
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 WT N=11 
 Grb10
+/p
 N=13 
 
Figure 4.3 Consumption and preference for food reward in Grb10+/p and WT control mice. Preference for the 
reward used in the delay discounting task was measured in a simple two-choice consumption test. All animals 
showed neophobia with an initial preference of less than 50%. However, over the course of testing preference 
increased until greater than 75% preference for the reward was reached on average for all mice, with no 
significant difference between Grb10+/p and WT mice (a). This pattern of effects was also reflected in the total 
volume of milk consumed, which increased during the testing procedure, but also did not differ between 
Grb10+/p and WT mice (b). Data are the mean ± SEM. 
***P<0.005. 
 
 
4.3.2 Delayed reinforcement task 
4.3.2.1 Task Acquisition 
During the training stages of the DRT (learning to single and double nose poke) the 
Grb10+/p animals acquired the task at the same rate as WT mice. Subjects took 9 sessions to 
acquire single nose-poking (successfully initiating >40 trials), and 4 sessions to acquire 
double nose-poking (successfully completing approximately 70 trials). All animals showed a 
similar progression throughout the single nose poke training stage, whereby the number of 
trials initiated (successfully making a centre nose poke when central stimulus was 
illuminated), improved with each session (Figure 4.4a; main effect of SESSION, F8,176=14.29, 
p<0.001), but did not differ between Grb10+/p and WT mice (Figure 4.4a; main effect of 
GENOTYPE, F1,22=0.88, p=0.36). During the double nose poke training stage, Grb10
+/p and WT 
mice showed consistently high levels of correct responding to the second stimulus (left or 
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right) after making the initial central nose poke, which increased with session (Figure 4.4b; 
main effect of SESSION, F2,42=23.38, p<0.05). Both Grb10
+/p and WT mice showed a similar 
proportion of correct responding to the second stimulus (Figure 4.4b; main effect of 
GENOTYPE, F1,22=0.05, p=0.83).  
 
  
 WT N=11 
 Grb10
+/p
 N=13 
 
Figure 4.4 Acquisition of the DRT during the single nose poke and double nose poke training stages in 
Grb10+/p and WT control mice. Grb10m+/p- and WT mice showed no differences in the number of trials they 
initiated (successfully making a centre nose poke when the central stimulus was illuminated), during the 
single nose poke training stage (a). Similarly, Grb10m+/p- and WT mice also showed very similar and 
consistently high correct responding to the second stimulus (left or right), after making an initial centre nose 
poke, during the double nose poke training stage (b). Data are the mean ± SEM.  
*P<0.05, ***P<0.005. 
  
4.3.2.2 Delayed reinforcement behaviour 
All subjects successfully learnt the task up to baseline performance. Initially choice 
for the large reward remained the same when only a small delay was associated with the 
large reward, during Stage B (Figure 4.5b; main effect of DELAY F2,42=0.28, p=0.75). However 
it was shown that increasing the delay time to the larger reward decreased the likelihood of 
choosing that reward, at both Stage C (Figure 4.5c; main effect of DELAY, F2,38= 3.73, p<0.05) 
and Stage D (Figure 4.5d; main effect of DELAY, F2,38=10.23, p<0.001). However Grb10
+/p 
mice were significantly slower to switch their choice to a less delayed, smaller reward than 
WT mice, during both Stage C (Figure 4.5c; main effect of GENOTYPE, F1,19=7.78, p<0.05) and 
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Stage D (Figure 4.5d; main effect of GENOTYPE, F1,19=7.87, p<0.05). Importantly, when the 
delay associated with the larger and smaller reward was equal (1s) across all three blocks, all 
subjects demonstrated a high preference for the large reward (Figure 4.5a; main effect of 
GENOTYPE, F1,21=0.87, p=0.36), which was maintained throughout the session (main effect 
of DELAY, F2,42=1.73, p=0.20). Bias scores were excluded from analysis if they had not 
successfully completed any choice trials, i.e. 100% of choice trials were either non-started 
trials or omissions, exclusions at each stage were as follows: Stage C n=2 (1 WT, 1 Grb10+/p), 
Stage D n=1 (1 WT). 
 
 
  
 WT N=11 
 Grb10
+/p
 N=13 
 
Figure 4.5 DRT performance in Grb10+/p and WT control mice. Under conditions in which the delay associated 
with the large and small reward was equal (1s) throughout the session, there were no differences in choice 
bias between Grb10
+/p
 and WT mice (a). Behaviour of Grb10
+/p
 and WT mice changed with increasing delay, 
20 
30 
40 
50 
60 
70 
80 
90 
100 
1s 1s 1s 
B
ia
s 
(%
) 
Delay 
20 
30 
40 
50 
60 
70 
80 
90 
100 
1s 2s 4s 
B
ia
s 
(%
) 
Delay 
20 
30 
40 
50 
60 
70 
80 
90 
100 
1s 4s 8s 
B
ia
s 
(%
) 
Delay 
20 
30 
40 
50 
60 
70 
80 
90 
100 
1s 8s 16s 
B
ia
s 
(%
) 
Delay 
* 
 
  
  
  
 
* 
a b 
c d 
* 
*** 
Chapter 4 | Assessment of delay discounting behaviour in Grb10+/p mice 
 
 
 
Page | 90  
 
such that choice bias initially stayed the same when there was only a small difference between the delays for 
the small and large reward, stage B (b), however choice bias moved away from the response leading to the 
large reward towards the smaller reward with increasing delay during stage C (c) (where WT, N=10, and 
Grb10
+/p
 N=12 due to exclusions) and stage D (d) (where WT N=10 and Grb10
+/p
 N=13 due to exclusions 
detailed in Section 4.3.2.2). However, there were systematic differences between the groups in their 
behaviour, such that Grb10+/p mice switched their choice to the smaller, less delayed reward, significantly less 
quickly than controls (c and d). Data are the mean ± SEM of three consecutive stable sessions.  
*P<0.05, ***P<0.005. 
 
 
At the baseline (Stage D) of the DRT, Grb10+/p and WT mice maintained high levels of 
responding, as shown by the low levels of non-started and omitted trials (Figure 4.6a & b). 
All subjects showed an increase in non-started trials as the session progressed (Figure 4.6a; 
main effect of DELAY, F2,42=23.38, p<0.001) with no difference between Grb10
+/p and WT 
littermate mice (main effect of GENOTYPE, F1,21=0.40, p=0.54). Furthermore the rate of 
omitted responses did not vary between Grb10+/p and WT mice (Figure 4.6b; main effect of 
GENOTYPE, F1,21=2.00, p=0.29). 
Grb10+/p and WT mice showed an increase in both start (Figure 4.6c; main effect of 
DELAY F2,42=41.01 p<0.001) and choice latency (Figure 4.6d; main effect of DELAY F2,42=6.14 
p=0.05) as the session progressed. However, all animals showed a high degree of stimulus 
control and there was no difference between Grb10+/p and WT mice on either start latency 
(Figure 4.6c; main effect of GENOTYPE, F1,21=1.44, p=0.24) or choice latency (Figure 4.6d; 
main effect of GENOTYPE, F1,21=0.54, p=0.47). Other behavioral indices were also similar 
between Grb10+/p and WT littermate mice, such as total number of nose pokes (Figure 4.6e; 
main effect of GENOTYPE, F1,21=0.10, p=0.76) and panel-pushes (Figure 4.6f; main effect of 
GENOTYPE, F1,21=2.13, p=0.16, respectively). Furthermore during the ‘forced’ trials (in which 
no choice was available), both Grb10+/p and WT mice made equal responses to the large and 
small reward-related stimuli at all delays (interaction GENOTYPE x DELAY x CHOICE, 
F2,42=0.35, p=0.65; data not shown). Taken together, these data show that Grb10
+/p and WT 
mice had an equivalent ability to learn and perform the DRT. However Grb10+/p have altered 
delay-discounting behaviour, specifically demonstrated by a significant preference for the 
large delayed reward, which is indicative of decreased choice impulsivity or increased self-
control. 
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 WT N=10 
 Grb10+/p N=13 
Figure 4.6 Ancillary data in the DRT for Grb10+/p and WT control mice. Although many measures were 
systematically altered by the increasing delay for the large reward, this did not result in significant differences 
in behaviour between Grb10
+/p
 and WT littermate mice in terms of the number of non-started trials (a) or 
omitted trials (b) (both out of a possible 8 trials), or the start (c) or choice (d) latency measures, or the number 
of nose pokes (e) and panel pushes (f). Data are the mean of three baseline sessions ± SEM. 
***P<0.005. 
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4.3.3 Progressive ratio task 
4.3.3.1 Task acquisition 
Of the 22 mice who took part in the progressive ratio task, 21 subjects successfully 
completed the task, 1 (WT) subject was excluded for failing to meet the baseline criteria. 
Mice were initially trained to respond on a CRF schedule for 5 sessions. During the CRF 
sessions subjects were able to carry out a maximum of 100 trials, which is equal to 100 x 22 
μl rewards within each 30 minute test session.  Analysis of initial CRF stage revealed that 
both genotypes achieved the required level of performance per session (see methods for 
criteria), showing no effect of genotype (t1,19=0.80, p=0.44; data not shown).  
 
4.3.3.2 Progressive ratio schedule 
Following CRF training subjects were switched to the progressive ratio (PR) schedule, 
where the number of nose pokes required to initiate a 22 μl reward delivery was gradually 
increased throughout the session. Subjects performed 3 PR sessions and values from these 
sessions were averaged together. To demonstrate the effects of the imposition of the PR 
schedule, performance during the PR sessions were compared to the average of the 3 CRF 
sessions following PR testing.  Imposition of the PR schedule led to a significant reduction in 
the number of rewards earned relative to CRF responding (Fig. 4.7a, main effect of SESSION, 
F1,19=212.15, p<0.001), and there was no difference between Grb10
+/p and WT mice (main 
effect of GENOTYPE, F1,19=0.84, p=0.37). There was also no significant genotype difference in 
the PR breakpoint, the number of nose pokes required to initiate a reward delivery,  (Fig. 
4.7b; t19= 1.42, p=0.17), suggesting equivalent levels of motivation to work for the reward 
between the Grb10+/p and WT littermate mice. The decrease in rewards earned in PR 
sessions relative to CRF sessions was not due to mice running out of time to collect all the 
available rewards, as the average PR session did not run for the full 30 minutes.  There were 
no significant differences in session duration between the PR and CRF sessions (Fig. 4.7c; 
main effect of SESSION F3,57=2.51, p=0.10) which did not differ between Grb10
+/p and WT 
mice (main effect of GENOTYPE F1,19=0.18, p=0.68). 
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Figure 4.7 PRT performance in Grb10
+/p
 and WT control mice. Imposition of the PR schedule led to a 
significant reduction in the number of rewards earned, in comparison to CRF responding, for both WT and 
Grb10
+/p
 mice (a). Grb10
+/p
 and WT mice showed equivalent break points, the maximum number of nose pokes 
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they were willing to make to earn a reward, during the PR schedule (b). This PR was not due to mice running 
out of time, as there were no significant differences in session duration between the PR and CRF sessions (c). 
Results also demonstrated that Grb10+/p and WT littermate mice showed equivalent levels of stimulus control 
in the PRT evidenced by no differences in the latency to complete the first nose poke(d),  the intra-trial nose 
poke latency (e) or the latency to collect the reward (f). Data are the mean of three baseline sessions ± SEM. 
***P<0.005. 
 
Analysis of additional measures of the PRT during the PR schedule revealed that the 
Grb10+/p and WT littermate mice also had comparable levels of stimulus control. Specifically, 
subjects showed equivalent latencies to make the first nose poke (Fig. 4.7d; main effect of 
GENOTYPE, t1.19=-1.08, p=0.29), equivalent intra-trial nose poke latencies (Fig. 4.7e; main 
effect of GENOTYPE t1.19=-1.37, p=0.18) and equivalent latency to collect the reward (Fig. 
4.7f; main effect of GENOTYPE t1.19=0.34, p=0.74). These data therefore demonstrate that 
Grb10+/p and WT mice have an equivalent motivation to work for the reward used in the 
DRT.  
 
4.4 Discussion 
 
 
The principal aim of this chapter was to assess impulsive choice behaviour in 
Grb10+/p mice, which was achieved using a delay-discounting paradigm. This behaviour was 
investigated as the overlapping expression patterns in brain regions related to impulsivity 
between Grb10 and Nesp, the reciprocity in imprinting status and the fact that previous 
research had showed that Nespm/+ mice to have altered behaviour in the DRT (Isles et al, 
unpublished results), suggests that Grb10 may influence the same behaviours as Nesp.  For 
consistency with the previous findings, the design of the DRT was the same, and based on a 
block design where the delay associated with the large reward increased between blocks, 
but was consistent within a block. This design encouraged flexible ‘trial discrete’ choices, 
which minimises choices being based on rigid habitual behaviour (Evenden and Ryan, 1996).  
Using this operant method, a cohort of Grb10+/p and their WT littermate mice were used to 
demonstrate that Grb10+/p subjects had altered delay-discounting behaviour, specifically an 
increased tolerance of longer delays before reward was delivered which can be interpreted 
as decreased choice impulsivity or increased self-control.  However, before pursuing this 
Chapter 4 | Assessment of delay discounting behaviour in Grb10+/p mice 
 
 
 
Page | 95  
 
argument, there are other possibilities that could account for the difference in behaviour; 
issues such as general competence in performing the task, motivation for the reward or 
different levels of satiation between Grb10+/p and their WT littermate mice. 
The patterns of behaviour shown in the DRT were not due to differences in 
competence at performing the task. Grb10+/p animals acquired the task at the same rate as 
WT littermate mice, and demonstrated an equally high degree of stimulus control as 
indicated by latency measures. Additionally, the difference in DRT performance between 
Grb10+/p and WT mice was not related to differences in experiencing the information trial 
contingencies. In the ‘forced’ information trials (in which no choice was available), both 
Grb10+/p and WT mice made equal responses to the large and small reward-related stimuli 
at all delays. This indicated that subjects received the same information in order to 
accurately complete the task. Both WT and Grb10+/p subjects showed equivalent levels of 
stimulus control and showed no deficit in the ability to perform both the DRT and the PRT, 
demonstrated by comparable latencies to make choices in the DRT, collect the reward and 
make the initial nose poke, and for the intra-trial nose poke latency in the PRT.  Taken 
together, these measures suggested that the only factor controlling the difference in 
behaviour between Grb10+/p and WT mice on the DRT, was the contingency between delay 
and reward and the resultant choice made by the Grb10+/p subjects. 
When using food reinforcement in cognitive tasks with mice, it is important to 
establish if mice demonstrate the equivalent levels of motivation for the reward. This is 
especially important in the DRT for two reasons.  Firstly, where the perceived value of the 
reward is paramount to the task, altered motivation for the reward could generate similar 
patterns of results to those found here. Secondly, the main effect found in relation to 
decreased choice impulsivity was most profound in the last block of a session (where the 
delay was greatest), and altered motivation would also be decreased due to satiety effects.  
Therefore reward motivation was specifically assessed using a progressive ratio task (PRT), 
which measured how much effort a subject will make to earn a reward, in the paradigm 
used here the amount of nose pokes needed to receive a single reward was increased 
throughout a session. Results demonstrated that both WT and Grb10+/p subjects successfully 
performed the task; under continuous reinforcement conditions (where a reward was 
earned after a single nose poke) subjects earned a high number of rewards. However under 
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the PR schedule, all subjects achieved significantly fewer rewards, with Grb10+/p and their 
littermate mice showing equivalent ‘breakpoints’, the measure of motivation to earn 
rewards.  Therefore motivation for reward, as indexed by the PRT, was equivalent between 
Grb10+/p and WT mice, and also would not account for the pattern of performance found in 
the DRT. 
Evidence from both the DRT and PRT would suggest that satiation also did not 
contribute to the behavioural differences in the DRT observed between Grb10+/p and WT 
littermate mice.   On average in the DRT, subjects were able to consume a maximum of 1.62 
ml (based on choosing the large reward in all 24 choice trials, in addition to 12 forced trials), 
an amount much less than the amount of reward consumed in the CRF stage of the PRT.  
Here, both WT and Grb10+/p subjects consumed approximately 80 rewards, equivalent to 
1.76ml (80 x 22 μl) of reward, significantly more than the maximum possible in the DRT.  
Thus, in a situation where there was no contingency on reward delivery (either by increased 
delays in the DRT or ratio increases in the PRT), Grb10+/p and WT littermate mice consumed 
equal amounts of reward.  Therefore, the decreased choice impulsivity shown by Grb10+/p 
mice in the DRT was not due to differences in motivation or satiation for the reward, but 
most likely due to increased tolerance of the reward-delay underlying altered impulsive 
behaviour. 
 Discounting paradigms have been used extensively to characterise decision making 
in a variety of animal species. Tests of delay-discounting are associated with the 
measurement of cognitive impulsivity or ‘impulsive choice’ (Ho et al., 1999, Winstanley et 
al., 2003), whereby the selection of a smaller immediate reward in preference to larger 
delayed reward has been considered to reflect ‘impulsive’ choice, whereas the opposite bias 
toward delayed gratification has been taken to indicate increasing ‘self-control’ (Rachlin et 
al., 1991). Based on this premise, the results presented in this chapter suggest that Grb10+/p 
mice are less impulsive relative to their littermate controls (showing a preference for 
delayed gratification), in contrast to previous research showing that Nespm/+ mice are more 
impulsive relative to their littermate controls (showing a preference for immediate 
gratification)(Isles et al, unpublished results). This therefore demonstrates a reciprocal 
effect on this type of behaviour with maternally expressed Nesp promoting self-control, and 
paternally expressed Grb10 promoting impulsivity.  
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Whilst using delay-discounting as a measure of impulsive choice has proved useful in 
clinical research with humans, it is also important to consider risk-sensitivity of animals 
(Kalenscher, 2007). Whilst risk-taking and impulsive behavior are often thought as one in 
the same (Xu et al., 2013) and indeed are usually correlated (Simon et al., 2009), in delay 
discounting tasks they may dissociate. It is thought that animals may equate temporal 
distance with collection risk, therefore a temporally proximal reward may be preferred over 
a temporally distant reward, in the same way as a certain reward is preferred over a less 
certain reward, since delayed benefits may be lost during waiting time and are hence 
realised with less confidence (Kalenscher, 2007). Ethobiologically, animals tend not to 
chance waiting for food if there is the option of an immediate food source available; due to 
the potential for predation or competition that may result in danger or loss of the food 
(Green and Myerson, 1996, Kacelnik and Bateson, 1996). Therefore it has been suggested 
that the discounting of delayed reward shown in animals is due to interpreting the large, 
delayed reward as a more risky outcome (Hayden and Platt, 2007, Kalenscher, 2007). 
As a result of these theoretical and empirical considerations, it has been suggested 
that choosing the small immediate reward would be a ‘safer’ option, whereas choosing the 
larger reward with a degree of uncertainty (delay) would be a ‘risky’ option (Kalenscher, 
2007). Consistent with this hypothesis, increasing the delay time to the larger reward 
decreased the likelihood of choosing that reward for both Grb10+/p and WT littermate mice. 
However, Grb10+/p and WT mice also showed significant differences in the extent to which 
they switched their preference to the smaller, less delayed reward in response to increased 
delay to the larger reward. Based on the risk-taking interpretation of delay-discounting 
behaviour, it could therefore be concluded that Grb10+/p mice showed significantly 
increased risk-taking behaviour in the DRT. Importantly, when the ‘risk’ element was 
removed in the equal delay manipulation, where the delay associated with the larger and 
smaller reward was equal (1s) across all three blocks, all subjects demonstrated an equal 
preference for the larger reward throughout the session. Under these conditions, the choice 
became much simpler, and demonstrated that the difference in behaviour between 
Grb10+/p and WT mice was only apparent when there is a trade-off between the benefit of 
the larger reward and the risk associated with a long delay.  
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Although the data presented in the current chapter showed a significant effect of 
genotype in the delay discounting task, it is somewhat surprising that a GENOTYPE x DELAY 
interaction was not found. If the behavior of the Grb10+/p mice was a function of the delay 
one would expect a significant interaction to be found; the lack of interaction is likely to be 
an effect of a potential deficit of the WT mice at the no delay (1s) stage. Whereby the WT 
group show an unexpectedly low preference for the large reward at the 1s stage (Figure 
4.5b and 4.5c), where preference is approximately 70-80%, previous research reports 90-
100% preference for the large reward when there is no delay (Evenden and Ryan, 1996). 
However it is important to note that this effect is driven by the behaviour of a small number 
of subjects (1-3) and is not seen across the whole cohort. Furthermore the initially low levels 
of responding at the 1s stage may be a result of a carry-over effect; whereby subjects may 
initially still associate the large reward with a long delay based on the end of the last 
session. 
The data presented here from the DRT, along with the previous Nespm/+ data (Isles et 
al, unpublished results), represent the first demonstration of imprinted genes influencing 
delay discounting behaviour. Moreover the behaviour demonstrated by Grb10+/p mice is 
opposite to that demonstrated by Nespm/+ mice; whereby Nespm/+ mice were significantly 
quicker to switch their choice to the small immediate reward (Figure 4.1). This directionality 
of empirical effects is concordant with the theoretical hypotheses, such that maternally 
expressed imprinted genes are thought to promote the tolerance of riskier outcomes, 
whereas paternally expressed imprinted genes are thought to reduce the tolerance of riskier 
outcomes (Wilkins and Haig, 2003). Moreover, the patterns of behaviour also support the 
assertion that risk-taking behaviour is a substrate for the evolution of genomic imprinting 
independent from the more familiar substrate of resource allocation between mother and 
offspring (Constancia et al., 2004), as these models are free from confounding gross effects 
on in utero or pre-weaning growth (Plagge et al., 2005, Garfield et al., 2011), supporting the 
rationale for the confliction hypothesis of genomic imprinting (Constancia et al., 2004). 
Expression of Nesp and Grb10 in the locus coeruleus and dorsal raphe nucleus 
(Plagge et al., 2005, Garfield et al., 2011) suggest that these genes may exert their influence 
on delay-discounting behaviour via the noradrenergic and/or serotonergic system. 
Moreover, expression of Grb10 in the ventral tegmental area and substantia nigra pars 
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compacta may also imply that this gene exerts influence on delay discounting behaviour via 
the dopaminergic system (Garfield et al., 2011). Each of these monoamine 
neurotransmitters systems have been shown to be important in the modulation of 
behaviour in discounting paradigms (Cardinal 2006, Robinson et al., 2008), as they are key to 
the control of choice impulsivity. Whereby evidence from animal studies indicate that 
alterations to the serotonergic, dopaminergic and noradrenergic systems causes altered 
delay discounting behaviour (Cardinal 2006). Furthermore the areas of the mid-brain that 
Nesp and Grb10 are expressed in have been identified as ‘hot-spots’ of imprinted gene 
expression in a recent genome-wide screen for parental-biased allele expression in the 
rodent brain (Gregg et al., 2010), therefore suggesting that other imprinted genes expressed 
in these areas, may also influence discounting or impulsive behaviour.  
The data presented here, show that Grb10+/p mice have altered delay-discounting 
behaviour, showing a significant preference for larger, more delayed rewards. This is 
opposite to that found in the previously tested Nespm/+ mice, whom showed a significant 
preference for the small immediate reward. Based on the different interpretations of delay-
discounting tasks, this behaviour could be interpreted as the genes having conflicting choice 
impulsivity or risk-taking behaviour. Further testing in assays of both impulsivity and risk-
taking are required to determine if the altered behaviour observed in Nespm/+ and Grb10+/p 
mice is a facet of impulsivity or risk-taking behavior (see Chapter 6). Nevertheless, the data 
shown here suggests that these behaviours may be a substrate for imprinted gene action; 
specifically paternally expressed Grb10 compared with maternally expressed Nesp (Isles et 
al, unpublished results). Therefore, these data provide a novel, and predicted mode of 
action for genomic imprinting in the brain, that is dissociated from resource allocation 
between mother and offspring.  
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4.4.1 Summary of key results from Chapter 4 
 Grb10+/p and WT littermate mice were able to learn and accurately complete the 
delayed reinforcement and progressive ratio tasks. 
 Grb10+/p mice had altered delay-discounting behaviour, showing a significantly 
higher preference for the large, delayed reward, in a delayed-reinforcement task; 
which is opposite to that found previously in Nespm/+ mice. 
 The behaviour found in the delay-discounting task was not a result of differing 
motivation for the reward, as Grb10+/p and WT mice showed equivalent motivation 
to earn rewards in the progressive ratio task. 
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Chapter 5 – Development of a novel test of risk-taking: the Predator 
Odour Risk-Taking (PORT) task 
 
5.1 Introduction 
 
 
Many paradigms used to assay risk-taking behaviour in humans have been 
successfully translated into tasks for use with rats and mice, for example the balloon-
analogue risk test (BART; Ashenhurst et al., 2012), the Iowa gambling task (de Visser et al., 
2011) and the probabilistic-discounting task (Onge et al., 2012).  Moreover, results of a 
delay discounting task, which produced dissociable behaviour between Nespm/+ (Isles, et 
al. unpublished results) and Grb10m/+ mice (See Chapter 4), can also be interpreted as 
demonstrating risk-taking behaviour. Most current rodent tests of risk-taking have 
successfully translated human risk-taking tasks where loss or attenuation of a reward is the 
potential ‘risk’. However, whilst these paradigms are useful for examining decision-making 
generally, many (Simon et al., 2009, Choi and Kim, 2010, Franks et al., 2012) have argued 
that these tasks do not examine real-life risk-taking behaviour, where there is a trade-off 
between a benefit (or reward) and a separate cost (or risk). Thus, the current range of 
rodent risk-taking tasks may not capture a ‘real-world’ risky situation relevant to an animal. 
The importance of ‘real-world’ animal decision-making tasks is being increasingly 
recognised in the pursuit of accurately measuring risk-taking in laboratory animals (Simon et 
al., 2009, Choi and Kim, 2010). This problem has recently begun to be addressed by the 
development of behavioural tasks that assess the degree to which a separate factor, such as 
probability of a foot-shock (Simon et al., 2009) or safety of a dark environment (Franks et al., 
2012) is traded against gaining a food reward. The current chapter describes the 
development of a novel test of risk-taking that exploits the conflict between two of the most 
biologically relevant aspects of a rodent’s life: the motivation to obtain food vs. the risk of 
meeting a predator. Thus, the novel test of risk for mice, the predator odour risk-taking 
(PORT) task, measures the trade-off between two separate factors; an unpleasant or 
unwelcome occurrence (potential danger), and something rewarding (obtaining food); 
therefore taxing a more ethobiologically valid type of risk-taking. In the PORT task water-
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restricted mice were trained to traverse a 3 chambered apparatus to collect a 10% 
condensed milk reward, but were required to pass through a compartment which contained 
standard bedding material that was mixed with an odour from a major mouse predator: rat, 
cat or fox. Mice have an innate fear of the odour of their major predator species and show 
an escape response in their presence (Belzung and Griebel, 2001, Kavaliers et al., 2001, 
Fendt and Endres, 2008). For example, the synthetic odour from fox anal secretions, 2,4,5-
trimethylthiazoline (TMT), has been shown to induce defensive behaviours including 
avoidance and escape, increased  acoustic startle responding, and elevated blood 
corticosterone (Blanchard et al., 2003, Hebb et al., 2003, Fendt and Endres, 2008, Galliot et 
al., 2012).  These studies have investigated the effects of predator odours in terms of 
avoidance of the stimuli rather than balancing the tension between their anxiogenic nature 
and the drive to reach a goal. The ability to appropriately assess such risks (exposure to a 
predator) and weigh them up against potential rewards (food) is a crucial component of 
optimal decision-making, a cost-benefit analysis. In the PORT task, the anxiogenic nature of 
these odours (the cost) was utilised in a conflict situation whereby the mice were motivated 
to seek a food reward (the benefit).  
In defining and validating the PORT task a mouse strain of mixed genetic 
background, F2[C57BL/6J*CBA/Ca] was used, as this is the strain on which both Nesp
m/+
 and 
Grb10m/+ mice are now maintained. As well as the characterisation the PORT task itself, this 
chapter will also address a number of ancillary measurements, carried out in order to 
ensure that the PORT task accurately measured risk-taking behaviour. These included an 
assessment of locomotor activity, an assessment of fear/anxiety using the elevated-plus 
maze (EPM) and an assessment of potentiated startle using exposure to a predator odour 
(TMT). 
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5.2 Methods 
 
 
5.2.1 Subjects 
13 male F2[C57BL/6J*CBA/Ca] mice were used, produced from in-house breeding of 
F1[C57BL/6J*CBA/Ca] with F1[C57BL/6J*CBA/Ca].  Mice were 6 months old at the start of 
testing (mean weight: 30.38 ± 0.49 g). Animals had ad libitum access to standard lab chow, 
but water access was restricted to 2 hours during testing (given after testing). Details of 
general housing, husbandry and handling leading up to the experimental period were as 
described in Section 2.3.  
 
5.2.2 PORT Apparatus 
The apparatus used in the PORT task is shown and briefly described in Chapter 2, 
Section 2.4.6. The apparatus consisted of a white Perspex arena divided equally into three 
chambers, with each chamber measuring 30 x 30 x 40 cm (depth x width x height), arranged 
in a row such that the middle chamber could be entered from either of the end chambers 
(Fig. 5.1).  Guillotine doors, operated with a pulley system, controlled access to the middle 
chamber (doorway was 5 x 5 cm, width x height).  The central chamber was where different 
odours were introduced; whilst the outer (left and right) chambers were used as either the 
start chamber or the reward chamber (counterbalanced between subjects).  For example, a 
mouse starting from the left hand chamber (designated the ‘start chamber’) would cross the 
middle chamber and collect the reward in the right hand chamber (designated the ‘reward 
chamber’).  Reward was a 100 μl aliquot of 10% solution of condensed milk (Nestlé, U.K.) 
placed in a small pot attached in the centre of the reward chamber floor by Velcro. 10% 
condensed milk has been shown previously to be extremely motivating for mice (Humby et 
al., 1999, Isles et al., 2003). Predator odours (see below) were mixed with an equal amount 
of regular bedding material (wood shavings) and distributed evenly over the entire floor of 
the middle chamber prior to a trial. 
Data were collected using EthoVision Observer software (Version 3.0.15, Noldus 
Information Technology, Netherlands), as described in Section 2.4.6, with a specific virtual 
arena and zone configurations.  Thus, each chamber was designated as a zone (left, middle, 
right), and a circular area around the reward container was also specified as an independent 
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zone (5cm diameter).  Calculations based on the start direction (left or right) were used to 
determine which data would be identified as collected in the start or rewarded chamber, 
and reward collection.  The EthoVision tracking system performed calculations over a series 
of frames (12 frames/sec) to derive a set of quantitative descriptors about the movement 
and location of subjects, and variables such as duration, movement, entries and latency to 
first enter each zone of the chamber were determined by the EthoVison programme in 
terms of location of the greater body-proportion of subjects. Tracking of the subject was 
calibrated for the test apparatus prior to testing using non-experimental mice of the same 
body size and coat colour as the experimental subjects. Data were analysed as total values 
for each test trial and in 5-minute intervals for the habituation session.  From the range of 
parameters generated, the primary measures analysed were the latency to collect the 
reward from the start of a trial, the duration of time spent in each chamber, the distance 
and movement velocity, and the amount of rearing in each chamber was also measured.  
Rearing behaviour was automatically determined by the EthoVision system by registering a 
decrease in the surface area of the object being tracked.  To confirm the accuracy of the 
digitised tracking system, all sessions were also recorded using DVD HD recorders (Sony 
Corp, U.K.) for further analysis if required. 
 
5.2.3 Predator odours 
For each test trial an equal amount (500 ml) of odour/bedding mixture was placed 
into the middle chamber prior to the test starting.  For the mouse and rat odours, this 
consisted of bedding material (wood shavings) collected from animal cages, whereas for the 
cat and fox odour mixtures, clean standard bedding material was mixed with the odorising 
substance/material.  For each odour/bedding mixture the volumes of bedding, amount of 
odorising material and the time between mixing and using was standardised. This was 
especially relevant for the rat and cat odours which were collected from the cages in other 
vivaria. All odour mixtures were made 2 days before use and were kept in sealed bags in a 
room separate to the holding or test rooms, and only the amount required was collected 
before a trial.   
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Control bedding.  500 ml of clean standard mouse bedding material. 
Mouse (self) odour.  500 ml of the bedding material from the subjects’ own home cage was 
collected on the day of testing and the same bedding was used for all subjects housed in the 
same home cage. 
Rat odour.  Bedding material was collected from the cages of male Lister-hooded rats 
(housed in pairs); 1 week old on day of collection. 
Cat odour. A pigeon liner was placed in a cat enclosure, housing two male cats, for 3 days.  
Approximately 100 ml of fur was also collected when the cats were being groomed.  The 
liner was cut into small squares and, with the fur, mixed with the standard bedding material 
and left in a sealed bag for 3 days.  Cat odour has previously been shown to be aversive to 
mice (Kavaliers et al., 2001). 
Fox odour.  2,4,5-trimethylthiazoline (TMT) (Contech Inc, Canada), a synthetic predator cue 
isolated from red fox (Vulpes vulpes) anal secretions, was used. A 10% TMT solution was 
made by diluting TMT in water and Tween (30 μl).  500 μl of the solution (in 50 μl aliquots) 
was pipetted on to 10 pieces of blotting paper (5 cm2), which were then placed in a bag 
containing 20 L of wood shavings.  Therefore, each 500 ml aliquot of standard bedding 
material placed into the middle chamber of the apparatus (volume of 3600 cm3) was 
equivalent to 12.5 μl of 10% TMT/cm3, which is consistent with the concentration levels of 
TMT used previously to engender aversion and anxiety (Galliot et al., 2012). 
 
5.2.4 Procedure 
 Initial training took place over an 8 day period consisting of 6 days habituation to the 
reward to be used (10% condensed milk), habituation to the test environment and finally 
acquisition of the basic test procedure.  All experiments were conducted in daily sessions, 
home cage water was always given once testing was completed.  On each day of training 
and testing, subjects were moved from the vivarium and kept in a separate room adjacent 
to the testing room until required.  Both the holding and test rooms were illuminated by 
dim lights and care was taken to minimise physical disturbance or excessive noise. Before 
and between trials, mice were kept in a cage in the test room adjacent to the apparatus.  
Between individual mice and between trials the apparatus was cleaned thoroughly with a 
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1% acetic acid solution, and odour/wood shaving mixtures were removed by vacuum 
cleaner. 
 
5.2.4.1 Habituation to the reward   
 Animals were habituated to the condensed milk reward using the milk preference 
test protocol as outlined in Section 2.3.5. 
 
5.2.4.2 Habituation to the test apparatus  
 Subjects were placed in the centre of the middle compartment of the apparatus, 
with both the doors open, and allowed to explore the 3 chambers for a period of 20 
minutes.  In order to keep the habituation trials consistent with the acquisition and test 
trials, the chamber was cleaned with 1% acetic acid and 500 ml of clean standard mouse 
bedding (wood shavings) was placed in the middle chamber before each mouse. There was 
no reward present during these habituation sessions. The time spent and the numbers of 
entries into each chamber (left, middle and right) were determined for each 5 minute 
period of the habituation session. 
 
5.2.4.3 Acquisition 
In this stage of training subjects learnt that reward (100 μl of 10% condensed milk) 
was available within the test apparatus.  Each subject completed 5 consecutive trials, 
whereby they were placed in one of the outer chambers (‘start’), the doors were opened 
and the subject was free to explore the 3 chambers and collect the reward situated in the 
opposite (‘reward’) chamber.  Direction of travel was counter-balanced between mice, such 
that some subjects moved from left to right and others, right to left, but direction was fixed 
for each individual subject throughout testing.  There was no time limit on these trials and 
each trial was stopped manually when the subject was observed to have collected the 
reward.  The subject was then removed and placed in a holding box before the reward was 
replenished and the apparatus cleaned using 1% acetic acid.  In order to keep the 
acquisition trials consistent with the probe trials, 500 ml of clean standard mouse bedding 
was placed in the middle chamber before each trial.  The latency to reach the reward 
chamber and collect the reward from the start of each trial the duration of time spent in 
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each chamber, the distance moved,  movement velocity, and the amount of rearing in each 
chamber were determined for each trial. 
 
5.2.4.4 Predator odour risk testing 
 Trials were carried out in the same way as the acquisition stage, whereby subjects 
were placed in the start chamber and were required to cross the middle chamber in order 
to collect the reward situated in the opposite chamber.  Trials ended when the subject had 
consumed the reward; with a maximum trial duration of 10 minutes.  On each day of 
testing, all subjects completed 6 trials: 3 training trials in the morning with control bedding 
and 3 test trials in the afternoon with an odour/bedding mixture (minimum delay between 
each set of trials was 2 hours).  Thus, for the 3 consecutive training trials the middle 
chamber contained 500 ml of clean standard mouse bedding and for the  3 consecutive test 
trials, 500 ml of ‘predator odour bedding’ or ‘self odour bedding’ was placed in the middle 
chamber.  After each subject had completed either the control or test trials, the bedding 
was removed, and the chamber cleaned with 1% acetic acid solution.  The self odour test 
session, using mouse bedding, was conducted on the day following acquisition, and 
subsequent sessions (with rat, cat and fox odours) with 3 day intervals. Further tests to 
investigate altered motivation were also performed with a 1% condensed milk solution as 
the reward instead of the normal 10% concentration. On each day of testing the animals 
received 1% milk in both the 3 training trials in the morning, and the test trials in the 
afternoon. Test sessions for different predator odours were carried out in separate sessions, 
3 days apart, counter-balanced for order. As previously, the main parameters assessed in 
each trial were the latency to reach the reward chamber and collect the reward from the 
start of each trial, the duration of time spent in each chamber, the distance moved, 
movement velocity, and the amount of rearing in each chamber. 
 
5.2.5 Locomotor activity (LMA) 
In order to assess reactivity to novelty and the general locomotor activity mice were 
assessed with a single 120 minute activity session. The LMA was carried out using the 
apparatus described in Section 2.4.1, and standard procedure outlined in Section 3.2.2.   
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5.2.6 The elevated-plus maze (EPM) 
In order to measure general levels of anxiety, mice were assessed on the EPM, using 
the apparatus described in 2.4.4. Subjects were placed at the centre of the EPM facing one 
of the exposed open arms and allowed to explore the maze over a single session of 5 min.  
To optimize data analysis using the EthoVision observer software, the different parts of the 
EPM were divided into 5 virtual zones representing the 2 open arms, 2 closed arms and the 
middle section (8 x 8 cm, length x width) from which all arms originated.  Data from the 2 
open arms was combined to generate a single open arm value and a similar cumulative 
closed arm value was also produced.  The main parameters used as indices of anxiety-
related behaviour were the proportion of time spent exploring the open arms (relative to 
the time spent on both open and closed arms) and the number of entries onto the open and 
closed arms.  In addition, the following parameters were manually scored: number of 
stretch attend postures (SAP, defined as an animal keeping its hindquarters in the closed 
arms but stretching forwards onto an open arm) and number of head dips from the open 
arms (looking over the edge of an open arm).   
 
 
5.2.7 Anxiety-induced Acoustic Startle (ASR) and Prepulse Inhibition (PPI).  
 It has been shown that ASR is increased in the presence of a predator odour, such as 
TMT, whereas PPI remains unaffected (Hebb et al., 2003). Therefore, mice were assessed 
using the ASR/PPI chambers as described in Section 2.4.5. Subjects were assessed in 2 
separate test sessions, a week apart, immediately following 10 min exposure to either 
untainted standard bedding material (control condition) or fox odour tainted bedding 
material, mixed at the same concentration of TMT as used in the PORT task (see above).  
The order of odour presentation was counter balanced between mice. ASR and PPI were 
monitored using SR-Lab apparatus (San Diego Instruments, U.S.A), according to previous 
method (Geyer and Dulawa, 2003). White noise stimuli were presented via a speaker 
mounted in the roof of a sound-attenuating chamber, 12 cm above the subject.  Animals 
were placed in a Perspex tube (internal diameter 35 mm) mounted onto a Perspex plinth. 
Startle responses were transduced and digitised by a piezoelectric transducer linked to the 
computer and placed directly under the centre of the Perspex tube.   
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A session consisted of a 5 min habituation period followed by 2 blocks of acoustic 
stimuli presented against a background white noise (65 db, A scale) with the startle 
amplitude set at 120 db in the first block (13 pulse-alone, 18 prepulse and 4 no stimulus 
trials) and a pseudorandom distribution of pulse-alone trials of increasing amplitude (3 trials 
each at 80, 90, 100, 110 and 120 db and 5 no stimulus trials) in the second block.  Stimuli 
were presented in a pseudorandom manner every 10 s.  Pulse-alone trials consisted of a 40 
ms 120 db startle stimulus and a prepulse trial consisted of an initial 20 ms prepulse 
stimulus at 4, 8, or 16 db above background and a 30 ms, 120 db startle stimulus, 70 ms 
after the prepulse offset.  In the first block of stimuli, prepulse trials at the different 
intensities and no-stimulus trials were pseudorandomly distributed between the pulse-
alone trials.  The whole body startle response to the pulse-alone trials and the gating (i.e. 
inhibition) of responding due to the presentation of prepulse stimuli was recorded as the 
average startle over a 65 ms period timed from the onset of the startle pulse, and each trial 
type was averaged together. PPI was calculated as the percentage reduction in startle 
amplitude between prepulse trials and pulse-alone trials.   
 
 
5.2.8 Data analysis and statistics 
All statistical analyses were carried out using SPSS 18.0 for Windows.  For each of the 
different test odour sessions (control bedding, self, rat, cat and fox odours), mean values 
were determined by averaging each of the 3 probe trials together. The following parameters 
were analysed for each session: latency to enter the reward chamber from the start of the 
trial, duration within the start, middle and reward chambers, distance moved in the start 
and middle chambers, the amount of rears in the start and middle chambers and the 
velocity of movement in the start, middle and reward chambers.  Data comparing the effect 
of different predator odours on behaviour was analysed by ANOVA with repeated measures 
of ODOUR (self, rat, cat and fox) and CHAMBER (start or middle).  To investigate the effect 
of reducing the reward concentration, parameters were analysed by ANOVA with a 
repeated measures of ODOUR (control, rat) and CONCENTRATION (10%, 1%).  Habituation 
data were analysed by ANOVA with a repeated measures of TIMEBIN (0-5, 6-10, 11-15, 16-
20) and CHAMBER, acquisition data with repeated measures of TRIAL (1-5) and CHAMBER 
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and habituation to the reward by ANOVA with factors of DAY (1-6) and solution (water, 10% 
condensed milk).  Beam breaks from the locomotor activity session was analysed by ANOVA 
with a repeated measure of BIN (0-30, 31-60, 61-90, 91-120 minutes from start of the 
session) and the elevated plus maze data (entries /arm) by ANOVA with repeated measures 
of ARM (open, closed) and BIN (1,2,3,4,5 minutes from the start of the session). Data from 
the duration spent in the arms of the elevated plus maze violated the ‘independence’ 
assumption for parametric tests; therefore a Wilcoxen signed rank test was used as a 
nonparametric substitute. Data from the first block of ASR testing were analysed by ANOVA 
with factors of ODOUR (control or fox) and TRIAL (1-13) for the pulse-alone trials, and 
TRIALTYPE (4db prepulse, 8db prepulse and 16 db prepulse) for degree of PPI).  Data from 
the second block of stimuli was analysed by ANOVA with factors of ODOUR and AMPLITUDE 
(70, 80, 90, 100, 110 and 120 db).  Pearson’s correlations were used to assess relationships 
between key parameters from each of the different tests.  For repeated-measures analyses, 
Mauchly’s test of sphericity of the covariance matrix was applied. Huynh-Feldt corrections 
were applied as necessary, and adjusted degrees of freedom are provided. Post hoc pairwise 
comparisons were performed using the Bonferroni test, with alpha values of <0.05 regarded 
as significant. 
 
 
5.3 Results 
 
 
5.3.1 Milk preference testing and acquisition of PORT task 
 Before the F2[C57BL/6J*CBA/Ca] mice could be assessed for risk-taking behaviour in 
the PORT task, they were first habituated to the 10% condensed milk reward solution and 
the test apparatus. Following this, subjects underwent training to acquire the basic 
procedure of traversing the middle chamber, on exiting the start chamber to collect reward 
in the furthermost chamber.  All mice showed a significant preference for the condensed 
milk reward solution over water, reaching >75% preference by the end of the habituation 
test (Fig 5.2a; main effect of SESSION, F4,48=22.89, p<0.001) and consuming on average 1.4 
ml of solution (Fig 5.2b; main effect of SESSION, F4,48=1.65, p<0.001). During the 20 minute 
habituation session, mice readily explored the 3-chamber apparatus, making more entries 
into the middle chamber (Fig 5.2c; main effect of CHAMBER, F2,24=14.62, p<0.001), as might 
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be expected as the mice traversed the apparatus, which was also reflected by an increase in 
the amount of time spent in this chamber (Fig 5.2d; main effect of CHAMBER, F2,24=97.54, 
p<0.001).  During acquisition of the PORT task procedure, the mice were trained to traverse 
the apparatus from the start chamber to collect 100 μl of 10% condensed milk in the reward 
chamber. Results show that mice readily traversed the middle chamber containing clean 
standard (control) mouse bedding, taking on average <2 minutes to collect the reward 
across all 5 trials (Fig 5.2e). Latency to collect reward increased with trial (Fig 5.2e; main 
effect of TRIAL, F4,48=10.41, p<0.005). 
 
  
Figure 5.2 Reward habituation and acquisition of the PORT task procedure by male F2[C57BL/6J*CBA/Ca]  
mice.  During habituation to the reward, all mice showed an increasing preference for the 10% condensed milk 
reward over water (a), consumption of condensed milk increased across testing days (b). During the 20 min 
habituation session to the 3-chamber apparatus F2[C57BL/6J*CBA/Ca] mice readily explored the different 
chambers of the PORT task apparatus, entering each compartment a number of times (c), but spending most 
time in the middle compartment (d).  During acquisition, the mice were trained to cross the PORT task 
apparatus to collect the reward, passing through the middle chamber which now had clean bedding material 
on the floor.  All the mice traversed the chambers quite rapidly across all 5 trials (e).  Error bars show 
mean±SEM. N=13. 
***P<0.005. 
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5.3.2 Predator odour alters behaviour in PORT task 
Following acquisition, F2[C57BL/6J*CBA/Ca] mice were assessed for risk-taking 
behaviour by mixing the bedding material in the middle chamber of the PORT task 
apparatus with rat, cat or fox odours (Fig. 5.3a). Control sessions were also carried out, with 
clean untainted bedding, as well as bedding from the subject’s own cages. Mice were given 
3 training trials with control bedding in the central chamber in the morning and then 3 test 
trials with bedding mixed with a control (own bedding) or predator odour in the afternoon. 
For ease of viewing the 3 trials of each test session have been collapsed to yield single 
values.  In the presence of a predator odour mice were more reluctant to collect the food 
reward relative to control (own) odour as evidenced by the EthoVision tracks and the overall 
collection latencies (Fig. 5.3b; main effect of ODOUR, F3,36=11.93, p<0.001). A breakdown of 
the overall duration indicated that the predator odour had a similar effect on time spent in 
the start chamber (Fig. 5.3c; main effect of ODOUR, F3,36=6.32, p<0.001) but not the middle 
chamber (Fig. 5.3d; main effect of ODOUR, F3,36=3.447, p=0.06); suggesting that increased 
latency was due to fear to leave the start chamber, not increased exploration of the odour. 
Pairwise comparison of F2[C57BL/6J*CBA/Ca] data revealed that total latency to collect was 
significantly increased for rat odour (p=0.020), fox odour (p=0.003) and cat odour (p=0.009) 
compared to control (self) odour (Fig. 3b).  
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Figure 5.3 Effects of different predator odours on risk-taking behaviour in male F2[C57BL/6J*CBA/Ca] mice.   
Mice were assessed for the time taken to cross the PORT task apparatus in the presence of different 
odour/bedding material combinations, including their own given bedding.  Mice were given 3 trials during each 
phase of testing and for ease of viewing we have collapsed the trials of each probe session to yield single 
values.  (a) Example traces for a F2[C57BL/6J*CBA/Ca] mouse to traverse the PORT task apparatus.  Overall, 
mice were slower to collect the reward in the presence of a predator odour (b). Increased latencies to collect 
the reward were mainly as a result of increased emergence times from the start chamber (c), rather than 
investigation of the novel odours in the middle chamber (d).  Error bars show mean ±SEM. N=13. 
***P<0.005. 
 
5.3.3 Value of food reward influences behaviour on PORT task 
The effect of altering the value of the food reward on behaviour of 
F2[C57BL/6J*CBA/Ca] mice in the PORT task was assessed by reducing the concentration of 
the condensed milk from 10% to 1%. This test was carried out on both a control and 
predator odour (rat) background on separate test days. Reducing the concentration for the 
food reward led to significantly increased reward collection latencies (Fig. 5.4a; main effect 
of CONCENTRATION, F1,12=14.50, p<0.05). However, there was no significant interaction 
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between altering the reward value and the presence of a predator odour (F1,12=25.80, 
p=0.91), suggesting that the effects of reduced reward concentration in the presence of 
predator odour were not additive. Again this slowing of behaviour was reflected in the 
component parts of the latency to collect the reward, with animals taking longer to leave 
the start chamber (Fig. 5.4b; main effect of CONCENTRATION, F1,12=7.03, p=0.02) and an 
increased duration in the middle chamber (Fig. 5.4c; main effect of CONCENTRATION, 
F1,12=6.15, p=0.03). Pairwise comparison of F2[C57BL/6J*CBA/Ca] data revealed that total 
latency to collect was significantly increased for 1% milk (p=0.002). 
  
                           
Figure 5.4 Effects of reduced reward on risk-taking behaviour in male F2[C57BL/6J*CBA/Ca] mice.  To further 
examine the cost/benefit of traversing the PORT task apparatus to collect reward in the presence of a predator 
odour, we decreased the ‘benefit’ by using a more dilute reward. Reducing the concentration for the reward 
from 10% to 1% led to significantly increased reward collection latencies, suggesting that the mice were less 
willing to take the risk of crossing the middle chamber to collect the reward (a).  The effect of the rat odour 
was maintained. In contrast to the effects of predator odour, this effect was not a result of increased 
emergence times from the start chamber (b), but rather a difference in behaviour in the middle chamber 
where strain differences in duration persisted (c).  Error bars show mean ±SEM. N=13. 
*P<0.05. 
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5.3.4 Correlation of independent measures with PORT task behaviour 
Independent measures of motivation, motor function and anxiety of 
F2[C57BL/6J*CBA/Ca]  mice were further investigated to assess whether general differences 
in these behaviours could account for the differences shown in the PORT task. To assess 
whether individual differences in motor activity could have impacted on the behavior in the 
PORT task, correlations were conducted between the total LMA and the latency to collect 
the reward in the different predator odour tests.  No significant correlations were found 
when LMA was compared to the latency to collect the reward in the cat odour test of the 
PORT task (Fig. 5.5a; r13=-0.13, p=0.68), nor with comparisons of LMA with collection latency 
on rat (r13=-0.43, p=0.14; data not shown) or fox (r13= -0.01, p=0.97; data not shown) odour 
tests, suggesting that individual levels of locomotion were having no effect on risk-taking 
behaviour per se.  Correlations between the final reward preference obtained from the 
reward habituation test and the latency to collect the reward in the different predator 
odour tests was also not significant for cat odour (Fig. 5.5b; r13=0.05, p=0.89), rat odour 
(r13=-0.17, p=0.58; data not shown) or fox odour (r13=0.01, p=0.99; data not shown); 
suggesting that levels of general motivation for reward also did not impact on PORT task 
performance, and that in all of the mice there was an equal drive to collect the reward. 
Overall, F2[C57BL/6J*CBA/Ca] mice showed the expected anxiogenic pattern of 
behaviour of avoidance of the open arms on the EPM test, making less entries (Fig. 5c; main 
effect of ARM, F1,12=82.50, p<0.001) and spending less time in the open arms (Fig. 5.5d; 
Wilcoxen signed ranks test, Z =-3.18, p<0.005). To assess whether individual differences in 
anxiety-related behaviours impacted on the behavior in the PORT task, correlations were 
conducted between the proportion of time spent on the open arm of the EPM and the 
latency to collect the reward in the PORT task. There was a significant positive correlation 
between time on the open arm of the EPM and the reward latency if cat odour was present 
in the PORT task (Figure 5.5e; r13=-0.58, p=0.04), similar significant correlations were 
observed in comparison with the rat (r13=-0.645, p=0.017; data not shown) and fox 
(r13=0.695, p=0.008; data not shown) odour tests, further suggesting that inherent anxiety 
played a significant role in the risk-taking behaviour assessed by the PORT task. 
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Figure 5.5 Measures of locomotor activity, motivation and anxiety in male F2[C57BL/6J*CBA/Ca] mice.  To 
further evaluate the effects of the PORT task testing, a number of ancillary assessments were performed which 
investigated motor activity, motivation and anxiety. Total activity levels were not significantly correlated with 
the latency to collect reward in the PORT task with cat odour present (a); suggesting that motor competence 
did not affect PORT task performance. Similarly, overall reward preference did not correlate with the latency to 
collect reward in the PORT task with cat odour present (b).  Anxiety-related behaviour was assessed using the 
elevated-plus maze, which measured entries on to (c) and time spent on (d) the open and closed arms. Results 
showed a significant negative correlation between open arm times and the latency to collect reward in the 
PORT task with cat odour present (e), which suggests that inherent anxiety played a significant role in the risk-
taking behaviour assessed by the PORT task.  For each of the correlations presented here, similar patterns were 
observed in comparison with the latency to collect the reward in the PORT task during the rat and fox odour 
tests. Error bars show mean±SEM. N=13. ***P<0.005. 
 
5.3.5 Predator odour induces changes in startle response 
To investigate if the F2[C57BL/6J*CBA/Ca] mice found the predator odour 
anxiogenic, we measured the acoustic startle response (ASR) and prepulse inhibition (PPI) 
following exposure to either clean bedding or bedding containing fox odour (10% TMT).  The 
mice demonstrated elevated startle responding following exposure to the fox odour 
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compared to exposure to control bedding (Fig. 5.6a; main effect of ODOUR, F1,12=14.78, 
p<0.005). Levels of PPI were generally unaffected by pre-exposure to the fox odour (Fig. 
5.6b; main effect of ODOUR, F1,12=1.02, n.s.) and differing prepulse intensities induced 
increasing amounts of PPI (Fig. 5.6c; F2,24=30.11, p<0.001), although there was a flattening of 
the PPI effect at the highest prepulse intensity (16 db) used (interaction between 
Odour*PPI, F2,24=12.44, p<0.001). Correlations between the mean ASR showed a significant 
relationship between the amount startle responding following pre-exposure with control 
(Fig. 5.6d; r13=0.77, p<0.005), but not fox odour (Fig. 5.6d; r13=0.45, n.s) and the latency to 
collect reward in the PORT task with cat odour present.  No such significant correlations 
were found between PPI (at 16 db prepulse amplitude) and the latency to collect reward in 
the PORT task with cat odour present (Fig. 5.6e; r13=-0.56, and r13=0.05, n.s.) for control and 
fox odour pre-treatment respectively).   
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Figure 5.6 Effects of predator odour on the acoustic startle response and prepulse inhibition in male 
F2[C57BL/6J*CBA/Ca] mice.  It has been shown previously that the acoustic startle response can be increased 
in the presence of a stress-inducing predator odour, such as TMT from fox urine (Hebb et al., 2003).  Exposure 
to fox odour, compared to control odour, significantly increased responding to 120 db startle stimuli (a), startle 
amplitude increased with stimulus intensity in both control and fox odour conditions (b). Increasing prepulse 
intensities led to increased prepulse inhibition (PPI) (c), which were mainly unaffected by pre-exposure to fox 
odour, although PPI was reduced at the highest prepulse stimulus tested.  Startle responding to 120 db startle 
stimuli  in control, but not fox odour, pre-exposure conditions significantly correlated with the latency to 
collect reward in the PORT task with cat odour present (d).  PPI with a 16 db prepulse intensity in either test 
condition did not correlate with the latency to collect reward in the PORT task with cat odour present (e).  For 
each of the correlations presented here, similar patterns were observed in comparison with the latency to 
collect the reward in the PORT task during the rat and fox odour tests.  These results suggest that mice showed 
stress-related patterns of behaviour after exposure to a predator odour.  Error bars show mean±SEM. N=13. 
***P<0.005. 
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5.4 Discussion 
 
 
 The principal aim of this chapter was to develop a novel murine test of risk-taking 
behaviour, which provides a more ethologically valid method than established tests of risk-
taking. By exploiting the innate fear that mice have of predator odours, we created a 
situation which caused a trade-off between the benefit of a food reward and the cost of 
potential danger. A cohort of WT mice with mixed genetic background 
(F2[C57BL/6J*CBA/Ca]), chosen as it provides the background strain for Nesp
m/+
 and Grb10
+/p 
mice used in the rest of this thesis, were used to demonstrate that the presence of a 
predator odour systematically increased the time to collect the food reinforcement in the 
task. A similar effect on latency was produced by decreasing the value of the reward. Taken 
together these data suggest that the PORT task is sensitive to changes in both the cost (risk 
of predation) and the benefit (food).  
Although a number of rodent tests have successfully measured the equivalent of 
‘human’ risk-taking behaviour, such as loss or attenuation of reward as the potential ‘risk’ 
(de Visser et al., 2011, Ashenhurst et al., 2012, St Onge et al., 2012), they fail to consider the 
normal risk-taking situation, where there is a trade-off between a benefit and a separate 
cost. Thus, the current battery of rodent risk-taking tasks may not capture an animal’s ‘real-
life’ risky situation. In this novel test of risk for mice, the PORT task, mice were trained to 
traverse a 3 chambered apparatus to collect a 10% condensed milk reward. On separate test 
days the subjects were required to pass through the middle compartment in which the 
odour from mouse predators (rat, cat or fox) had been placed. Under these conditions the 
overall latency to collect the reward was significantly increased. Furthermore when this 
measure was examined in detail, it was found that under predator odour conditions, mice 
spent significantly more time in the start chamber, but not in the middle chamber; 
suggesting that the increased latency to collect the reward was a result of reluctance to 
leave the start chamber and not increased exploration of the odour in the middle chamber. 
In contrast, during test days when their own bedding was present, mice would readily pass 
through the centre and ‘open’ areas of the arena. The different predator odours had 
proportionally different effects on latency, such that rat<fox<cat. Given the nature of how 
these odours were obtained it is difficult to draw any conclusion from this finding, other 
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than that in general behaviour in the PORT task was sensitive to a number of different 
predator odours. Observationally, and as evidenced by the EthoVision tracking (Fig 5.3a), it 
was clear that under predator odour conditions, mice spent significantly more time in the 
corners of the three arenas and displayed greater levels of thigmotaxis (wall-seeking 
behaviour). Thigmotaxis is a fear-based reaction, and rodents display this behaviour as a 
way of avoiding potentially dangerous areas or threats (Choleris et al., 2001).  
Converging evidence for the role of fear in mediating behaviour in the PORT task 
came from measures on the elevated plus-maze (EPM), which correlated with behaviour in 
the PORT task. Specifically the amount of time spent on the open arms was positively 
correlated with latency to collect the reward. Furthermore, the presence of fox odour (TMT) 
produced an increased startle reaction in the acoustic startle response (ASR), consistent 
with previous findings (Hebb et al., 2003) and demonstrated a fear inducing reaction to the 
odour, as opposed to a noxious reaction. Taken together these findings indicate that under 
certain test conditions the PORT task successfully constituted a sufficiently fear evoking 
environment, in which collecting the reward would be perceived as a risk. In addition to this, 
general levels of locomotor activity did not correlate with latency to collect the reward, 
suggesting that the effect found was not caused by general motoric ability. Furthermore, 
the latency to collect the reward was not correlated with preference for the condensed milk 
reward, suggesting that all animals regarded the reward as equally valuable, and the effects 
found in the PORT task were not due to differing motivation for the reward. 
Importantly the PORT task is sensitive to manipulation of the motivation for the food 
reward, whereby when reward value was reduced, risk-taking behaviour also reduced. 
Under both control and predator odour conditions, subjects took significantly longer to 
collect a food reward when reduced from a 10% concentration to a 1% concentration of 
condensed milk, with the effect on collection latency being comparable to the latency to 
collect the reward in the presence of rat odour. Therefore the behaviour measured in the 
PORT task was not just a result of anxiety/fear, but also motivation for the reward. Although 
there was no general correlation between milk preference and behaviour in the PORT task, 
these findings indicate that this task successfully measured the trade-off between cost and 
benefit, which defines risk-taking behaviour.  
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The data collected here provide evidence for the successful development of a novel 
risk-taking task, encapsulating a naturalistic and ‘real-world’ approach to the measurement 
of risk-taking behaviour in rodents.  The robust results show an effect which has been 
replicated across a number of predator odours. The task could be very effective in 
understanding the neurobiology and neurochemistry of risk behaviour, where the 
serotonergic, noradrenergic and dopaminergic neurotransmitter systems have been 
strongly implicated (Belzung and Griebel, 2001, Cardinal, 2006, Doya, 2008). Furthermore 
the PORT task will be important in assessing the Nespm/+ and Grb10+/p mice, in order to 
ascertain if this aspect of risk-taking behaviour is altered in these animals. This explicit test 
of risk-taking will contribute to our understanding of what specific adult behaviours are 
affected by Nesp and Grb10. 
 
 
5.4.1 Summary of key results from Chapter 5 
 A cohort of WT male F2[C57BL/6J*CBA/Ca]
 mice were used to successfully develop a 
novel test of risk-taking behaviour. Under control conditions mice readily crossed the 
central chamber of the PORT apparatus to collect a food reward; however under 
predator odour conditions (rat, cat, fox) subjects took significantly longer to cross 
the central chamber to collect the reward. 
 It was demonstrated that when the value of the food reward was reduced, risk-
taking behaviour was reduced. This provides evidence that the behaviour in the 
PORT task was a function of balancing motivation for the reward and fear of 
predation. 
 Evidence from ancillary measures (LMA, EPM and ASR) demonstrated that subjects 
had a fear/anxiety based response to the predator odour and that behaviour in the 
PORT task was not driven by general levels of locomotion. 
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Chapter 6 – Investigating risk-taking behaviour in Nespm/+ and 
Grb10+/p mice, using the Predator Odour Risk-Taking (PORT) task. 
 
6.1 Introduction 
 
 
Previous research has suggested that the maternally expressed imprinted gene Nesp 
may be associated with the promotion of risk-taking behaviour, in that Nespm/+ mice were 
shown to have altered reactivity to a novel environment in both a locomotor activity task 
(LMA) and a reduced propensity to explore a novel environment in a novelty place 
preference (NPP) task (Plagge et al., 2005). Chapter 3 of this thesis showed the testing of 
Grb10+/p mice on the LMA and NPP tests and found that Grb10+/p do not exhibit altered 
behaviour in these tests compared to WT animals. However, Nespm/+ mice (Isles et al. 
unpublished data) and Grb10+/p mice (Chapter 4) were shown to have opposite behaviour in 
a test of delay discounting, as measured by the delayed-reinforcement task. Specifically, 
Nespm/+ mice were significantly more likely to discount the large delayed reward in favour of 
the small reward, whilst Grb10+/p mice demonstrated the opposite behaviour, having a 
preference for the large delayed reward.  
Although more generally recognised as a test of impulsive behaviour, both 
theoretical (Kalenscher, 2007) and experimental (Hayden and Platt, 2007) evidence has led 
some to conclude that discounting tasks measure a facet of risk-taking behaviour in animals, 
with the argument that animals view temporally distant rewards as risky (Kalenscher, 2007). 
Therefore, the behaviour of Nespm/+ and Grb10+/p mice in the delayed reinforcement task 
could be interpreted as suggesting that Nesp acts to promote risk taking and Grb10 acts to 
promote risk aversion. However the delayed-reinforcement task is based on inter-temporal 
decision making (choosing between a temporally close or temporally distant reward), and 
therefore does not measure a cost/benefit analysis, where a potential gain is weighed up 
against potential harm/danger. Consequently, it was of interest to examine this behaviour in 
an additional, more explicit, test of risk-taking. 
Chapter 5 outlined the development of a novel test of risk taking, the predator odour 
risk-taking task (PORT), which provides an ethobiologically relevant test in which mice are 
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faced with the decision to collect a reward under the potential threat of a predator (see also 
Dent et al. 2013). The PORT task measures the trade-off between two separate factors; an 
unpleasant or unwelcome occurrence (potential danger), and something rewarding 
(obtaining food); therefore taxing a more ethobiologically valid type of risk-taking. During 
the development of the PORT task in F2[C57BL/6J*CBA/Ca] mice (Chapter 5), various 
ancillary measurements were made in order to ensure that the task accurately measured 
risk-taking behaviour. These included measures of locomotor activity, anxiety, potentiated 
startle response and pre-pulse inhibition following exposure to predator odour. 
Furthermore, the effect of reducing the reward value was assessed, which confirmed that a 
reduction in reward value increased the latency to collect the reward, during both predator 
odour and control trials. This suggested that the behaviour measured in the PORT task was 
not just a result of anxiety/fear, but also motivation for a reward. As a result of this wide 
range of measurements, we are satisfied that the PORT task successfully measures risk-
taking behaviour in rodents, and therefore provides a useful tool which can be applied to 
transgenic mice in order to assess how certain genes may influence this behaviour.  
This chapter investigated Nespm/+ and Grb10
+/p mice performance in the PORT task, 
to analyse if this aspect of risk-taking is mediated by the imprinted genes Nesp and Grb10. 
Based on previous findings it may be expected that Nespm/+ mice will be less risk-taking, and 
therefore take longer to collect the reward in the PORT task. Conversely Grb10+/p mice may 
be expected to be more risk-taking, and therefore be significantly quicker to collect the 
reward in the PORT task. The results of this task will contribute to our understanding of 
which specific facets of risk-taking behaviour the imprinted genes Nesp and Grb10 influence. 
 
6.2 Methods 
 
 
6.2.1 Subjects 
Two lines of mice were used: a cohort of Nespm/+ mice and their WT littermates, and 
separately a cohort of Grb10+/p and their WT littermates. All mice were 6 months old at the 
start of testing. Details of specific samples sizes per genotype and weights at the start of 
testing can be found in Table 6.1. All subjects were group housed (2 to 5 mice/cage) in 
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environmentally enriched cages (i.e. with cardboard tubes, shred-mats and tissue paper) in 
a temperature and humidity controlled vivarium (21 ± 2°C and 50 ± 10%, respectively) with a 
12-hour light-dark cycle (lights on at 07:00 hours/lights off at 19:00 hours).  Animals had ad 
libitum access to standard lab chow, but home cage water was restricted to 2 hour access 
per day during the period of testing (access occurred after testing). This regime maintained 
the subjects at ~90% of free-feeding body weight.  Further details of animal husbandry and 
handling prior to testing can be found in Chapter 2, Section 2.3.   
 
 Nesp cohort Grb10 cohort 
 WT Nespm/+ WT Grb10+/p 
Number 17 19 14 11 
Average weight (g) 29 (±2) 30 (±3) 35 (±4) 33 (±3) 
Table 6.1 Details of the sample sizes and average weights of each cohort used in PORT task. 
 
6.2.2 Predator odour risk taking task 
 The predator odour risk-taking (PORT) task was carried out using the 3-chamber 
apparatus as shown in Chapter 2, Section 2.4.6, and procedure as described in Chapter 5, 
Section 5.2. The two cohorts of mice were tested separately but consecutively within the 
same period of time, such that the Nesp cohort completed the task during the 1st week, 
then the Grb10 cohort completed the task the following week. During the development of 
the PORT task (see Chapter 5, Section 5.2.3) an array of predator odours were used (rat, cat 
and fox), and the result of these experiments showed that fox odour (synthetic TMT) was 
highly effective in inducing robust behavioural effects, and was also the most controllable 
and quantifiable (due to the nature of it being a synthetic chemical). The fox odour also gave 
robust potentiated startle response effects (Chapter 5, Section 5.3.5); therefore only this 
odour was used for testing Nespm/+ and Grb10+/p mice in the PORT task, in comparison to 
control tests using the subjects own bedding.  
 
6.2.2.1 Habituation and Acquisition 
Details of the habituation and acquisition stages of the PORT task are outlined in 
Chapter 5 section 5.2.4, but in brief; both cohorts of animals were first habituated to the 
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condensed milk reward using the milk preference test protocol as outlined in Chapter 2, 
Section 2.3.5. Subjects were then given a single 20 minute period of habituation to the 
apparatus, in which they were given the opportunity to freely explore all three chambers of 
the apparatus without any reward or odour stimuli present. Following habituation, each 
subject completed the acquisition stage; consisting of 5 consecutive trials, in which mice 
were placed in the apparatus and required to cross the central chamber, containing clean 
bedding, in order to collect the reward available in the opposite chamber. These stages of 
the task allowed subjects to become familiar with the apparatus, and learn that a reward 
was available. During the 5 acquisition trials, the latency to collect the reward was recorded; 
as determined from analysis of the tracking data collected by EthoVision tracking software 
(see Chapter 2, Section 2.4.7). Subjects had a maximum of 10 minutes to collect the reward. 
 
6.2.2.2 Predator odour risk testing 
 When subjects had successfully completed the habituation and acquisition stages, 
they moved on to the PORT task proper. Trials were carried out in the same way as 
previously described in Chapter 5, Section 5.2.4.4, in brief; subjects were individually put in 
either the left or right chamber (counterbalanced across subjects) and required to cross the 
middle chamber (containing bedding) in order to collect the reward (10% condensed milk 
solution) located in the opposite chamber (see Chapter 5, Figure 5.1). Subjects completed 3 
consecutive ‘control’ trials (where clean bedding was present) in the morning, and 3 
consecutive ‘test’ trials in the afternoon (where bedding containing an odour was present). 
The odours tested in this experiment were self odour (bedding from home cage) and fox 
odour (TMT). As previously, the main parameters assessed in each trial were the latency to 
reach the reward chamber and collect the reward from the start of each trial, the duration 
of time spent in each chamber, the distance moved, movement velocity, and the amount of 
rearing in each chamber. 
 
6.2.3 Data analysis and statistics 
For each of the different test odour sessions (control bedding, self and fox odours), 
mean values were determined by averaging each of the 3 probe trials together. The 
following parameters were analysed for each session: latency to enter the reward chamber 
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from the start of the trial, duration within the start, middle and reward chambers, distance 
moved in the start and middle chambers, the amount of rears in the start and middle 
chambers and the velocity of movement in the start, middle and reward chambers.  Data 
comparing the effect of predator odour on behaviour was analysed by ANOVA with 
repeated measures of ODOUR (self and fox) and CHAMBER (start or middle). Habituation 
data was analysed by ANOVA with a repeated measures of TIMEBIN (0-5, 6-10, 11-15, 16-20) 
and CHAMBER, acquisition data with repeated measures of TRIAL (1-5) and CHAMBER and 
habituation to the reward by ANOVA with factors of DAY (1-6) and solution (water, 10% 
condensed milk). Pearson’s correlations were used to assess relationships between key 
parameters from each of the different tests.  For repeated-measures analyses, Mauchly’s 
test of sphericity of the covariance matrix was applied. Huynh-Feldt corrections were 
applied as necessary, and adjusted degrees of freedom are provided. Data presented are 
mean ± SEM. All statistical analyses were carried out using SPSS version 18.0.  
 
 
6.3 Results 
 
 
6.3.1. Nespm/+ 
6.3.1.1 Milk preference testing and acquisition of PORT task 
 Before subjects could be assessed for risk-taking behaviour in the PORT task, they 
were first habituated to the 10% condensed milk reward solution. Habituation to the 
condensed milk reinforcer showed that all mice had a significant preference for the 
condensed milk reward solution over water, reaching >60% preference by the end of the 
habituation test (Fig 6.1a; main effect of SESSION F4,136=28.02, p<0.001, main effect of 
GENOTYPE F1,34=1.10, p=0.30), consuming an average 1.2 ml of solution in the final session. 
Subjects were then habituated to the test apparatus in a single 20 minute session. During 
the 20 minute habituation session, all mice readily explored the 3-chamber apparatus, 
making more entries into the middle chamber (Fig 6.1c; main effect of CHAMBER, F2,68=5.46, 
p<0.01) as might be expected, as the mice traversed the apparatus, which was also reflected 
by an increase in the amount of time spent in this chamber (Fig 6.1b; main effect of 
CHAMBER, F2,68=640.83, p<0.001). Following the habituation stage, subjects underwent 
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training to acquire the basic procedure of exiting the start chamber, traversing the middle 
chamber, and collecting the reward in the furthermost chamber. During acquisition of the 
PORT task procedure, the mice were trained, across 5 trials, to traverse the apparatus from 
the start chamber to collect 100 μl of 10% condensed milk in the reward chamber, 
traversing the middle chamber which contained clean standard (control) bedding. All 
subjects spontaneously exhibited this behaviour, and readily collected the reward in a 
relatively quick time, whereby both Nespm/+ and WT mice showed an average latency of 
under 60 seconds on the first trial. The time taken to collect the reward subsequently 
increased with trial number in all mice (Fig 6.1d; main effect of SESSION, F4,136=17.45, 
p<0.001: main effect of GENOTYPE, F1,34=0.88, p=0.36), a pattern of behaviour which was 
also seen in the F2[C57BL/6J*CBA/Ca] mice during the development of the PORT task 
(Chapter 6, Figure 6.2). 
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 WT N=17 
 Nespm/+ N=19 
 
Figure 6.1 Reward habituation and acquisition of the PORT task procedure by Nespm/+ mice.  During 
habituation to the reward, all mice showed an increasing preference for the 10% condensed milk reward over 
water (a). During the 20 min habituation session to the 3-chamber apparatus all mice readily explored the 
different chambers of the PORT task apparatus, spending most time in the middle compartment (b), but 
entering each compartment a number of times (c).  During acquisition, the mice were trained to cross the 
PORT task apparatus to collect the reward, passing through the middle chamber which now had clean bedding 
material on the floor.  All the mice traversed the chambers quite rapidly (d).  Data shows mean±SEM.  
**P<0.01 , ***P<0.005. 
 
6.3.1.2 Behaviour in PORT task 
Following acquisition, subjects were assessed for risk-taking behaviour by mixing the 
bedding material in the middle chamber of the PORT task apparatus with either their own 
odour, or fox (TMT) odour. Control sessions were also carried out, with clean untainted 
bedding. Mice were given 3 training trials with control bedding in the central chamber in the 
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morning and then 3 test trials with bedding mixed with a control (own bedding) or fox odour 
in the afternoon. For ease of viewing the 3 trials of each test session have been collapsed to 
yield single values.   
In the presence of a predator odour all mice were more reluctant to collect the food 
reward relative to control (own) odour as evidenced by the overall latencies to collect the 
reward (Fig. 6.2a; main effect of ODOUR, F1,34=31.66, p<0.001). In the presence of 
unthreatening odour (i.e. own or clean odour) mice would readily cross the central chamber 
in order to collect the reward. Under predator odour conditions Nespm/+ mice appeared to 
take longer than WT controls to collect the reward, however this finding did not reach 
significance (Fig. 6.2a; main effect of GENOTYPE, F1,34=0.59, p=0.49). A breakdown of the 
overall duration indicated that the presence of fox odour significantly increased the time 
spent in the start chamber (Fig. 6.2b; main effect of ODOUR, F1,34=15.72, p<0.001, main 
effect of GENOTYPE, F1,34=0.81, p=0.36) but not the time spent in the middle chamber (Fig. 
6.2c; main effect of ODOUR, F1,34=3.89, p=0.06,  main effect of GENOTYPE, F1,34=0.04, 
p=0.85) across all subjects. 
The Latency to collect the reward in the port task did not correlate with the 
condensed milk preference (on final day of testing) during either fox odour (r36=-0.03, n.s. 
data not shown) or self odour (r36=0.17, n.s. data not shown) trials. This provided evidence 
that the behaviour shown in the PORT task was not driven by decreased preference for the 
reward alone.   
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 WT N=17 
 Nespm/+ N=19 
 
Figure 6.2 Effects of different predator odours on risk-taking behaviour in Nesp
m/+ 
mice. Mice were assessed 
for the time taken to cross the PORT task apparatus in the presence of different odour/bedding material 
combinations, including their own given bedding.  Mice were given 3 control trials and 3 test trials in each 
session, for ease of viewing, the 3 trials in each phase have been collapsed to yield single values.  Overall, mice 
were slower to collect the reward in the presence of a predator odour (a). Increased latencies to collect the 
reward were as a result of increased emergence times from the start chamber (b), and not increased time 
spent in the middle chamber (c).  Data shows mean±SEM. ***P<0.005.                                                                                                                    
 
6.3.2 Grb10+/p 
6.3.2.1 Milk preference testing and acquisition of PORT task 
As with the Nespm/+ cohort habituation to the condensed milk reinforcer showed 
that all mice had a significant preference for the condensed milk reward solution over 
water, reaching >60% preference by the end of the habituation test (Fig 6.3a; main effect of 
SESSION, F4,92=24.71, p<0.001, main effect of GENOTYPE, F1,23=0.01, p=0.91), consuming an 
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average 1.0 ml of solution in the final session. During the 20 minute habituation session, 
mice readily explored the 3-chamber apparatus, making more entries into the middle 
chamber (Fig 6.3c; main effect of CHAMBER, F2,46=132.88, p<0.001), as might be expected as 
the mice traversed the apparatus, which was also reflected by an increase in the amount of 
time spent in this chamber (Fig 6.3b; main effect of CHAMBER, F2,46=929.67, p<0.001).  
During acquisition of the PORT task procedure, the mice were trained, across 5 trials, to 
traverse the apparatus from the start chamber to collect 100 μl of 10% condensed milk in 
the reward chamber, traversing the middle chamber which contained clean standard 
(control) bedding. The time taken to collect the reward increased with trial number (Fig 
6.3d; main effect of SESSION, F4,64=22.99, p<0.001) cohorts. Both Grb10
+/p and WT mice 
showed similar times to collect the reward (Fig 6.2d; main effect of GENOTYPE, F1,16=0.39, 
p=0.54). 
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 WT N=14 
 Grb10+/p N=11 
 
Figure 6.3 Reward habituation and acquisition of the PORT task procedure by Grb10
+/p
 mice.  During 
habituation to the reward, all mice showed an increasing preference for the 10% condensed milk reward over 
water (a). During the 20 min habituation session to the 3-chamber apparatus all mice readily explored the 
different chambers of the PORT task apparatus, spending most time in the middle chamber (b), but entering 
each chamber a number of times (c).  During acquisition, the mice were trained to cross the PORT task 
apparatus to collect the reward, passing through the middle chamber which now had clean bedding material 
on the floor.  All the mice traversed the chambers quite rapidly (d). Data shows mean±SEM.                 
***P<0.005. 
 
6.3.2.2 Behaviour in PORT task 
Generally the Grb10 cohort (both Grb10+/p and WT mice) were slower to collect the 
reward in the PORT task than the Nesp cohort, but showed an analogous pattern of 
behaviour. Whereby in the presence of a predator odour, all mice were more reluctant to 
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collect the food reward relative to control (own) odour as evidenced by the overall latencies 
to collect the reward (Fig. 6.4a; main effect of ODOUR, F1,23=21.66, p<0.001). In the 
presence of unthreatening odour (i.e. own or clean odour) mice would readily cross the 
central chamber in order to collect the reward. Under predator odour conditions Grb10+/p 
mice appeared to be quicker to collect the reward than WT controls, however this finding 
also did not reach significance (Fig. 6.4a; main effect of GENOTYPE, F1,23=3.05, p=0.09).  
A breakdown of the overall duration to collect the reward revealed that the 
presence of fox odour significantly increased the time spent in the start chamber (Fig. 6.4b; 
main effect of ODOUR, F1,23=15.60, p<0.005, main effect of GENOTYPE, F1,23=1.87, p=0.19), 
as well as the time spent in the middle chamber (Fig. 6.4c; main effect of ODOUR, F1,23=6.48, 
p<0.05, main effect of GENOTYPE, F1,23=0.40, p=0.54) across all subjects. Furthermore the 
latency to collect the reward in the port task did not correlate with the condensed milk 
preference (on final day of testing) during either fox odour (r25=0.62, n.s. data not shown) or 
self odour (r25=-0.03, n.s. data not shown) conditions. This provided evidence that the 
behaviour shown in the PORT task was not driven by increased preference for the reward 
alone.   
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 WT N=14 
 Grb10+/p N=11 
 
 
Figure 6.4 Effects of different predator odours on risk-taking behaviour in Grb10
+/p
 mice. Mice were assessed 
for the time taken to cross the PORT task apparatus in the presence of different odour/bedding material 
combinations, including their own given bedding. Mice were given 3 control trials and 3 test trials in each 
session, for ease of viewing, the 3 trials in each phase have been collapsed to yield single values.  Overall, mice 
were slower to collect the reward in the presence of a predator odour (a). Increased latencies to collect the 
reward were mainly as a result of increased emergence times from the start chamber (b), as well as increased 
time in the middle chamber (c). Data shows mean±SEM.  
*P<0.05, ***P<0.005. 
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6.4 Discussion 
 
 
 The principal aim of this chapter was to assess the effect the imprinted genes Nesp 
and Grb10 have on risk-taking behaviour; using a novel predator odour risk-taking task 
(PORT), which provides a more ethologically valid method than established tests of risk-
taking (Dent et al., 2013). Two lines of genetically modified mice, Nespm/+ and Grb10+/p along 
with their respective littermate controls, were assessed using the PORT task. In the presence 
of a predator odour, both cohorts systematically increased the time taken to cross the 
central chamber and collect the food reinforcement, demonstrating an attenuation of risk-
taking behaviour in the presence of fox odour compared to control conditions. However, no 
significant differences in risk-taking behaviour were seen between Nespm/+ and their WT 
littermate controls, and Grb10+/p and their WT littermate controls. 
     The data collected here provided evidence for the successful application of a novel 
risk-taking task, whereby the previous effects found in cohort of F2[C57BL/6J*CBA/Ca] mice 
(Chapter 5) have been replicated in two further mouse lines. Both lines of mice showed a 
similar progression through the task, showing equivalent amounts of time spent in each 
chamber during habituation (Fig. 6.1b and 6.2b) and the same pattern of behaviour in terms 
of latency to collect the reward during the acquisition stage (Fig. 6.1d and 6.2d). During the 
task proper, the Nesp cohort demonstrated quicker overall levels to collect the reward, than 
the Grb10 cohort, across control and fox odours; this is likely to be due to the fact that the 
two lines are maintained on slightly different genetic backgrounds. Independent measures 
of motivation for the food reward were analysed, and correlated with subjects’ 
performance in the PORT task. Results indicated that both Nespm/+ and Grb10+/p subjects, 
and their respective WT subjects had equal motivation for the condensed milk and that 
preference for this reward was not correlated with the time taken to collect the reward in 
the PORT task when predator odour was present. Therefore the behaviour found in the 
PORT task was not a result of differing motivation for the food reinforcement.  
The data collected here provided evidence for the application of the PORT task to 
transgenic mouse models. Whereby subjects in two separate transgenic lines successfully 
learnt the task and exhibited altered behaviour under the threat of predator odour, 
Chapter 6 | Investigating risk-taking behaviour in Nesp
m/+
 and Grb10
+/p
 mice, using the Predator Odour Risk-
Taking (PORT) task 
 
 
 
Page | 136  
 
demonstrated by significant increases in the latency to collect the reward. The results of the 
PORT task revealed no significant differences between transgenic mice (Nespm/+ or Grb10
+/p) 
and their respective WT littermates, in risk-taking behaviour. Based on this finding, it can be 
concluded that these genes do not influence this aspect of risk-taking and that perhaps 
delay-discounting and the PORT task channel separate neurological systems that control 
these aspects of risk-taking behaviour.  
Whilst the results of the PORT task did not yield any significant differences between 
Nespm/+ or Grb10
+/p and their respective WT controls, it is interesting to note that the 
direction of the trends in the PORT task were opposite for Nespm/+ and Grb10+/p mice, and in 
a direction that is consistent with previous results. The Nespm/+ mice showed more risk-
averse behaviour (slower to collect the reward), and Grb10+/p mice showed more risk-taking 
behaviour (quicker to collect the reward). The trends demonstrated in the genetically 
altered animals, mimic the effects found in previous experiments. It was previously 
demonstrated that Nespm/+ animals showed increased delay-discounting behaviour, whilst 
Grb10+/p showed decreased delay-discounting behaviour, in the delayed reinforcement task 
(outlined in Chapter 4).  The atypical behaviour in the delay-discounting task, as well as 
altered reactivity to novel environments in the LMA, OF and NPP tasks,  suggests that 
Nespm/+ mice could be interpreted as having increased risk aversion, whilst results from the 
delayed-reinforcement task suggest that Grb10+/p mice could be interpreted as having 
increased risk-taking behaviour. It would therefore be valuable to examine Nespm/+ or 
Grb10+/p mice in the PORT task with an increased number of subjects, in order to observe if 
increased power would yield a significant difference in risk-taking behaviour in this task. 
The use of the PORT task in conjunction with pharmacological manipulation may 
provide another way to elucidate if Nesp and Grb10 do have effects on risk-taking behaviour 
in this task. Expression of Nesp and Grb10 in the locus coeruleus and dorsal raphe nucleus 
(Plagge et al., 2005, Garfield et al., 2011) suggests that these genes may exert their 
influence on risk-taking behaviour via the noradrenergic and/or serotonergic system. 
Furthermore expression of Grb10 in the ventral tegmental area and substantia nigra pars 
compacta may also imply that this gene exerts influence on behaviour via the dopaminergic 
system (Garfield et al., 2011). Therefore by using drugs that target the monoaminergic 
systems, it may be possible to find a differential effect on behaviour in Nespm/+ and Grb10+/p 
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mice in the PORT task. However the nature of the PORT task means it is vulnerable to the 
effects of habituation as the potential threat of a predator attenuates over time, meaning 
that repeated measures experimental designs are not prohibitive (Dent et al., 2013). 
Therefore the PORT task is less amenable to drug studies which are useful for understanding 
the neurobiological underpinnings of risk-taking behaviour (Zeeb et al., 2009). However a 
drug study using a within-subjects experimental design could elucidate any potential 
differences Nesp and Grb10 may have on this aspect of risk-taking behaviour.  
The delay-discounting task is based in a highly controlled but ethologically artificial 
environment, whilst the PORT task is based in an ‘ethologically plausible semi-naturalistic 
environment’ (Choi and Kim, 2010). Therefore the additional contextual information 
provided in the PORT task, as well as the heightened involvement of affective processes (i.e. 
the increased emotion of the fear response to the predatory threat) may cause different 
neurological processes to control this behaviour. For example the Amygdala is the crucial 
brain structure for regulating emotion/fear (Blanchard and Blanchard, 1972), and plays a 
pivotal role in mediating risk-taking behaviour under fear conditions in environments such 
as that used in the PORT task (Choi and Kim, 2010). Therefore the risk-taking behaviour in 
the PORT task may be controlled by different neurological structures to risk-taking 
behaviour in operant chamber-based tasks. Consequently, another route to further 
understand the effect Nesp and Grb10 have on risk-taking behaviour would be to test 
Nespm/+ and Grb10
+/p mice on operant tasks of risk-taking, such as rodent analogues of the 
Iowa gambling task (Zeeb et al., 2009) and the balloon analogue risk-taking task (BART) 
(Jentsch et al., 2010). 
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6.4.1 Summary of key results from Chapter 6 
 The PORT task was successfully applied to two separate transgenic mouse lines, to 
examine risk-taking behaviour in Nespm/+ and Grb10+/p mice. 
 All subjects demonstrated a significant change in behaviour when exposed to 
predator (fox) odour compared to control conditions, whereby presence of fox 
odour increased the latency to collect the reward. 
 Nespm/+ and Grb10+/p mice showed no significant difference to WT controls in latency 
to collect the reward in the PORT task, suggesting that Nesp and Grb10 do not 
influence this aspect of risk-taking behaviour.  
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Chapter 7 – Histological investigation into Nesp and Grb10 
 
7.1 Introduction 
 
 
Previous work investigating a knockout mouse model of Nesp (Isles et al, 
unpublished results), and work from this thesis (Chapter 4) investigating a knockout mouse 
model of Grb10 has identified delay discounting as behaviour upon which both these genes 
may impact. Moreover, these oppositely expressed imprinted genes appear to act 
antagonistically on this behaviour with Nespm/+ mice being less tolerant, and Grb10+/p more 
tolerant, of increasing delays. On a biochemical level, this may suggest that their levels of 
expression could be inter-related and opposite. The current understanding of the 
biochemical functions of Nesp55 and Grb10 do not point to an obvious cellular interaction 
(Ischia et al., 1997, Garfield et al., 2011) therefore to address this, the levels of expression of 
Nesp and Grb10 in the knock-out models of the opposite gene were investigated to 
establish if the absence of expression of one of the genes significantly affected expression of 
the other, and vice versa. 
As outlined in the General Introduction, previous studies have demonstrated that 
these two genes show discrete patterns of expression in the mouse brain (Plagge et al., 
2005). Furthermore expression of Nesp and Grb10 appears to be highly overlapping in some 
specific hindbrain nuclei: Edinger-Westphal, dorsal raphe (DRN) and the locus coeruleus 
(LC), and in the hypothalamus (Figure 7.1), although investigations to date have not 
demonstrated if the expression of each gene are co-localised in the same cells. Analysis of 
tissue from adult Grb10+/p mice has revealed that Grb10 is co-localised with the key 
monoamine neurotransmitters (Garfield et al., 2011), specifically serotonin (5-HT) in the 
DRN, dopamine (DA) in the substantia nigra pars compacta (SNC), and also acetylcholine 
(ACh) in the caudate putamen (Figure 7.2), which as outlined in the General Introduction, 
may provide a link between Grb10 and the regulation of impulsivity and risk-taking 
behaviours.  Although the expression of Nesp within the rodent brain has been previously 
described with high levels of expression in the hypothalamus, pons, DRN and LC (Bauer et 
al., 1999, Plagge et al., 2005), it is not clear whether this gene is expressed in 5-HT or 
noradrenaline positive cells found in these regions. 
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Figure 7.1 Schematic of the expression of 
Nesp and paternal Grb10 in the mouse 
brain. Coronal sections (most anterior 
shown at the top, most posterior shown at 
the bottom) showing regions where both 
Nesp and paternal Grb10 are co-expressed 
are highlighted in purple, including the 
hypothalamus (HYP), Edinger–Westphal 
nucleus (EWn), dorsal raphe nucleus (DRN), 
and locus coeruleus (LC). Regions where 
paternal Grb10 is expressed only are 
highlighted in blue, specifically the ventral 
tegmental area (VTA) and substantia nigra 
pars compacta (SNC). These latter brain 
regions are recognised as ‘hotspots’ of 
imprinting in the brain. Figure taken from 
Dent and Isles, 2013. 
 
 
 
Figure 7.2 Histological sections of Grb10
+/p
 adult brain tissue showing co-localisation of Grb10 with 
monoamine neurotansmitters and acetylcholine. Immunofluorescence staining for β-gal, expressed from the 
Grb10 paternal allele, with markers specific for (a) dopaminergic neurons within the substantia nigra pars 
compacta, identified with the dopamine transporter (DAT), (b) serotonergic neurons within the dorsal raphe 
nucleus, identified with a marker for serotonin (5-HT), and (c) cholinergic inter-neurons within the caudate 
putamen, identified with the choline acetyltransferase (ChAT). Arrows indicate cells with co-localisation of 
staining of these markers and β-gal, used as the marker for Grb10. Figure taken from Garfield et al. 2011. 
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Therefore the aims of this series of experiments was, firstly, to investigate the 
reciprocity of gene expression in Grb10+/p and Nespm/+ mutant mice using qPCR; secondly, to 
expand upon the previous findings that Grb10 and Nesp are co-expressed in the same brain 
regions. Immunofluorescence was used to investigate if Nesp55 and Grb10 are expressed in 
the same cells of these areas; and finally, whether Nesp55 co-localises in 5-HT or 
noradrenergic neurones of the DRN and LC, respectively, consistent with the previous 
results found with Grb10 (Figure 7.2, Garfield et al., 2011). 
 
 
7.2 Methods 
 
 
7.2.1 qPCR analysis of expression 
 Brains were removed from adult Grb10+/p mutant mice, Nespm/+mutant mice and 
their respective wild-type (WT) littermates. Whole brains were hand-dissected to remove 
the hypothalamus and the midbrain. RNA was extracted and prepared according to the 
protocol previously described (Chapter 2, Section 2.5.2.2). cDNA samples were then made 
using Clontech® RNA to cDNA (Oligo dT) kit for PCR, according to the protocol in Chapter 2, 
Section 2.5.2.6. Real-time quantitative PCR (qPCR) was then carried out using optimised 
primers specific to Nesp and Grb10, to assess gene expression levels relative to a 
housekeeping gene (18S rRNA). All reactions were carried out in 72-well GeneDisk® in 
triplicates to minimize pipetting error, using a robotic liquid handling system (Corbett Life 
Science, CAS-1200); reactions were also carried out alongside NTC (Non-Template Control) 
samples containing no RNA. Samples were then run on the Rotor-GeneTM6000 qPCR 
machine (Corbett Life Science) according to the manufacturer’s specifications. 18S was used 
as the housekeeping gene to which expression data of Nesp and Grb10 were normalised to 
using the ΔΔCt method, as described in Chapter 2, Section 2.5.2.9. Acquired data were 
transformed (2-ΔΔCt) and statistically analysed using a two-tailed t-test. 
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7.2.2 Immunohistochemistry and Immunofluorescence  
 
7.2.2.1 Preparation of tissue 
 Grb10+/p mutant mice, plus their WT littermates, and Nespm/+ mutant mice and their 
WT littermates were perfused as outlined in Section 2.5.3.1. Whole brains were then 
dissected and sectioned into 40 μm coronal slices using a freezing microtome, according to 
the protocol outlined in Section 2.5.3.2. 
 
7.2.2.2 Antibodies 
The Grb10+/p mutant mouse strain is derived by insertion of a LacZ:neomycinr gene-
trap cassette within Grb10 exon 8 (as described in Garfield et al. 2011), therefore 
transmission of the Grb10KO allele separately through the paternal line generates 
heterozygous progeny in which the paternal Grb10 allele is disrupted by the β-geo cassette 
(Grb10+/p) . Therefore, the LacZ reporter gene is expressed in place of paternal Grb10. As a 
proxy for Grb10 a β-galactosidase (β-gal) specific antibody was used as previously (Garfield 
et al., 2011). The Nesp55 primary antibody (generated and obtained from Prof. R. Fischer-
Colbrie Lab, Innsbruck Medical University, Austria) is a rabbit anti-Nesp55 polycolonal 
antibody, recognizing the free terminal end (GAIPIRRH) of Nesp55. It has been successfully 
characterised and used previously (see Ischia et al. 1997) at a 1:1000 dilution. The batch 
acquired was obtained from a new bleed and therefore required characterising. For 
immunohistochemistry, a biotinylated secondary antibody (as part of the Vectastain® Elite 
ABC Kit) was used. All antibodies were optimised (with the exception of anti-Nesp55), using 
3 relevant dilutions of the antibodies (based on recommended dilution), in order to 
determine the optimal dilution. The antibodies used for immunofluorescence are detailed in 
Table 7.1.  
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Primary antibodies Secondary antibodies 
Antibody Dilution Antibody Dilution 
Rabbit polycolonal anti-Nesp55 
(R. Fisher-Colbrie) 
1:1000 Donkey anti-rabbit ALEXA 
FLUOR 568 (Life Technologies) 
1:1000 
Goat polycolonal anti-β-gal 
(Abcam) 
1:1000 Donkey anti-goat ALEXA FLUOR  
488 (Life Technologies) 
1:1000 
Goat polycolonal anti-Tyrosine 
Hydroxylase (Abcam) 
1:500 Donkey anti-goat ALEXA FLUOR 
488 (Life Technologies) 
1:1000 
Rat polycolonal anti-Serotonin 
(Abcam) 
1:500 Chicken anti-rat ALEXA FLUOR 
488 (Life Technologies) 
1:1000 
Table 7.1 Primary and secondary antibodies used for immunofluorescence analysis 
 
7.2.2.3 Immunohistochemistry 
For the Immunohistochemistry of brain sections from Nespm/+ and WT littermates a 
Vectastain® Elite ABC Kit (PK-6100) was used. Sections were first washed in TBS (4 x 10 
minutes). They were then incubated in a peroxidase block on a stirrer for 30 minutes (0.6% 
hydrogen peroxidase in TBS) to block endogenous peroxidase. Sections were washed in TBS 
again (3 x 10 minutes in TBS), and then incubated in TBST with 3% normal goat serum (NGS) 
(S-1000, vector labs) on a stirrer for 30 minutes at room temperature. Following NGS 
blocking, sections were incubated in primary antibody (anti-Nesp55) diluted at 1:1000 in 
TBST with 3% NGS. This was stirred for 10 minutes and then covered and stored overnight at 
4˚c. The following day the sections were washed 3 x 10 minutes in TBST with 3% NGS. 
Sections were then incubated for 1 hour in the secondary antibody diluted 1:200 in TBST 
with 3% NGS at room temperature. Following the secondary antibody incubation sections 
were washed 3 x 10 minutes in TBST, and then allowed to incubate in the ABC complex 
(made as per kit specifications) at room temperature, on a stirrer for 1 hour. Sections were 
then washed as before (3 x 10 minutes in TBST), then washed 2 x 10 minutes in 0.05 M Tris 
buffer. Sections were then incubated in DAB solution for 35 seconds at room temperature; 
they were then immediately washed in cold PBS in order to stop the reaction. Finally 
sections were then washed in TBST for 2 minutes and left in a new change of TBST solution 
overnight. The following day sections were mounted on polysine coated slides, and allowed 
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to dry overnight. The mounted slides were then dehydrated through a process of incubation 
in a rising concentration of alcohol followed by xylene, then cover-slipped and sealed using 
DPX (Raymond Lamb DPX), and allowed to dry overnight. All experiments were carried out 
alongside negative controls. 
 
7.2.2.4 Immunofluorescence 
Dual-labelling immunofluorescence of Nesp55 with 5-HT/TH was carried out in WT 
free-floating sections alongside Nespm/+ sections as a control. Dual-labelling 
immunofluorescence analysis of Nesp55 co-localisation with Grb10 (β-gal) was carried out 
on Grb10+/psections, in order to stain for the Lac-Z reporter gene which is expressed in place 
of Grb10. Sections were washed three times for 10 min each in 0.1% PBS before being 
incubated for 15 minutes in 0.3 M glycine in 0.1% PBS at room temperature, to neutralise 
endogenous aldehyde groups. Sections were washed, as before, in 0.1% PBS and then 
incubated at room temperature for 1 hour in 10% blocking solution; 0.5% BSA (BB 
International, Cardiff, UK), 0.5% Triton X-100 (v/v, Sigma Aldrich) in 0.1% PBS. Sections were 
then transferred to a solution containing the relevant concentration of primary antibody 
diluted in a 1% blocking solution (dual labelling was achieved by incubation with both 
primary antibodies of interest); this was allowed to incubate overnight at 4°C whilst gently 
shaking. The next day sections were washed three times for 10 minutes in 0.1% PBS. The 
relevant fluorescent secondary antibodies (Alexa Fluor; Life technologies) were diluted 
1/1000 in 1% blocking solution, sections were incubated in this solution in the dark at room 
temperature for 2 hours, whilst gently shaking. Sections were then washed in 0.1% PBS as 
before (in the dark) and transferred to polysine coated slides and allowed to dry over-night 
in a dark dust-free environment. The mounted slides were then dehydrated through a 
process of incubation in a rising concentration of alcohol, followed by xylene, then cover-
slipped and sealed using DPX (Raymond Lamb DPX), and allowed to dry over-night. To 
control for non-specific binding of the secondary antibodies, secondary-only negative 
controls were carried out alongside all experiments. 
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7.2.2.5 Image analysis 
Immunohistochemistry slides were viewed and images captured using an upright 
light microscope (Leica DMRB). Immunofluorescence slides were viewed and images 
captured using an upright fluorescence microscope (Leica DM5000 B). Dual-labelled 
immunofluorescence images were acquired through separate channels for different 
wavelengths (488 and 568 nm) then subsequently merged using ImageJ 
(Image>colour>merge channels). 
 
7.3 Results 
 
 
7.3.1 qPCR analysis of reciprocal expression of Nesp and Grb10 
 
7.3.1.1 Nesp expression in Grb10+/p and WT littermate brain 
 qPCR was used to quantify the expression levels in the midbrain and hypothalamus 
of Nesp in Grb10+/p and WT mice. The melting profiles of 18S and Nesp are shown in Figure 
7.3; each reaction was carried out in triplicate therefore values were obtained by collapsing 
across the triplicates to yield an average value for each sample. The results indicate that 
there were no differences in the amount of Nesp expression in either the midbrain (Figure 
7.4a; t13=-0.99, p=0.35) or hypothalamus (Figure 7.4b; t13=1.26, p=0.34) between Grb10
+/p 
and WT mice.  
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Figure 7.3 Melt curves for housekeeping gene 18S and gene of interest Nesp in Grb10+/p and WT littermate 
brain. Graphs show the melt curve proﬁles and melting temperatures for 18S (a) and Nesp (b) in the midbrain 
and hypothalamus of Grb10+/p (N=9) and WT mice (N=7).  Each sample was run in triplicate. 
 
 
 
Figure 7.4 Analysis of Nesp expression in the midbrain and hypothalamus of Grb10+/p and WT littermate 
mice. Expression of Nesp55 was analysed by qPCR and calculated relative to expression of the housekeeping 
gene 18S. Results show that there were no significant differences in expression of Nesp55 in either the 
midbrain (a) or hypothalamus (b) of WT (N=7) and Grb10+/ p (N=9) mice. 
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7.3.1.2 Grb10 expression in Nespm/+and WT littermate brain 
 qPCR was used to quantify the expression levels of Grb10 in Nespm/+and WT 
littermate mice, in the midbrain and hypothalamus. The melting profiles of 18S and Grb10 
are shown in Figure 7.5, and as before, all reactions were carried out in triplicate and final 
values were obtained by collapsing across the triplicates to yield an average value for each 
sample. The results indicate that there was no significant differences in the amount of 
Grb10 expression in either the midbrain (Figure 7.6a; t8=-0.01, p=0.99) or hypothalamus 
(Figure 7.6b; t9=-2.23, p=0.05) between Nesp
m/+and WT mice.   
 
 
 
Figure 7.5 Melt curves for the housekeeping gene 18S and gene of interest Grb10 in Nesp
m/+
 and WT 
littermate brain. Graphs show the melt curve proﬁles and melting temperatures for 18S and Grb10 in the 
midbrain and hypothalamus of Nespm/+ (N=7) and WT mice (N=5).  Each sample was run in triplicate. 
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Figure 7.6 Analysis of Grb10 expression in the midbrain and hypothalamus of Nesp
m/+
and WT littermate 
mice. Expression of Grb10 was analysed by qPCR and calculated relative to expression of the housekeeping 
gene 18S. Results show that the expression of Grb10 was not significantly different in either the midbrain (a) or 
hypothalamus (b) of Nespm/+ (N=7) and WT (N=5) mice. 
 
 
7.3.2 Immunohistochemistry for Nesp55 
Initial characterisation of the Nesp55 primary antibody was required as it was a new 
bleed of antibody (obtained from Prof. R. Fischer-Colbrie, Innsbruck Medical University, 
Austria) that had not yet been characterised (unlike the β-gal antibody which was available 
commercially). Initial validation was carried out by completing immunohistochemistry 
staining on brain sections from WT, Nespm/+ and Nesp+/p adult mice (Figure 7.7). Staining 
revealed that the Nesp antibody successfully targeted the Nesp55 protein, showing cell 
specific staining in samples from both WT and Nesp+/p mice (whereby maternal Nesp55 is 
present in the brain) in the hypothalamus, pons and midbrain regions, consistent with the 
discrete regions previously described (Plagge et al., 2005); and demonstrating an absence of 
staining in the brain tissue from Nespm/+ (whereby maternal Nesp55 is absent). 
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Figure 7.7 Immunohistochemistry staining for Nesp in coronal sections of the adult mouse brain. As 
expected, the presence of discrete expression of Nesp was observed in the hypothalamus in both WT (a) and 
Nesp+/p(b) mice, but not Nespm/+mice (c). Further examination of WT tissue showed distinct staining in 
different nuclei of the hypothalamus (d), specifically the dorsomedial hypothalamic nucleus (DM), arcuate 
hypothalamic nucleus (Arc), and the lateral hypothalamus (LH), and in the midbrain (e), the Edinger-Westphal 
nucleus (EWn) and in the pons (f), specifically the locus coeruleus (LC).  
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7.3.3 Immunofluorescence for expression of Nesp55 and Grb10  
 
7.3.3.1 Initial characterisation of specific antibodies to be used 
Characterisation of antibodies was carried out to ensure the specificity of the 
fluorescent staining. Control staining was carried out on Nespm/+ (where Nesp55 is not 
present in the brain) and a WT sibling, under the same experimental conditions. The Nesp55 
antibody showed discrete staining in areas consistent with previous research in WT mouse 
brain (Plagge et al., 2005), and no discrete staining in Nespm/+tissue (Figure 7.8). 
Furthermore antibodies for 5-HT and TH showed discrete staining in regions previously 
shown (Kolmac and Mitrofanis, 1999, Heisler et al., 2007), and no staining in negative 
controls (Figure 7.9a-b and d-e). Finally the β-gal antibody successfully targeted the reporter 
gene LacZ in Grb10+/p brain tissue, showing discrete staining in expected regions (Garfield et 
al., 2011) and no presence in WT brain tissue (Figure 7.9c and f). 
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Figure 7.8 Control immunofluorescence staining of Nesp55 in coronal sections of adult Nespm/+ and WT mice. As 
previous research (Plagge, et al. 2005) has shown theNesp55 is mainly expressed in regions of the mid- and 
hindbrain, only brain sections from these regions were assessed (at level bregma= -0.82mm).In tissue from a 
Nespm/+ mouse, where Nesp55 is not present in the brain, there were no positive cells labelled with the antibody 
specific to Nesp55, (a-c).  However, in WT brains, staining of Nesp55 was consistent with previous research (Plagge 
et al., 2005), showing discrete areas of dense reaction in the lateral hypothalamus (LH), Edinger-Westphal nucleus 
(EWn), and locus coeruleus (LC). 
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Figure 7.9 Control immunofluorescence staining of 5-HT, TH and β-gal in coronal sections of adult Grb10+/p mice. 
As previous research (Garfield et al., 2011) has shown the Grb10 is mainly expressed in regions of the mid- and 
hindbrain, only brain sections from these regions were assessed (at level bregma= -1.28mm).  In the absence of 
primary antibodies, used as a control, there were no significant signs of reactivity for 5-HT (a), TH (b) and β-gal (c) in 
brain sections from Grb10+/p mice, as expected.  However, in the presence of the primary antibodies, reactivity was 
observed for 5-HT in the hypothalamus (HYP) (d), TH in the zona Incerta (ZI) (e) and β-gal in the ventral tegmental 
area (VTA) (f). 
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7.3.3.2 Co-localisation of Nesp55 with Grb10 in Grb10+/p brain 
To assess if Nesp55 is co-localised with Grb10, dual-labelled immunofluorescence 
was carried out in sections from Grb10+/p animals, where the reporter gene LacZ is 
expressed in place of Grb10.Therefore LacZ can be targeted using an antibody for β-gal, as a 
proxy for Grb10. Sections were therefore dual-labelled with antibodies to Nesp55 and β-gal, 
imaged at separate fluorescent wavelengths and finally the images merged (Figure 7.10).  
Inspection of the merged images revealed evidence for the co-localisation of Nesp55 and β-
gal (Grb10) in the same cells in the LC, HYP and DRN. 
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Figure 7.10 Dual-labelling immunofluorescence histochemistry of Nesp55 and Grb10 in coronal sections of an adult WT 
Grb10+/p mouse. Sections were dual-labelled with antibodies against Nesp55 and β-gal, where the reporter gene LacZ is 
expressed in place of Grb10 in tissue from Grb10
+/p
 mice, and can be used to identify Grb10-positive cells, images were 
viewed at different light intensities (568nm and 488nm for Nesp55 and b-gal, respectively), and were then merged to gauge 
cellular co-localisation of the two target proteins, depicted by white arrows in the merged figures. A number of cells showed 
evidence for co-localisation: within the locus coeruleus (LC) (a-c), the hypothalamus (HYP) (d-f) and the dorsal raphe nuclei 
(DRN) (g-i). LC and HYP images at x40 magnification, DRN at x20. 
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7.3.3.3 Co-localisation of Nesp55 with 5-HT and TH in WT brain 
To assess if Nesp55 is co-localised with 5-HT and/or TH in cells of the mid- and 
hindbrain, dual-labelled immunofluorescence was carried out in sections from 
unmanipulated WT animals. Sections were therefore dual-labelled with antibodies to 
Nesp55 and 5-HT (Figure 7.11) or TH (Figure 7.12), imaged at separate fluorescent 
wavelengths and finally the pairs of images merged. Inspection of the merged images 
revealed evidence for the co-localisation of Nesp55 and 5-HT in the same cells, of the LC 
(Figure 7.11a-c), HYP (Figure 7.11d-f), but not in the EWn (Figure 7.11g-i). Dual-staining of 
Nesp55 and TH, showed no evidence for co-localisation of these two proteins in any of the 
regions investigated including the periaqueductal grey (PAG)(Figure 7.12a-c), HYP (Figure 
7.12d-f) and the EWn (Figure 7.12g-i).  
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Figure 7.11 Dual-labelling immunofluorescence histochemistry of Nesp55 with 5-HT in coronal sections of an 
adult WT mouse. Sections were dual-labelled with antibodies against Nesp55 and 5-HT, images were viewed at 
different light intensities (568nm and 488nm for Nesp55 and 5-HT, respectively), and were then merged to gauge 
cellular co-localisation of the two target proteins, depicted by white arrows in the merged figures. A number of 
cells showed evidence for co-localisation: within the locus coeruleus (LC) (a-c), and the hypothalamus (HYP) (d-f), 
but not the edinger westphal nucleus (EWN) (g-i). LC and HYP images at x40 magnification, EWn at x20. 
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Figure 7.12 Dual-labelling immunofluorescence histochemistry of Nesp55 with TH in coronal sections of an 
adult WT mouse. Sections were dual-labelled with antibodies against Nesp55 and 5-HT, images were viewed at 
different light intensities (568nm and 488nm for Nesp55 and TH, respectively), and were then merged to 
gauge cellular co-localisation of the two target proteins. There was no evidence for co-localisation: within 
periaqueductal grey (PAG) (a-c), the hypothalamus (HYP) (d-f), or the edinger westphal nucleus (EWN) (g-i). All 
images were at x40 magnification. 
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7.4 Discussion 
 
 
 In order to begin to understand the neural roles of Nesp and Grb10, the expression 
profiles of these genes in the brain were examined. Real time-PCR (qPCR) analysis was used 
to examine the amount of expression of Nesp in the Grb10+/p mouse brain, as well as the 
converse of this, Grb10 expression in Nespm/+ mouse brain. The results showed that the 
level of expression of Nesp is unaltered in Grb10+/p mice compared to WT mice, in both the 
hypothalamus and midbrain regions. Similarly the expression of Grb10 was not significantly 
altered in the brain of Nespm/+ mice, in these regions also. Therefore, these data suggest 
that lack of either Nesp or Grb10 does not affect expression (i.e. down- or up-regulation) of 
the other gene (i.e. Grb10 and Nesp, respectively) in the brain regions analysed. However 
protein-protein interaction assays could be utilised to examine if Nesp55 and Grb10 are 
interacting biochemically or function separately. 
Although it is known that Nesp and Grb10 are expressed in the same brain regions 
(see Figure 7.1) (Plagge et al., 2005, Garfield et al., 2011), it is not known if Nesp55 and 
Grb10 are present in the same cells within these areas. Previous research examining the 
expression of Nesp in the brain showed that Nesp mRNA is not expressed widely in all 
neurons of the rat brain, nor is its distribution restricted to a single transmitter system or 
cell population (Bauer et al., 1999). Therefore, it is thought that Nesp55 may have functional 
significance for several neurotransmitter systems (Plagge et al., 2005). The main sites of 
Nesp expression are the noradrenergic and serotonergic systems. These are systems in 
which Grb10 and Nesp have overlapping expression (Plagge et al., 2005, Garfield et al., 
2011). Grb10 has previously been shown to be co-localised with serotonergic, cholinergic 
and dopaminergic neurons (Garfield et al., 2011), suggesting that Grb10 may too be 
important in the intracellular pathways of neurotransmitters that are involved in impulsivity 
and risk-taking behaviour; however it was unknown if Nesp55 co-localises with serotonergic 
or noradrenergic markers. In order to address these questions, dual-labelling 
immunofluorescence was carried out to discover if Nesp55 is expressed in the same cells as 
Grb10, and additionally if Nesp55 is co-localised with the neurotransmitter 5-HT and 
Tyrosine Hydroxylase (TH) a rate limiting enzyme for catecholamine synthesis. 
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In answering the first point, dual-labelled immunofluorescence staining was 
achieved using a previously characterised antibody for Nesp55 (Bauer et al., 1999, Plagge et 
al., 2005), and an antibody for β-gal as a substitute for Grb10 expression; importantly this 
has been validated in previous experiments (Garfield et al., 2011), and is therefore 
considered a valid proxy. Dual-labelled immunofluorescence revealed that Nesp55 and 
Grb10 were detectable in many of the same neurons of the different brain regions analysed 
(Figure 7.10); specifically showing co-localised expression in the LC, HYP, and DRN. The 
expression of these two proteins was not completely overlapping, whereby Nesp55 
appeared to be expressed in parts of the cell where Grb10 was not expressed. However 
both Nesp55 and Grb10 appeared to be predominantly perinuclear in their expression, 
Nesp55 was particularly abundant in the perinuclear region, which is typical for this protein 
(Bauer et al., 1999). The discovery that these two imprinted genes are not completely 
segregated in the brain, and appear to be in the same cells has important implications for 
the behavioural effects that have been found in Grb10+/p and Nespm/+ mice, both previously 
and presented in the current thesis. Specifically the finding that Grb10 and Nesp55 appear 
to oppositely affect measures of risk-taking/impulsive behaviour, such as novelty 
exploration and social dominance, as well as delay discounting behaviour (Chapter 4), and 
additionally are co-expressed in some cells would suggest that the Grb10 and Nesp55 
proteins could influence these behaviours via the same neural systems, such as the 
noradrenergic or serotonergic systems. However future work using more in-depth molecular 
analysis would be required to confirm this hypothesis. Although this histological analysis 
provides evidence that Nesp55 and Grb10 may be influencing the same behaviours via the 
same neural systems, Grb10 is also expressed in other parts of the brain (Garfield et al., 
2011). For example the expression of Grb10 in the SNC gives rise to the possibility that it 
may influence impulsive behaviour via a completely different system to Nesp55, namely the 
dopaminergic system. Finally, the dense presence of Nesp55 and Grb10 in the 
hypothalamus opens the possibility of these two genes influencing numerous other 
behaviours, including functions such as the stress response, feeding behaviour and sexual 
function (Bauer et al., 1999). 
The dual-labelled immunofluorescence staining also revealed that Nesp55 was 
detectable in serotonergic neurons; showing distinct punctate areas of co-localisation 
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(yellow) within parts, but not all, of the cell body. The 5-HT antibody gave a widespread 
staining throughout the cells in the LC and HYP, which was similar in appearance to the 
distribution of the Nesp55 protein. Merged images indicated significant but not total co-
localisation of 5-HT and Nesp55. Specifically Nesp55 distribution was perinuclear, and 
confined to the stoma of the cell; whilst 5-HT was expressed in both the stoma and the 
processes of the cell (Figure 7.11e). Furthermore Nesp55 appeared to be present in many 
more cells in the hypothalamus than 5-HT, showing that 5-HT and Nesp55 overlap was not 
exclusive. No such co-localisation was found in the EWn, whereby there was distinct staining 
of Nesp55, as previously found (Plagge et al., 2005), but no presence of 5-HT, as was 
expected. The staining of Nesp55 in the EWn (Figure 7.11g) shows the presence of this 
protein in the processes of the cell, indicating vestibular transport of Nesp55 to this site. 
These data imply that although Nesp55 is expressed in some serotonergic neurones, the 
expression is not universal or exclusive to this neurotransmitter system. Nevertheless, these 
data provide further evidence for the suggestion that Nesp55 exerts an influence on 
impulsive/risk-taking behaviour via the serotonergic system. 
Previous research has shown that the expression of Nesp overlaps nearly completely 
with brain regions of the noradrenergic, adrenergic and serotonergic systems (Bauer et al., 
1999). However the immunofluorescence results presented here showed that Nesp55 was 
not in the same cells as TH, showing distinct expression in separate cells that did not overlap 
in the PAG, HYP or EWn. TH is a marker for dopamine, noradrenaline, and adrenaline 
containing (catecholamine) neurons and endocrine cells (Weihe et al., 2006). It is therefore 
somewhat surprising that Nesp does not appear to be expressed in neurons of this kind. It 
would be of interest to assess co-localisation of Nesp55 and NA specifically, in order to 
establish if Nesp55 is present in noradrenergic neurons, despite not being present in TH 
containing neurons. 
 The data presented here provide important preliminary findings, which contribute to 
current understanding of the molecular functioning, and interactions of Nesp55 and Grb10 
in the brain. It would therefore be of interest to analyse Nesp55 and Grb10 protein levels, 
instead of mRNA, in order to better understand if they are altered in the KO mouse of the 
opposite gene. The immunofluorescence data presented here provides support for the idea 
of co-localisation of Grb10 and Nesp55, as well as Nesp55 and 5-HT; however the limited 
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resolution capabilities of the fluorescence microscopy techniques mean that they should be 
treated cautiously. Verification with more advanced microscopy techniques such as confocal 
microscopy or super resolution microscopy, are necessary to confirm these data. If these 
proteins are confirmed to be in the same cells, it would be of interest to carry out a 
proximity-ligation assay (PLA), which allows the fluorescent visualisation of protein 
proximity in situ (Weibrecht et al., 2010). This technique is highly selective and therefore 
would accurately confirm if Nesp55 is localised in the same cells as 5-HT and Grb10, and 
whether it is in close enough proximity to suggest an interaction. Protein-protein interaction 
could then be further investigated by co-immunoprecipitation or western blotting. 
However, despite these caveats, based on the preliminary data here it can be concluded 
that Nesp is expressed neuronally, and may be contributing to the same neural circuitry as 
5-HT. Furthermore the finding that Nesp55 and Grb10 appear to be in the same cells 
provides the first piece of evidence that these imprinted genes could influence adult 
behaviour via the same neural systems. Moreover the co-localisation with 5-HT and lack of 
co-localisation with TH, points toward this influence being via the serotonergic system.  
 
 
7.4.1 Summary of key results from Chapter 7 
 qPCR data revealed no difference in amount of expression of Nesp and Grb10 in 
Grb10+/p and Nespm/+ mice, respectively, compared to WT littermates.  
 Dual-labelled immunofluorescence revealed that Nesp55 appeared to be co-localised 
in the same cells as Grb10. 
 Dual-labelled immunofluorescence revealed that Nesp55 appeared to be expressed 
in serotonergic cells, but not in the same cells as tyrosine hydroxylase. 
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Chapter 8 – General Discussion 
 
8.1 Overview 
 
The overall aim of this thesis was to compare mice null for brain expression of 
Nesp55 and Grb10 to test whether these two oppositely imprinted genes influence the 
same behaviours, specifically impulsivity/ risk-taking. The rationale for this was that these 
genes show overlapping expression in discrete brain regions related to these behaviours and 
therefore may be influencing the same functions, similar to the actions of other co-
expressed imprinted genes in other physiological systems (Constancia et al., 2004). This 
hypothesis was given further credence by findings presented in Chapter 7, which suggests 
that in some cells within those overlapping brain regions, Nesp55 and Grb10 are also co-
expressed (discussed further below). 
The behaviours assessed in Nespm/+ and Grb10+/p mice were chosen on the basis of 
the expression patterns of Nesp and Grb10 in the brain and, particularly on the basis of 
previous behavioural analyses. Behaviourally, it has been shown previously that Nespm/+ 
animals demonstrate a reluctance to explore novel environments (Plagge et al. 2005), 
whereas Grb10+/p mice exhibit a number of phenotypes that suggest a role for this gene in 
mediating social dominance (Garfield et al., 2011). Although these behaviours seem 
unrelated, it has been proposed that they can both be viewed as indicative of altered risk-
taking and/or impulsivity generally (Isles et al., 2006, Davies et al., 2008). However, further 
and more explicit tests were required to ascertain if and how Nesp55 and Grb10 may 
influence these functions. Nevertheless, investigation into this aspect of behaviour is 
particularly interesting due to its recognition as a clinical symptom of various psychiatric 
disorders, including schizophrenia, attention deficit hyperactivity disorder (ADHD) and 
obsessive compulsive disorder (OCD). This paired with the fact that some imprinted genes 
have already been associated with the incidence of neuropsychiatric illness (McNamara and 
Isles, 2013), leads to important possibilities about Nesp55 and Grb10 having a potential role 
in human behavioural disorders.   
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The specific experimental aims of this thesis were to: 
 Assess Grb10+/p in the behavioural assays previously found to be altered in Nespm/+ 
mice, including the locomotor activity, novelty place preference and delayed 
reinforcement tasks.  
 Develop a novel, more ethobiologically relevant test of risk-taking behaviour, the 
predator odour risk taking (PORT) task, and use this task to examine if risk-taking is 
altered in Nespm/+ and Grb10+/p mice.  
 Analyse the expression profiles of Nesp and Grb10, including examining if they are 
co-localised within the same cells, whether loss of expression of one gene has 
consequences for the expression of the other; and finally, if Nesp is co-localised with 
neurotransmitters central to the control of impulsivity/risk-taking behaviour.   
 
8.2 Main findings 
 
A summary of the results of the behavioural assays can be found in Table 8.1. Briefly, 
previous experiments assessing the effect Nesp has on behaviour, found that Nespm/+ mice 
had an increased locomotor activity on the first day of 3 day LMA testing. Furthermore 
Nespm/+ mice made an significantly increased number of entries into, but spent less time in, 
a novel environment in the novelty place preference (NPP) task, behaviours which were not 
driven by altered anxiety (Plagge et al., 2005). Taken together this showed that Nespm/+ mice 
had increased excitement towards, but are less willing to explore, a novel environment. This 
pattern of behaviour has been suggested to be indicative of altered risk-taking (Plagge et al. 
2005., Isles et al. 2006). In the same experiments, presented in this thesis, Grb10+/p mice 
showed no difference to WT littermates in behaviour, completing an equivalent amount of 
activity in the LMA, and making a similar number of entries into, and spending a similar 
amount of time in, the novel environment of the NPP task (Chapter 3). This suggests that 
Grb10 does not influence novelty exploration, in the way that Nesp has been shown to.   
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Task Nespm/+ Grb10+/p 
Locomotor Activity task Altered*  Unaltered 
Novelty Place Preference task Altered*  Unaltered 
Delayed Reinforcement task Altered*  Altered  
Progressive Ratio task Unaltered** Unaltered 
Predator Odour Risk-taking task Unaltered Unaltered 
 
Table 8.1 Summary of behavioural findings of Nesp
m/+ 
and Grb10
+/p
 mice from previous and current research. 
Results from the behavioural assays carried out in the two transgenic lines of mice indicate that both Nespm/+ 
and Grb10
+/p
 mice have altered behaviour in the delay-discounting task.  
* Represents previous research, all other results represent those presented in this thesis, except **which 
represents data not presented in this thesis. 
 
Previous research also assessed behaviour in a delay-discounting task, and found 
that Nespm/+ mice were significantly quicker to discount the large delayed reward in favour 
of the small immediate reward relative to their WT littermates (Isles et al., unpublished 
data). As presented in the current thesis, Grb10+/p mice showed the opposite behaviour in 
the same task of delay-discounting behaviour; whereby Grb10+/p mice were significantly 
more willing to wait for the large reward relative to WT littermates (Chapter 4). 
Furthermore the opposite behaviour of Nespm/+ and Grb10+/p mice in the delay-discounting 
task was not due to an effect of motivation. This was demonstrated by results from the 
progressive ratio task (PRT), which indicated that mice lacking Grb10 expression showed 
equivalent levels of motivation to work (nose poke) for a reward. Although not presented in 
the current thesis, Nespm/+ mice were also assessed in the PR task, and also demonstrated 
an equivalent level of motivation to work for the reward. Thus, Nesp and Grb10 appear to 
have opposing effects on delay-discounting behaviour specifically. 
In order to further understand the specific behaviours that Nesp and Grb10 affect, it 
was of interest to examine Nespm/+ and Grb10+/p mice in a further explicit test of risk-taking 
behaviour with greater ethobiological relevance. I successfully developed a novel risk-taking 
task, the Predator Odour risk-taking (PORT) task (Dent et al., 2013), which examined the 
propensity to traverse a chamber to retrieve a reward whilst under the potential threat of a 
predator (Chapter 5). The PORT task adds to the growing number of tasks which approach 
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risk-taking from a ‘real-world’ perspective, and uses an ethobiologically relevant 
environment with high levels of control (Olsson et al., 2003, Choi and Kim, 2010, Franks et 
al., 2012). This task was first validated in WT mice of the same background strain as Nespm/+ 
and Grb10+/p mice (Chapter 5). Using this task it was demonstrated that mice will readily 
traverse a central chamber containing their own odour to collect a reward; however when 
the odour of a predator is present, all mice systematically changed their behaviour and 
became more reluctant to traverse the central chamber to collect the reward. Therefore, 
the latency with which they collected the reward gauged the level of risk-taking. In this task 
it was demonstrated that both Nespm/+ and Grb10+/p mice showed behaviour indicative of 
normal levels of risk-taking (Chapter 6), specifically showing equivalent latencies to collect 
the reward to their own WT littermates.  
Finally, in an attempt to understand the neurological correlates of the behaviour 
presented in this thesis, an investigation into expression patterns of Nesp and Grb10 was 
carried out (Chapter 7), to extend the previous literature (Plagge et al., 2005, Garfield et al., 
2011). First, qPCR was used to investigate if knock-down of each gene affected expression of 
the other.  Results showed that there were no differences in the amount of Nesp55 
expression in either the midbrain or hypothalamus of Grb10+/p and WT mice, or Grb10 
expression in the same brain regions of Nespm/+ and WT littermate mice.  Therefore, altering 
the expression of each gene did not affect the expression of the other. Dual-labelled 
immunofluorescence histochemistry was used to identify if Nesp55 and Grb10 are 
expressed in the same cells in regions of the brain in which they have overlapping 
expression, such as the locus coeruleus (LC), hypothalamus (HYP) and dorsal raphe nucleus 
(DRN). The results provided evidence for a high-level of co-localisation between Nesp55 and 
Grb10 in each of these areas. This interesting result may be indicative of an interaction 
between these two proteins, and thus may underlie the mechanism for antagonistic 
behaviour found in the Nespm/+ and Grb10+/p mice. Moreover, both Grb10, in previous 
research (Garfield et al., 2011), and Nesp55 in the current research, were found to be 
present in serotonergic neurons. Serotonin is one of the major neurotransmitters that 
regulate impulsivity and risk-taking behaviour (Winstanley et al., 2003, Dalley and Roiser, 
2012). Current research showed that Nesp55 was not found to be co-localised in the same 
cells as tyrosine hydroxylase (TH), which is a marker for dopamine, noradrenaline and 
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adrenaline containing cells. Therefore based on the expression analysis data presented in 
the current thesis as well as previous research (Garfield et al., 2011) it could be suggested 
that it may be through the serotonergic system that Nesp55 and Grb10 act in order to 
influence delay-discounting behaviour.  However the involvement of the dopamine and 
noradrenaline systems has not been ruled out, and would be an important aspect for future 
investigation in order to determine the mechanisms through which Nesp55 and Grb10 
affect behaviour.    
 
8.3 Discussion of findings 
 
The functional role of genomic imprinting remains an interesting and largely 
unresolved phenomenon. Although our understanding of imprinted gene regulation and 
physiological relevance has developed considerably, the reason for the existence of this 
subset of genes remains conjecture until their function has been completely characterised 
throughout the body and the brain. Recent advances have suggested that there may be 
significantly more brain-expressed imprinted genes in the genome than first thought (Gregg 
et al., 2010); this coupled with their growing association with psychiatric illness (Ingason et 
al., 2011b, Rees et al., 2013) and important role in development leave intriguing possibilities 
about what exactly imprinted genes may do, and why they have evolved.  
The functions that have already been shown to be influenced by imprinted genes 
suggest they have important effects on a number of aspects of adult behaviour (Plagge et al. 
2005., Garfield et al., 2011). The aim of this thesis was to investigate the brain role of the 
imprinted genes Nesp and paternal Grb10, as these two genes provide an example of where 
neural and in utero growth functions dissociate. Moreover, these two oppositely imprinted 
genes show discrete but highly overlapping patterns of expression in the brain, reflecting 
the current suggested “hot-spots” of imprinting in the mouse brain, namely the HYP, 
Edinger-Westphal nucleus (EWn) and monoaminergic mid-brain regions including the LC, 
DRN and ventral tegmental area (VTA) (Gregg et al., 2010). Advances in targeted 
mutagenesis have provided an excellent opportunity to investigate these genes, and 
specifically how they might be controlling behaviour. Research employing the use of animal 
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models where particular imprinted genes can be targeted and deleted, have begun to 
uncover a fascinating role for imprinted genes in mediating adult behaviour (Isles and 
Wilkinson, 2000, Davies et al., 2008).  
Prior to this research no direct antagonistic effect on behaviour had been observed 
for any imprinted genes, although previous studies of Nesp and paternal Grb10 knock-out 
models raised some interesting possibilities (Plagge et al. 2005, Garfield et al. 2011). The 
suggested involvement of Nesp and Grb10 in the control of impulsive/ risk-taking behaviour, 
may be significant for clinical populations. Pathological levels of impulsivity and risk-taking is 
a significant symptom in serious mental illnesses, such as schizophrenia and bipolar (Reddy 
et al., 2014), as well as gambling and drug addiction (Verdejo-García et al., 2008). The 
previously identified behavioural phenotypes seen in both Nespm/+ and Grb10+/p mice could 
be seen under the umbrella of risk-related behaviour (Plagge et al. 2005., Garfield et al. 
2011). In a naturalistic environment, novelty exploration, as is altered in Nespm/+ mice, 
would be considered risky behaviour due to an innate fear of predation (Cryan and Holmes, 
2005, Choi and Kim, 2010). Similarly, social dominance behaviour, as is altered in Grb10+/p 
mice, may also be correlated with the propensity to take risks (Davis et al., 2009). Social 
dominance is achieved through a series of aggressive encounters, where access to food, 
water and reproductive partners are the incentive. Thus, social dominance is indicative of 
taking the risk of engaging in an aggressive encounter, where there is a possibility of harm 
or loss of status (Sapolsky, 2005). It has now been demonstrated that as well as this existing 
evidence, Nespm/+ and Grb10+/p mice have opposite delay discounting behaviour, whereby 
Nespm/+ mice have a significant preference for the small reward, whilst Grb10+/p mice have a 
significant preference for the large reward. 
Delay discounting has been predominantly used to measure choice impulsivity in 
humans (Reynolds, 2006) and laboratory animals (Winstanley et al., 2003). However there is 
evidence to suggest that delay discounting could also be interpreted as risk-taking 
behaviour in animals, due to the understanding that animals view temporally distant 
rewards as more risky (Hayden and Platt, 2007, Kalenscher, 2007). Based on this 
interpretation it could therefore be concluded that Nespm/+ mice are less risk-taking, due to 
preference for the ‘safe’ temporally immediate reward, and Grb10+/p mice are more risk-
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taking, due to preference for the ‘risky’ temporally distant reward. This interpretation 
agrees with previous findings that Nespm/+ mice were risk-averse in the NPP, LMA and open 
field tests of novelty exploration. Based on this interpretation it could be suggested that 
Nesp and Grb10 have antagonistic roles in mediating risk-taking behaviour. However in an 
explicit test of risk-taking behaviour, the PORT task, it was found that both Nespm/+ and 
Grb10+/p mice exhibited normal behaviour. The finding that neither Nespm/+ nor Grb10+/p 
mice differed from WT littermate mice in risk-taking behaviour in the PORT task, was 
somewhat surprising, due to the altered delay-discounting behaviour, as well as previous 
alterations in novelty exploration and social dominance (in Nespm/+ and Grb10+/p mice 
respectively). However the finding that there was no evidence from the PORT task to 
suggest altered risk-taking behaviour in Grb10+/p mice may also indicate that the altered 
delay-discounting phenotype measured here is not risk-taking behaviour, but is indeed 
altered impulsivity, and specifically impulsive choice. Involvement of these two genes in this 
facet of behaviour is not only interesting, but clinically relevant, as abnormalities in 
impulsive choice behaviour and specifically delay discounting behaviour are associated with 
psychiatric disorders such as pathological gambling and drug addiction (Petry, 2001, Alessi 
and Petry, 2003). 
In order to confirm that the effect found in delay discounting behaviour is specific to 
impulsive choice, the decisional aspect of impulsivity, it would be interesting to examine 
Nespm/+ and Grb10+/p mice in an assay of impulsive action, the motoric aspect of impulsivity. 
Since the completion of the experiments presented in this thesis, Nespm/+ and Grb10+/p mice 
have subsequently been examined in the stop-signal reaction time task (SSRTT) (Lewis and 
Dent, 2013 unpublished data). The SSRTT, a test of ‘impulsive action’ or ‘motor impulsivity’ 
(Winstanley et al., 2010) evaluates response inhibition through measuring the ability to stop 
or cancel a motor action that has already been initiated, in response to a ‘stop-signal’. This 
task has been used widely in the clinical setting and with rats, and has recently been 
successfully translated for use with mice (Humby et al., 2013). Deficits in the ability to stop 
or ‘inhibit’ a pre-potent response have been associated with pathological conditions such as 
ADHD (Rubia et al., 2007), are sensitive to dopaminergic, serotonergic and noradrenergic 
manipulations (Humby et al., 2013), and furthermore, have been shown to have a 
dissociation from impulsive choice (Eagle et al., 2008, Robinson et al., 2008). During the task 
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for mice, following an initial response, subjects learn to make a second (rapid) nose poke 
response when cued to do so by a ‘go’ signal, however on some trials a ‘no-go’ (stop) signal 
is presented after the presentation of a ‘go’ signal.  By varying the position of the stop-signal 
within the go response the ability to inhibit a response once it has already been initiated can 
be evaluated, where the main measure of impulsivity is considered at the point where the 
go and stop responses compete (50% correct stopping) (Winstanley et al., 2006). Using this 
task, it was demonstrated that Nespm/+ and Grb10+/p mice both successfully learnt the task, 
and showed no difference in the ability to withhold a pre-potent response, demonstrated by 
comparative stop-signal reaction times (calculated at ~50% correct stopping ) (Figure 8.1). 
Nespm/+ and Grb10+/p mice do not have altered response inhibition in this task, indicating 
that Nesp and Grb10 do not exert an influence on impulsive action. This suggests that the 
function of these two imprinted genes on impulsivity, is predominantly restricted to only 
impulsive choice behaviour.  
  
Figure 8.1 Nespm/+ and Grb10+/p mice performance in the stop-signal reaction time task (SSRTT). Equivalent 
SSRTs (calculated at 50% correct stopping position) were observed in both Nespm/+ (Figure 8.1a; one-way 
ANOVA, main effect of GENOTYPE, F1,28=0.12, P=0.74) and Grb10
+/p cohorts (Figure 8.1b; one-way ANOVA, 
main effect of DELAY, F1,21=0.07, P=0.79). Nesp cohort: WT N=12 Nesp
m/+ N=17, Grb10 cohort: WT N=13, 
Grb10+/p N=9. 
 
Nesp and Grb10 have been found to have overlapping expression in areas that have 
been shown to influence impulsive behaviours, such as the HYP, EWn, DRN, and LC (Plagge 
et al., 2005, Garfield et al., 2011). As such the underlying neural basis of the antagonistic 
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delay discounting behaviour found in Nespm/+ and Grb10+/p brain tissue was investigated and 
found that, like Grb10 (Garfield et al., 2011), Nesp55 was co-localised in the same cells as 
serotonin in both the HYP and the LC, however not in the EWn (Chapter 7). Furthermore, 
the Nesp55 and Grb10 proteins were also found to be co-localised within the same cells, in 
the HYP, LC and DRN, although qPCR investigation did not find evidence for altered 
expression of each gene in the absence of the other. The co-localisation evidence points 
towards the possibility that Nesp55 and Grb10 may exert their influence on the same or 
similar neurological pathways, and specifically via the serotonergic system. However, 
despite the significant overlap in expression, the additional expression of Grb10 in the 
ventral tegmental area (VTA) and substantia nigra pars compacta (SNC) also allows the 
possibility that Nesp55 and Grb10 could be influencing impulsive behaviour via entirely 
separate systems. For instance Grb10 may influence this behaviour via the dopaminergic 
system. 
Due to knocking out Nesp and Grb10 on two separate mouse lines a direct 
comparison cannot be drawn between the two groups of KO subjects; Nespm/+ and Grb10+/p 
subjects can only be compared to their respective WT littermates. However in future 
research it would be interesting to generate a double knock-out of both Nesp and Grb10 in a 
single mouse line, in order to assess the impact of this upon impulsive and risk-taking 
behaviours. This would allow an insight in to whether Nesp and Grb10 are interacting and 
the systems upon which they are acting. If an effect on behaviour was found in double KO 
subjects the direction of effect would determine whether the action of one gene is 
upstream of the other. Alternatively if the behaviour was the same as WT subjects, this 
would be indicative of Nesp and Grb10 acting in the same pathway but cancelling each 
other out, or acting on different pathways that influence the same function. For example 
this may confirm the premise that Nesp acts via the serotonergic system and Grb10 acts via 
the dopaminergic system.  
The concept that the oppositely imprinted genes (maternal) Nesp and (paternal) 
Grb10 have antagonistic effects on impulsive behaviour is not the first demonstration of this 
kind. In fact it adds to a growing number of examples of imprinted genes in plants and 
animals that seem to have antagonistic roles (Moore and Haig, 1991, Kinoshita et al., 2008). 
This concept is explained by the conflict (or kinship) theory of imprinted genes, which is 
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based on the premise that parental alleles act to promote their own interests, resulting in 
antagonistic action between maternal and paternal alleles (Haig, 2000). It is proposed that 
paternally expressed genes maximise the father’s reproductive success through promoting  
embryonic and early post-natal growth by extracting nutritional resources from mother. This 
theory is most prominent in the case of the paternally expressed imprinted gene Igf2 which 
promotes foetal growth, and the maternally expressed imprinted gene Igf2r which restricts 
foetal growth (Haig and Graham, 1991). The results presented in this thesis are in 
agreement with the conflict theory of imprinted genes (Haig, 2000); whereby Nesp and 
Grb10 which are oppositely imprinted genes show antagonistic effects on impulsive 
behaviour.  However further investigation into the molecular and network mechanisms of 
Nesp55 and Grb10 and their possible interactions is required to determine if the opposite 
behaviour found in the transgenic mice is a result of antagonism at a molecular level.  Whilst 
the behavioural effects of these two genes are in agreement with theories, and increasing 
evidence suggesting that oppositely imprinted genes can be in conflict when governing 
functions (Moore and Haig, 1991, Haig, 2000), what functions Nesp and Grb10 are in conflict 
about and the underlying mechanism of this relationship remains unclear. 
 
8.4 Future behavioural directions 
 
8.4.1 Previous behaviour 
In future research, in order to investigate the specificity of the influence on Nesp and 
Grb10 further, it would be of interest to test Nespm/+ and Grb10+/p on further tests of 
impulsive choice and risk-taking behaviours. The different findings from the battery of 
behavioural tests presented in this thesis may be reflective of the multi-faceted nature of 
decision-making behaviour. Human studies have found that performance in the Iowa 
gambling task and the Balloon Analogue Risk Task (BART) correlate with “real-world” risky 
behaviour in healthy controls and clinical populations such a drug-abusers, alcoholics and 
problem gamblers (Schonberg et al., 2011). This is supported by work with rats showing that 
individual behaviour in the operant Risky Decision Making (RDM) task correlates with 
performance in a probabilistic discounting task (Simon et al., 2009). In contrast this same 
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study found no correlation between behaviour in the RDM task and a delay discounting task 
(Simon et al., 2009). Therefore it would be of interest to test Nespm/+ and Grb10+/p mice in 
operant tests of risk-taking/ impulsive choice, such as rodent analogues of the probabilistic 
discounting task, Iowa gambling task, and the BART. With a possible hypothesis that Nespm/+ 
mice may exhibit decreased risk-taking behaviour, whilst Grb10+/p mice may exhibit 
increased risk-taking behaviour. It would also be interesting to correlate the behaviour 
measured in tasks such as these and behaviour in the PORT task; in order to better 
understand if the PORT task is taxing the same or separate risk-taking processes as existing 
tests of risk-taking. Furthermore this would determine if Nesp and Grb10 affect impulsive 
choice generally or specifically affect delay-discounting behaviour. Based on previous 
research (Simon et al., 2009) and the research presented here, it is hypothesized that 
behaviour in the PORT task would correlated with existing tests of risk-taking/impulsive 
choice behaviour, such as those mentioned above. 
The principle limitation of the PORT task is its vulnerability to habituation, whereby 
extended repeated exposure to a predator odour would allow subjects to learn that there is 
no actual threat; therefore the task is not amenable to repeated-measures experimental 
designs. This limited our ability to carry out pharmacological experimentation, however 
future use of the PORT task with much larger cohorts of mice would prohibit a within-
subjects design to further examine risk-taking behaviour in mice. Manipulations of 
dopamine and serotonin in animal studies have shown a profound effect on behaviour in 
risk-based decision making tasks (Zeeb et al., 2009). For instance, dopamine functioning in 
the brain, particularly D2-like receptors, are known to have profound effects on risk-taking 
behaviour (Norbury et al., 2013). Previous research with mice demonstrated that systemic 
activation of D2-like receptors attenuated risk-taking behaviour in the RDM task (Simon et 
al., 2011a). Therefore the use of dopamine agonists/antagonists may elucidate potential 
differences in the risk-taking behaviour of Nespm/+ and Grb10+/p mice. Evidence presented in 
this thesis that both Nesp55 and Grb10 are found in serotonergic neurons, suggests that the 
use of serotonin agonists/ antagonists may also be a valuable manipulation to elucidate 
potential effects of Nesp and Grb10 on this aspect of behaviour. The importance of 
serotonin in risk-sensitive decision making has been shown previously, whereby 
administration of 5-HT receptor agonist impaired the ability of rats to perform a rodent 
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gambling task (Zeeb et al., 2009), furthermore reducing brain serotonin synthesis in 
macaques decreased preference for the safe option in a gambling task (Long et al., 2009).   
 Pathological impulsivity is a clinical symptom of numerous psychiatric disorders such 
as schizophrenia, where cognitive and memory-related difficulties are also highly prevalent 
(Heerey et al., 2007). Moreover it is thought that deficits in cognition and memory 
contribute to the impulsive decision making process (Heerey et al., 2007). Based on this 
concept it may also be valuable to assess if Nesp and Grb10 contribute to cognitive and 
memory functions also, such as attention and learning. Although ability to learn tasks (such 
as DRT, PR, SSRTT) was highly comparable between WT and mutant subjects for both the 
Nespm/+ and Grb10+/p lines, it would be of interest to examine these functions in explicit 
tests of attention, learning and memory in Nespm/+ and Grb10+/p mice, such as 5-choice, 
reversal learning and set-shifting paradigms (Bissonette and Powell, 2012). This may 
elucidate a further system through which Nesp and Grb10 influence impulsive behaviour, 
and may even suggest that deficits in cognition and learning may be driving the impulsive 
phenotype found in Nespm/+ and Grb10+/p mice. 
 
8.4.2 Expression led behaviours   
The expression of Nesp and Grb10 in the hypothalamus (Plagge et al., 2005, Garfield 
et al., 2011), and indeed the discovery of these transcripts in the same hypothalamic cells 
(see Figure 7.10) suggests a role for Nesp and Grb10 in mediating behaviours beyond those 
examined here. This thesis has principally focused on decision-making behaviours, however 
it is known that the hypothalamus also regulates motivation and goal-directed behaviours, 
such as feeding, drinking, aggression and sexual-behaviours (Sternson, 2013). Therefore it 
would be of interest to examine Nespm/+ and Grb10+/p mice in assays that examine 
behaviours such as food/drink seeking and consumption behaviours, such as lick-cluster 
analysis, or high-fat diet consumption, in order to determine if Nesp and Grb10 affect 
feeding and appetite. Furthermore, assays such as the resident-intruder paradigm could be 
used to examine social aggression (Koolhaas et al., 2013). Moreover, the previous finding 
that Grb10 influences social dominance in the tube-test (Garfield et al., 2011) may suggest a 
hypothalamic influence on behaviour. Social dominance in animals is a sexual/aggressive 
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behaviour essential for species propagation, therefore it is likely to be mediated by the 
hypothalamus (Sternson, 2013) and neurotransmitter projections to the forebrain (Wang et 
al., 2012). Therefore it would be of interest to examine Nespm/+ mice in the tube test also, to 
asses if Nespm/+ mice show altered social dominance. Further assays of social dominance 
such as the partition test (Kudryavtseva, 1994) and urine marking (Drickamer, 2001) could 
also be used to corroborate the social dominance phenotype found previously in Grb10+/p 
mice (Garfield et al., 2011), and to determine if Nesp has any influence on this behaviour 
also. Based on the findings in this thesis it would be hypothesized that Nespm/+ mice would 
have reduced social dominance, due to the finding that Grb10+/p mice have increased social 
dominance (Garfield et al., 2011), and Nesp and Grb10 were found to have conflicting 
effects on delay discounting behaviour. This assessment would allow us to better 
understand through which neuroanatomical regions Nesp and Grb10 are exerting an 
influence.  
In addition to heightened social dominance in the tube test found in Grb10+/p mice, 
results of the tube test correlated with levels of ‘social barbering’, thought to be another 
measure of social dominance. Whereby the dominant mouse in a cage barbers the whiskers 
of cage-mates, known as the ‘Dalila effect’ (Sarna et al., 2000). However it has been argued 
that the social barbering observed in mice without expression of Grb10, is not indicative of 
social dominance/risk-taking, but is instead a type of pathological stereotypy, akin to the 
impulse control disorder Trichatillamania in humans (Garner et al., 2004). Social barbering 
could therefore be interpreted as impulsive behaviour and not risk-taking behaviour. Based 
on this hypothesis it could therefore be suggested that Grb10 exerts an influence on 
impulsive behaviour, evidenced by increased social barbering, a phenomenon that is not 
observed in Nespm/+ mice. This argument provides further evidence that the behavioural 
phenotype measured in Grb10+/p mice is that of impulsivity, not risk-taking behaviour. 
Furthermore expression of Grb10 in the VTA and SNC, areas where Nesp is not expressed, 
suggest that this behaviour may also occur via these areas, and specifically through the 
dopaminergic system.   
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8.5 Summary 
 
In summary, the data presented in this thesis show that Nesp and Grb10 both 
contribute to risk-taking and/or impulsive choice behaviour thus providing a novel mode of 
action for genomic imprinting in the brain. Results from expression analysis revealed the 
presence of Nesp and Grb10 in the same cells of the LC, HYP and DRN, suggesting that these 
two imprinted genes may be influencing this behaviour through the same or similar 
signalling pathways.  Previous evidence, as well as evidence presented in this thesis, point 
towards Nesp and Grb10 mediating risk-taking/impulsive choice via serotonergic and 
possibly noradrenergic cells, in regions in which they have over-lapping expression, such as 
the HYP, DRN and LC. The exact neural bases of imprinted gene action on delay discounting 
behaviour remain to be established. Nevertheless, this is the first evidence of an 
antagonistic action of maternally and paternally expressed imprinted genes on a brain 
function. Therefore this work indicates that paternal and maternal genomes can contribute 
differentially and perhaps antagonistically, not only on facets of impulsivity in the normal 
range, but also to pathological conditions such as gambling and drug addiction.  
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